| |
這些材料很重要,需要您立即關注。他們要求哥倫比亞護理公司的股東做出一個重要的決定。如果您對如何做出這樣的決定有疑問,請聯繫您的財務、法律或其他專業顧問。如果您對本文描述的交易或投票程序有任何疑問或需要更多信息,請聯繫公司在北美的代理徵集代理Morrow Sodali,電話:1-888-999-2785,或致電北美以外的對方付費電話:1-289-695-3075,或發送電子郵件至assistate@morrowsodali.com。
|
| |
|
•
Nicholas Vita
董事和首席執行官 |
| | | |
| | | | BY ORDER OF THE BOARD | |
| | | |
Nicholas Vita
董事和首席執行官 |
|
|
GENERAL MATTERS
|
| | | | 1 | | |
| SUMMARY | | | | | 13 | | |
|
致美國證券持有人的通知
|
| | | | 23 | | |
|
有關前瞻性信息的警示聲明
|
| | | | 26 | | |
|
一般代理信息
|
| | | | 27 | | |
|
Solicitation of Proxies
|
| | | | 27 | | |
|
Appointment of Proxies
|
| | | | 27 | | |
|
Revocation of Proxies
|
| | | | 27 | | |
|
哥倫比亞關懷中心的非註冊股東
|
| | | | 28 | | |
|
Voting of Proxies
|
| | | | 29 | | |
|
Voting at the Meeting
|
| | | | 29 | | |
|
如何出席和參與會議
|
| | | | 30 | | |
|
Quorum
|
| | | | 31 | | |
|
有投票權的證券和本金
HOLDERS THEREOF |
| | | | 31 | | |
|
THE ARRANGEMENT
|
| | | | 32 | | |
|
Purpose of the Arrangement
|
| | | | 32 | | |
|
安排的背景
|
| | | | 32 | | |
|
安排説明
|
| | | | 37 | | |
|
ATB Fairness Opinion
|
| | | | 38 | | |
|
CANACCORD GENINITY公平意見
|
| | | | 46 | | |
|
哥倫比亞關懷特別委員會的推薦
|
| | | | 51 | | |
|
哥倫比亞關懷委員會的推薦
|
| | | | 51 | | |
|
安排原因
|
| | | | 51 | | |
|
Arrangement Mechanics
|
| | | | 54 | | |
|
Downward Adjustment
|
| | | | 56 | | |
|
需要股東批准
|
| | | | 56 | | |
|
Voting Support Agreements
|
| | | | 56 | | |
|
Lock-up Agreements
|
| | | | 58 | | |
|
某些人在安排中的利益
|
| | | | 59 | | |
|
安排費用
|
| | | | 64 | | |
|
法院批准安排並完成安排
|
| | | | 64 | | |
|
安排協議
|
| | | | 64 | | |
|
陳述和保修
|
| | | | 65 | | |
|
Covenants
|
| | | | 65 | | |
|
完成安排的條件
|
| | | | 72 | | |
|
Notice and Cure
|
| | | | 74 | | |
|
關於非邀請權的其他公約
|
| | | | 75 | | |
|
收購建議通知
|
| | | | 76 | | |
|
迴應收購建議
|
| | | | 76 | | |
|
Right to Match
|
| | | | 77 | | |
|
Termination of Arrangement
Agreement |
| | | | 78 | | |
|
Termination Fee
|
| | | | 80 | | |
|
未經審計的備考簡明財務信息
|
| | | | 80 | | |
|
SECURITIES LAW MATTERS
|
| | | | 81 | | |
|
Canadian Securities Laws
|
| | | | 81 | | |
|
U.S. Securities Laws
|
| | | | 83 | | |
|
REGULATORY MATTERS
|
| | | | 86 | | |
|
U.S. Antitrust Matters
|
| | | | 86 | | |
|
Stock Exchange Matters
|
| | | | 86 | | |
|
Cannabis Licenses
|
| | | | 86 | | |
|
異議股東權利
|
| | | | 87 | | |
|
與安排有關的風險因素
|
| | | | 91 | | |
|
PROCEDURES FOR THE SURRENDER
OF SHARE CERTIFICATES AND PAYMENT OF CONSIDERATION |
| | | | 97 | | |
|
Letter of Transmittal
|
| | | | 97 | | |
|
Delivery of Consideration
|
| | | | 99 | | |
|
針對股東的某些加拿大聯邦所得税考慮因素
|
| | | | 100 | | |
|
針對股東的重要美國聯邦所得税考慮因素
|
| | | | 108 | | |
|
LEGAL MATTERS
|
| | | | 117 | | |
|
OTHER BUSINESS
|
| | | | 117 | | |
|
某些人在待採取行動的事項中的利益
|
| | | | 117 | | |
|
INDEBTEDNESS OF DIRECTORS AND
OFFICERS |
| | | | 117 | | |
|
知情人士在重大交易中的利益
|
| | | | 117 | | |
|
STATEMENT OF RIGHTS
|
| | | | 118 | | |
|
ADDITIONAL INFORMATION
|
| | | | 118 | | |
| APPROVAL | | | | | 119 | | |
|
CONSENT OF CANACCORD
GENUITY |
| | | | 120 | | |
|
ATB資本市場公司同意
|
| | | | 121 | | |
|
Appendix A
GLOSSARY OF TERMS
|
| | | | A-1 | | |
|
Appendix B
安排解決方案
|
| | | | B-1 | | |
|
Appendix C
PLAN OF ARRANGEMENT
|
| | | | C-1 | | |
|
Appendix D
INTERIM ORDER
|
| | | | D-1 | | |
|
Appendix E
請願聆訊通知書
|
| | | | E-1 | | |
|
Appendix F
SECTION 237 TO 247 OF THE BCBCA
|
| | | | F-1 | | |
|
Appendix G
ATB FAIRNESS OPINION
|
| | | | G-1 | | |
|
Appendix H
CANACCORD GENINITY公平意見
|
| | | | H-1 | | |
|
Appendix I
有關哥倫比亞關懷中心的其他信息
|
| | | | I-1 | | |
|
Appendix J
關於Cresco的信息
|
| | | | J-1 | | |
|
Appendix K
形式財務報表
|
| | | | K-1 | | |
| | | | | | | | | |
直接或間接實益擁有的哥倫比亞護理公司的證券,對其實施控制或指示(1)
|
| |||||||||||||||||||||||||||||||||||||||||||||
|
Name and
Position(s) / Relationship with Columbia Care |
| |
Number of
Columbia Care Common Shares Held(2) |
| |
Number of
Columbia Care PV Shares Held(3) |
| |
Percentage
of Voting Rights of Columbia Care Shares(4) |
| |
Number of
Columbia Care Options Held(5) |
| |
Number of
Columbia Care Warrants Held(6) |
| |
Number of
Columbia Care Convertible Notes Held(7) |
| |
Number of
Columbia Care RSUs Held(8) (%) |
| |
Number of
Columbia Care PSUs Held(9) (%) |
| |
Total Estimated
Value of Consideration to be Received from the Arrangement(10) |
| |||||||||||||||||||||||||||
|
Nicholas Vita,
Chief Executive Officer and Director |
| | | | 36,283,801 | | | | | | — | | | | | | 9.10% | | | | | | — | | | | | | — | | | | | | — | | | | | | 9.36% | | | | | | 29.55% | | | | | $ | 95,545,145.49 | | |
|
Michael Abbott,
董事執行主席兼執行主席 |
| | | | 481,550 | | | | | | — | | | | | | 0.12% | | | | | | — | | | | | | — | | | | | | — | | | | | | 7.32% | | | | | | 26.85% | | | | | $ | 11,186,526.94 | | |
|
Frank Savage,
Director |
| | | | 106,987 | | | | | | — | | | | | | 0.03% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.23% | | | | | | 0.00% | | | | | $ | 329,015.60 | | |
|
James A.C. Kennedy,
Director |
| | | | 98,618 | | | | | | 18,234.28 | | | | | | 0.48% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.04% | | | | | | 0.00% | | | | | $ | 4,431,522.38 | | |
|
Jonathan P. May,
Director |
| | | | 89,388 | | | | | | 29,467.67 | | | | | | 0.76% | | | | | | — | | | | | | 60,775 | | | | | | — | | | | | | 0.25% | | | | | | 0.00% | | | | | $ | 7,068,103.53 | | |
|
Jeff Clarke,
Director |
| | | | 453,039 | | | | | | 47.29 | | | | | | 0.11% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.23% | | | | | | 0.00% | | | | | $ | 1,135,204.72 | | |
|
Alison Worthington,
Director |
| | | | 43,257 | | | | | | — | | | | | | 0.01% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.23% | | | | | | 0.00% | | | | | $ | 182,546.91 | | |
|
Julie Hill,
Director |
| | | | — | | | | | | — | | | | | | 0.00% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.35% | | | | | | 0.00% | | | | | $ | 124,694.89 | | |
|
Philip Goldberg,
Director |
| | | | 7,760,627 | | | | | | — | | | | | | 1.95% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.55% | | | | | | 0.00% | | | | | $ | 18,035,117.08 | | |
|
David Hart,
首席運營官 |
| | | | 1,035,419 | | | | | | 746.92 | | | | | | 0.28% | | | | | | — | | | | | | — | | | | | | — | | | | | | 5.25% | | | | | | 9.48% | | | | | $ | 7,401,746.85 | | |
|
Lars Boesgaard,(11)
前首席財務官 軍官 |
| | | | 48,866 | | | | | | — | | | | | | 0.01% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.00% | | | | | | 0.00% | | | | | $ | 112,307.22 | | |
|
Dr. Rosemary Mazanet,
首席科學官 |
| | | | 1,286,858 | | | | | | 186.74 | | | | | | 0.33% | | | | | | — | | | | | | — | | | | | | — | | | | | | 2.31% | | | | | | 4.31% | | | | | $ | 5,412,559.21 | | |
|
Bryan Olson,
首席人員和管理人員 Officer |
| | | | 397,698 | | | | | | 248.97 | | | | | | 0.11% | | | | | | — | | | | | | — | | | | | | — | | | | | | 2.60% | | | | | | 4.51% | | | | | $ | 3,555,917.64 | | |
|
Guy Hussussian,
Chief Data Officer |
| | | | 131,070 | | | | | | 31.13 | | | | | | 0.03% | | | | | | — | | | | | | — | | | | | | — | | | | | | 1.23% | | | | | | 2.79% | | | | | $ | 1,835,245.51 | | |
|
Jesse Channon,
Chief Growth Officer |
| | | | 270,417 | | | | | | — | | | | | | 0.07% | | | | | | — | | | | | | — | | | | | | — | | | | | | 3.89% | | | | | | 4.97% | | | | | $ | 3,763,460.52 | | |
|
Derek Watson,
首席財務官 |
| | | | — | | | | | | — | | | | | | 0.00% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.00% | | | | | | 0.00% | | | | | $ | 731,736.00 | | |
|
David Sirolly,
Chief Legal Officer and General Counsel |
| | | | — | | | | | | — | | | | | | 0.00% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.46% | | | | | | 0.45% | | | | | $ | 1,002,549.94 | | |
| | | | BY ORDER OF THE BOARD | |
| | | |
•
Nicholas Vita |
|
| | | | 董事和首席執行官 | |
| | | |
(Signed) “Canaccord Genuity Corp.”
|
|
| | | |
CANACCORD GENUITY CORP.
|
|
| | | |
Toronto, Ontario
|
|
| | | |
•
|
|
| | | |
(Signed) “ATB Capital Markets Inc.”
|
|
| | | |
ATB CAPITAL MARKETS INC.
|
|
| | | |
Toronto, Ontario
|
|
| | | |
•
|
|
| | | | CRESCO LABS INC. | | |||
| | | | Per: | | |
Name:
Title: |
|
| | | | COLUMBIA CARE INC. | | |||
| | | | Per: | | |
Name:
Title: |
|
|
![]() |
| |
Canaccord Genuity Corp.
P.O. Box 516 161 Bay Street, Suite 3100 Toronto, ON M5J 2S1 Canada T: 416.869.7368 www.canaccurity.com |
|
Name of Company
|
| |
State of Organization
|
|
203 Organix, L.L.C.
|
| |
Arizona
|
|
Columbia Care – Arizona, Tempe, L.L.C. (90% owned)
|
| |
Arizona
|
|
Columbia Care – Arizona, Prescott, L.L.C.
|
| |
Arizona
|
|
健康健康診所,Inc.
|
| |
Arizona
|
|
Access Bryant SPC (49.9% owned)
|
| |
California
|
|
CA Care LLC
|
| |
California
|
|
CC CA Realty LLC
|
| |
California
|
|
CC California LLC
|
| |
California
|
|
哥倫比亞關愛安西尼塔斯公司
|
| |
California
|
|
哥倫比亞關愛國家城市公司
|
| |
California
|
|
Focused Health LLC
|
| |
California
|
|
Mission Bay, LLC
|
| |
California
|
|
PHC Facilities, Inc.
|
| |
California
|
|
資源推薦服務公司
|
| |
California
|
|
聖地亞哥康復中心
|
| |
California
|
|
Name of Company
|
| |
State of Organization
|
|
The Wellness Earth Energy Dispensary Inc.
|
| |
California
|
|
Beacon Holdings, LLC
|
| |
Colorado
|
|
Columbia Care Thornton LLC
|
| |
Colorado
|
|
Dellock Digital, LLC
|
| |
Colorado
|
|
未來展望智庫有限責任公司
|
| |
Colorado
|
|
Futurevision, Ltd.
|
| |
Colorado
|
|
High Rise Media, LLC
|
| |
Colorado
|
|
Infuzionz, LLC
|
| |
Colorado
|
|
Mj Brain Bank, LLC
|
| |
Colorado
|
|
落基山脈耕作有限責任公司
|
| |
Colorado
|
|
TGS Colorado Management,LLC
|
| |
Colorado
|
|
TGS Global, LLC
|
| |
Colorado
|
|
The Green Solution, LLC
|
| |
Colorado
|
|
The Launch Pad LLC
|
| |
Colorado
|
|
Columbia Care CT LLC
|
| |
Connecticut
|
|
14 Street Health, LLC
|
| |
Delaware
|
|
Avum, LLC
|
| |
Delaware
|
|
CC MergerSub, LLC
|
| |
Delaware
|
|
CC Procurement LLC
|
| |
Delaware
|
|
CC VA HoldCo LLC
|
| |
Delaware
|
|
Col. Care (Delaware) LLC
|
| |
Delaware
|
|
哥倫比亞關懷 - ,亞利桑那州,普雷斯科特,L.L.C.(擁有90%股權)
|
| |
Delaware
|
|
Columbia Care – Arizona, Tempe DE, L.L.C.
|
| |
Delaware
|
|
Columbia Care Co Inc.
|
| |
Delaware
|
|
Columbia Care DC LLC
|
| |
Delaware
|
|
哥倫比亞關愛DE管理公司(91%持股)
|
| |
Delaware
|
|
哥倫比亞關懷特拉華州有限責任公司
|
| |
Delaware
|
|
哥倫比亞關懷伊利諾伊州有限責任公司
|
| |
Delaware
|
|
哥倫比亞關懷國際控股有限公司
|
| |
Delaware
|
|
Columbia Care LLC
|
| |
Delaware
|
|
緬因州哥倫比亞護理控股公司
|
| |
Delaware
|
|
哥倫比亞關懷馬裏蘭州有限責任公司
|
| |
Delaware
|
|
哥倫比亞關懷夥伴有限責任公司
|
| |
Delaware
|
|
Columbia Care PR LLC
|
| |
Delaware
|
|
哥倫比亞關懷-亞利桑那州有限責任公司
|
| |
Delaware
|
|
Deacon Merger Sub LLC
|
| |
Delaware
|
|
地區社會公平夥伴公司
|
| |
Delaware
|
|
Equity Health Partners DE LLC
|
| |
Delaware
|
|
Green Leaf Medical, LLC
|
| |
Delaware
|
|
La Yerba Buena LLC
|
| |
Delaware
|
|
Oveom LLC
|
| |
Delaware
|
|
Tetra FinCo LLC
|
| |
Delaware
|
|
Tetra Holdings LLC
|
| |
Delaware
|
|
Tetra OpCo LLC
|
| |
Delaware
|
|
Name of Company
|
| |
State of Organization
|
|
Columbia Care CA LLC
|
| |
Delaware
|
|
CCF HoldCo, LLC
|
| |
Delaware
|
|
哥倫比亞關懷佛羅裏達有限責任公司
|
| |
Florida
|
|
治癒養生有限責任公司
|
| |
Illinois
|
|
Curative Health LLC
|
| |
Illinois
|
|
哥倫比亞關懷領養家庭公司
|
| |
Massachusetts
|
|
Patriot Care Corp
|
| |
Massachusetts
|
|
Columbia Care MD, LLC (96% owned)
|
| |
Maryland
|
|
Green Leaf Extracts, LLC
|
| |
Maryland
|
|
綠葉管理有限責任公司
|
| |
Maryland
|
|
Time For Healing, LLC
|
| |
Maryland
|
|
馬裏蘭健康學院有限責任公司(擁有99%的股份)
|
| |
Maryland
|
|
Columbia Care ME LLC
|
| |
Maine
|
|
哥倫比亞關愛密歇根有限責任公司
|
| |
Michigan
|
|
哥倫比亞關懷新澤西有限責任公司(92.5%的股份)
|
| |
New Jersey
|
|
哥倫比亞關懷新澤西州房地產有限責任公司
|
| |
New Jersey
|
|
Columbia Care NM LLC
|
| |
New Mexico
|
|
CC物流服務有限責任公司(70%持股)
|
| |
New York
|
|
哥倫比亞關懷工業大麻有限責任公司
|
| |
New York
|
|
Columbia Care NY LLC
|
| |
New York
|
|
Columbia Care NY Realty LLC
|
| |
New York
|
|
Columbia Care NY RO LLC
|
| |
New York
|
|
Cannascend Alternative Logan,L.L.C.
|
| |
Ohio
|
|
Cannascend Alternative,LLC
|
| |
Ohio
|
|
CC OH Realty LLC
|
| |
Ohio
|
|
Columbia Care OH LLC
|
| |
Ohio
|
|
Corsa Verde LLC
|
| |
Ohio
|
|
俄亥俄州第二綠葉醫療有限責任公司
|
| |
Ohio
|
|
Ohio III,LLC綠葉醫療公司(持有99.9%的股份)
|
| |
Ohio
|
|
俄亥俄州綠葉醫療有限公司(49%持股)
|
| |
Ohio
|
|
CC PA Realty LLC
|
| |
Pennsylvania
|
|
CCPA Industrial Hemp LLC
|
| |
Pennsylvania
|
|
哥倫比亞關懷賓夕法尼亞有限責任公司
|
| |
Pennsylvania
|
|
Green Leaf Medicals LLC
|
| |
Pennsylvania
|
|
哥倫比亞關愛波多黎各有限責任公司(49%持股)
|
| |
Puerto Rico
|
|
CCUT Pharmacy LLC (94.5% owned)
|
| |
Utah
|
|
Columbia Care UT LLC
|
| |
Utah
|
|
哥倫比亞關愛東弗吉尼亞有限責任公司(92.75%的股份)
|
| |
Virginia
|
|
弗吉尼亞綠葉醫療有限責任公司
|
| |
Virginia
|
|
VentureForth, LLC
|
| |
Washington D.C.
|
|
哥倫比亞護理WV工業大麻有限責任公司
|
| |
West Virginia
|
|
Columbia Care WV LLC (95% owned)
|
| |
West Virginia
|
|
Columbia Care UK Ltd
|
| |
United Kingdom
|
|
Period
|
| |
High
|
| |
Low
|
| |
Volume
|
| |||||||||
May 2022 (through • )
|
| | |
|
•
|
| | | |
|
•
|
| | | |
|
•
|
| |
April 2022
|
| | CAD$3.82 | | | CAD$2.60 | | | | | 4,905,358 | | | ||||||
March 2022
|
| | CAD$4.20 | | | CAD$3.10 | | | | | 9,350,744 | | | ||||||
February 2022
|
| | CAD$4.29 | | | CAD$3.41 | | | | | 5,131,673 | | | ||||||
January 2022
|
| | CAD$4.16 | | | CAD$3.23 | | | | | 3,408,249 | | | ||||||
December 2021
|
| | CAD$4.25 | | | CAD$3.46 | | | | | 4,850,856 | | | ||||||
November 2021
|
| | CAD$4.83 | | | CAD$3.54 | | | | | 12,165,438 | | |
Period
|
| |
High
|
| |
Low
|
| |
Volume
|
| |||||||||
May 2022 (through • )
|
| | |
|
•
|
| | | |
|
•
|
| | | |
|
•
|
| |
April 2022
|
| | CAD$3.82 | | | CAD$2.61 | | | | | 2,098,359 | | | ||||||
March 2022
|
| | CAD$4.20 | | | CAD$3.10 | | | | | 3,937,013 | | | ||||||
February 2022
|
| | CAD$4.28 | | | CAD$3.41 | | | | | 2,355,652 | | | ||||||
January 2022
|
| | CAD$4.18 | | | CAD$3.23 | | | | | 3,050,416 | | | ||||||
December 2021
|
| | CAD$4.24 | | | CAD$3.53 | | | | | 2,803,070 | | | ||||||
November 2021
|
| | CAD$4.83 | | | CAD$3.54 | | | | | 4,405,502 | | |
Date of Distribution
|
| |
Issuance Price per
Columbia Care Common Share |
| |
Number of
Columbia Care Common Shares Issued |
| |
Aggregate
Gross Proceeds |
| |||||||||
May 4, 2021
|
| | | $ | 6.34 | | | | | | 236,306 | | | | | $ | 1,498,180.04 | | |
May 18, 2021
|
| | | $ | 4.29 | | | | | | 178,619 | | | | | $ | 766,275.51 | | |
May 31, 2021
|
| | | $ | 7.49 | | | | | | 263,200 | | | | | $ | 1,971,368 | | |
June 11, 2021
|
| | | $ | 4.44 | | | | | | 42,993,938 | | | | | $ | 190,893,084.72 | | |
June 24, 2021
|
| | | $ | 4.15 | | | | | | 1,499,043 | | | | | $ | 6,221,028.45 | | |
July 7, 2021
|
| | | $ | 6.85 | | | | | | 949,379 | | | | | $ | 6,503,246.15 | | |
November 1, 2021
|
| | | $ | 5.75 | | | | | | 4,857,184 | | | | | $ | 27,928,808 | | |
December 13, 2021
|
| | | $ | 3.80 | | | | | | 4,162,413 | | | | | $ | 15,817,169.40 | | |
April 7, 2022
|
| | | $ | 3.04 | | | | | | 1,099,549 | | | | | $ | 3,342,628.96 | | |
April 25, 2022
|
| | | $ | 2.81 | | | | | | 18,755,082 | | | | | $ | 52,701,780.42 | | |
| Schedule 1 | | |
—
|
| |
為2021年6月30日召開的年度股東大會和特別大會編寫的Cresco管理信息通告,日期為2021年6月2日
|
|
| Schedule 2 | | |
—
|
| |
日期為2022年4月1日的重大變更報告,與Cresco與Columbia Care簽訂安排協議有關,根據該協議,Cresco將收購Columbia Care的所有已發行和流通股
|
|
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs Inc. | | |
British Columbia,
Canada |
| | Parent Company | | | | |
CannaRoyalty Corp.(原產地)
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Cali-AntiFragile Corp.
|
| | California | | | Holding Company | | |
100%
|
|
Alta Supply Inc. (Continuum)
|
| | California | | | Distribution | | |
100%
|
|
Kaya Management Inc.
|
| | California | | | Production | | |
100%
|
|
River Distributing Co., LLC
|
| | California | | | Distribution | | |
100%
|
|
FloraCal Farms
|
| | California | | | Cultivation | | |
100%
|
|
Cub City, LLC
|
| | California | | | Cultivation | | |
100%
|
|
CRHC Holdings Corp.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Laurel Harvest Labs, LLC
|
| | Pennsylvania | | |
栽培和藥房
Facility |
| |
100%
|
|
JDRC Mount Joy, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
JDRC Scranton, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bluma Wellness Inc.
|
| |
British Columbia,
Canada |
| | Holding Company | | |
100%
|
|
CannCure Investments Inc.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
大麻治癒投資有限責任公司
|
| | Florida | | | Holding Company | | |
100%
|
|
3 Boys Farm,LLC(佛羅裏達州一家工廠)
|
| | Florida | | |
種植、生產和
藥房設施 |
| |
100%
|
|
Farm to Fresh Holdings, LLC
|
| | Florida | | |
種植、生產和
藥房設施 |
| |
100%
|
|
Cresco U.S. Corp. | | | Illinois | | | Cresco Labs LLC經理 | | |
100%
|
|
MedMar Inc.
|
| | Illinois | | | Holding Company | | |
100%
|
|
MedMar Lakeview, LLC
|
| | Illinois | | | Dispensary | | |
88%
|
|
MedMar Rockford, LLC
|
| | Illinois | | | Dispensary | | |
75%
|
|
Gloucester Street Capital,LLC
|
| | New York | | | Holding Company | | |
100%
|
|
山谷農業有限責任公司
|
| | New York | | | Operating Entity | | |
100%
|
|
JDRC Ellenville, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
CMA Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BL Real Estate, LLC
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培育許可有限責任公司
|
| | Massachusetts | | |
種植、生產和
藥房設施 |
| |
100%
|
|
Cultivate Worcester, Inc
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Leicester, Inc
|
| | Massachusetts | | |
種植、生產和
藥房設施 |
| |
100%
|
|
培育Framingham,Inc.
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Burncoat, Inc
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培植公司
|
| | Massachusetts | | |
種植和生產實體
|
| |
100%
|
|
Good News Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Wonder Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
JDRC Seed, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
CP賓夕法尼亞控股有限責任公司
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bay, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Bay Asset Management, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Ridgeback, LLC
|
| | Colorado | | | Holding Company | | |
100%
|
|
Cresco Labs, LLC | | | Illinois | | | Operating Entity | | |
57%
|
|
Cresco Labs Notes Issuer,LLC
|
| | Illinois | | | Holding Company | | | | |
Cresco Labs Ohio, LLC
|
| | Ohio | | |
種植、生產和
藥房設施 |
| |
99%
|
|
Wellbeings, LLC
|
| | Delaware | | |
CBD Wellness Product
Development |
| |
100%
|
|
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs SLO, LLC
|
| | California | | | Holding Company | | |
100%
|
|
SLO Cultivation Inc.
|
| | California | | |
種植和生產
Facility |
| |
80%
|
|
Cresco Labs Joliet, LLC
|
| | Illinois | | |
種植和生產
Facility |
| |
100%
|
|
Cresco Labs Kankakee, LLC
|
| | Illinois | | |
種植和生產
Facility |
| |
100%
|
|
Cresco Labs Logan, LLC
|
| | Illinois | | |
種植和生產
Facility |
| |
100%
|
|
Cresco Labs PA, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Cresco Yeltrah, LLC
|
| | Pennsylvania | | |
種植、生產和
藥房設施 |
| |
100%
|
|
JDC Newark, LLC | | | Ohio | | | Holding Company | | |
100%
|
|
紐瓦克綠地創造有限責任公司
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Marion, LLC | | | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Marion,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Chillicothe, LLC | | | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Chillicothe,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Columbus, LLC | | | Ohio | | | Holding Company | | |
100%
|
|
Care Med Associates, LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
亞利桑那州Cresco Labs LLC | | | Arizona | | | Holding Company | | |
100%
|
|
亞利桑那州設施供應有限責任公司
|
| |
Arizona/Maryland
|
| |
種植、生產和
藥房設施 |
| |
100%
|
|
Cresco Labs Tinad, LLC | | | Illinois | | | Holding Company | | |
100%
|
|
PDI Medical III, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
克雷斯科實驗室鳳凰農場有限責任公司 | | | Illinois | | | Holding Company | | |
100%
|
|
伊利諾伊州鳳凰農場有限責任公司
|
| | Illinois | | | Dispensary | | |
100%
|
|
JDC Elmwood, LLC | | | Illinois | | | Holding Company | | |
100%
|
|
FloraMedex, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
Cresco Edibles, LLC | | | Illinois | | | Holding Company | | |
100%
|
|
TSC Cresco, LLC
|
| | Illinois | | | Licensing | | |
75%
|
|
Cresco HHH, LLC | | | Massachusetts | | |
種植、生產和
藥房設施 |
| |
100%
|
|
Cresco Labs Michigan,LLC(A) | | | Michigan | | |
種植和生產設施
|
| |
85%
|
|
State
|
| |
Current Cultivation
Space (sq ft)12 |
| |
Planned Cultivation
Space (sq ft)13 |
| |
Total
|
| |||||||||
Illinois
|
| | | | 202,000 | | | | | | — | | | | | | 202,000 | | |
Pennsylvania
|
| | | | 85,000 | | | | | | — | | | | | | 85,000 | | |
Ohio
|
| | | | 27,000 | | | | | | 27,000 | | | | | | 54,000 | | |
California
|
| | | | 165,000 | | | | | | 193,000 | | | | | | 358,000 | | |
Massachusetts
|
| | | | 97,000 | | | | | | — | | | | | | 97,000 | | |
Arizona
|
| | | | 91,000 | | | | | | — | | | | | | 91,000 | | |
New York
|
| | | | — | | | | | | 145,000 | | | | | | 145,000 | | |
Michigan
|
| | | | 53,000 | | | | | | — | | | | | | 53,000 | | |
Florida
|
| | | | 66,000 | | | | | | — | | | | | | 66,000 | | |
Total
|
| | | | 786,000 | | | | | | 365,000 | | | | | | 1,151,000 | | |
State
|
| |
Offering
|
|
伊利諾伊州(目前為製造商) | | |
大麻乾花、大麻霧化形式、膠囊中的大麻油、口服液和舌下液、大麻食用產品和其他大麻產品。產品線包括克雷斯科品牌的花卉、蒸汽筆和多種形式的提取物的重點產品;“High Supply®”產品,包括鮮花、蒸氣和濃縮物;“Good News®”產品,包括蒸氣和可食用產品;“Wonder Wellness Co.®”可食用產品;以及“RemediTM”產品,包括酊劑、膠囊和舌下油。Cresco授權“Kiva”品牌,生產注入大麻的可食用食品,包括但不限於巧克力糖果、口香糖、薄荷和餡餅。Cresco還通過與詹姆斯·比爾德獎獲得者明迪·西格爾合作,以“Mindy‘s TM”的品牌銷售注入大麻的可食用食品,包括但不限於:巧克力和太妃糖糖果、水果味口香糖、硬糖果和太妃糖。伊利諾伊州的零售點銷售各種各樣的這些品牌及其相應的產品。
|
|
賓夕法尼亞州(目前為製造商) | | |
大麻乾花、大麻的霧化形式、膠囊中的大麻油、口服和舌下溶液、外用產品中的大麻以及其他大麻產品。產品線包括“Cresco®”品牌下的花卉、蒸汽筆和多種形式的萃取物;“High Supply®”品牌下的鮮花和蒸氣筆以及“RemediTM”產品。
|
|
State
|
| |
Offering
|
|
| | |
包括精確劑量的不可燃產品,包括藥酒、膠囊、藥膏和舌下油。賓夕法尼亞州的零售點銷售各種各樣的這些品牌及其相應的產品。
|
|
俄亥俄州(目前為製造商) | | |
大麻乾花、大麻霧化形式、膠囊中的大麻油、口服液和舌下液、大麻可食用產品和其他大麻產品。產品線包括以鮮花、蒸氣筆和多種形式的萃取物為主的“Cresco®”品牌產品;“High Supply®”產品,包括花、蒸氣和提取物;“Good News®”產品,包括蒸氣和可食用產品;“Wonder Wellness Co.®”系列可食用產品;以及“RemediTM”產品,包括藥酒、膠囊和舌下油。Cresco還通過與詹姆斯·比爾德獎獲獎廚師明迪·西格爾合作,以“Mindy‘sTM”的品牌銷售注入大麻的可食用食品,包括但不限於水果轉發口香糖。
|
|
加州(目前為製造商) | | |
大麻乾花、大麻蒸發劑、膠囊中的大麻油、大麻食用產品和其他大麻產品。產品線包括花卉、VAPE筆以及“FLORACAL®”、“CRESCO®”、“High Supply®”和“Good News®”品牌下的多種萃取物。克雷斯科還以“Mindy‘s TM”和“Good News®”的品牌銷售注入大麻的可食用食品。所有品牌均由Cresco擁有的“Continuum”經銷業務經銷,在該經銷業務中,上述自有產品與合作品牌一起銷售給加利福尼亞州的特許零售藥房。
|
|
亞利桑那州(目前為製造商) | | |
大麻乾花、大麻蒸發劑、膠囊中的大麻油、大麻食用產品和其他大麻產品。產品線包括花卉、VAPE筆以及“Cresco®”和“High Supply®”品牌下的多種形式的提取物。所有品牌都出售給有執照的零售藥房,包括克雷斯科旗下的一家門店,名為“Sunnyside*®”。
|
|
馬薩諸塞州(目前為製造商) | | |
大麻乾花、大麻霧化形式、膠囊中的大麻油、口服和舌下溶液、外用產品中的大麻、大麻可食用產品和其他大麻產品。這些產品系列包括“Cresco®”品牌的花卉、蒸汽筆和多種形式的提取物;“High Supply®”品牌的鮮花和蒸氣筆;“RemediTM”產品,包括精確劑量的不可燃產品,包括酊劑、膠囊、藥膏和舌下油。Cresco大麻通過與詹姆斯·比爾德獎獲得者明迪·西格爾合作,以“Mindy‘s TM”的品牌注入可食用大麻。Cresco出售注入大麻的水果轉發口香糖。馬薩諸塞州的零售點銷售各種各樣的這些品牌及其相應的產品。
|
|
馬裏蘭州(目前為製造商) | | |
產品線包括Cresco Liquid Live Resin、Cresco Live Resin和Cresco一次性鋼筆。
|
|
紐約(目前在生產) | | |
大麻的霧化形式、膠囊中的大麻油、口服和舌下溶液、外用產品和其他大麻產品中的大麻。該產品線包括“RemediTM”產品,其中包括精確劑量的不可燃產品,包括藥酒和膠囊。Sunnyside*®在紐約的零售點銷售這些品牌和相應的產品。
|
|
佛羅裏達州(目前為製造商) | | |
大麻乾花、大麻霧化形式、大麻可食用產品以及舌下溶液和其他大麻產品中的大麻油。產品線包括花卉、電子煙筆和多種形式的萃取物;包括電子煙的“High Supply®”產品;包括電子煙的“Good News®”產品;以及包括香油、注射器在內的“RemediTM”產品
|
|
State
|
| |
Offering
|
|
| | |
和舌下油。Cresco授權“One Plants”品牌,生產花卉、蒸氣、濃縮液和舌下油。克雷斯科還生產“Sunnyside*®”品牌的大麻食品。
|
|
密歇根州(目前為製造商) | | |
大麻乾花、膠囊中的大麻油、口服液和舌下液、大麻食用產品和其他大麻產品。產品線包括電子煙筆中的重點產品和“Cresco®”品牌下的多種形式的提取物;“High Supply®”產品,包括鮮花、電子煙和提取物;“Good News®”產品,包括電子煙和可食用的“Wonder Wellness Co.®”系列食品;以及“RemediTM”產品,包括藥酒、膠囊和舌下油。Cresco還通過與詹姆斯·比爾德獎獲得者明迪·西格爾合作銷售注入大麻的可食性食品,品牌為“Mindy‘sTM”。Cresco銷售注入大麻的可食用食品,包括但不限於水果膠糖。
|
|
Description
|
| |
Stylized Design
|
| |
重新命名的風格化設計
(as applicable) |
|
“Cresco”的文本和風格化標誌
|
| |
![]() |
| |
![]() |
|
“Cresco Labs”的文本和風格化標識
|
| |
![]() |
| |
![]() |
|
“Cresco Sun”的風格化標誌
|
| | | | |
![]() |
|
“Remedi”的文本和風格化標誌
|
| |
![]() |
| |
![]() |
|
“Cresco Reserve”的文本和風格化標識
|
| |
![]() |
| |
![]() |
|
The stylized logo “r”
|
| |
![]() |
| | | |
Description
|
| |
Stylized Design
|
| |
重新命名的風格化設計
(as applicable) |
|
《明迪的廚房》的文字和風格化標識
|
| |
![]() |
| | | |
《明迪手工食品》的文字和風格化標識
|
| |
![]() |
| | | |
“Mindy‘s Chef Lead手工食品”的文字和風格化標識
|
| |
![]() |
| | | |
The text and stylized logo for “CY+”
|
| |
![]() |
| | | |
“Sunnyside*”的文本和風格化標誌
|
| |
![]() |
| | | |
The stylized logo for “ * “
|
| |
![]() |
| | | |
《Wonder Wellness Co.》的文字和風格化標識。和《Wonder Wellness》
|
| |
![]() |
| | | |
“好消息”的文字和樣式徽標
|
| |
![]() |
| | | |
“高供應量”的文字和風格化標誌
|
| |
![]() |
| | | |
“Alta Supply”的文本和風格化標識
|
| |
![]() |
| | | |
“Continuum”的文本和樣式徽標
|
| |
![]() |
| | | |
“Continuum”的風格化標識
|
| |
![]() |
| | | |
“FloraCal Farm”和“FloraCal”的文本和樣式徽標
|
| |
![]() |
| | | |
“FloraCal”的風格化標誌
|
| |
![]() |
| | | |
Description
|
| |
Stylized Design
|
| |
重新命名的風格化設計
(as applicable) |
|
“FloraCal Farm”和“FloraCal”的文本和樣式徽標
|
| |
![]() |
| | | |
《起源之家》的文字和風格化標識
|
| |
![]() |
| | | |
Jurisdiction
|
| |
No. Registration
已提交申請 |
| |
No. Registration
Awarded as of May 24, 2022 |
| |
Earliest
Renewal Year |
| |||||||||
美國專利商標局(1)
|
| | | | 49 | | | | | | 28 | | | | | | 2021 | | |
Arizona
|
| | | | 6 | | | | | | 6 | | | | | | 2029 | | |
California(1) | | | | | 19 | | | | | | 17 | | | | | | 2024 | | |
Florida(1) | | | | | 5 | | | | | | 5 | | | | | | 2026 | | |
Illinois
|
| | | | 45 | | | | | | 45 | | | | | | 2024 | | |
Maryland(1) | | | | | 4 | | | | | | 4 | | | | | | 2029 | | |
Massachusetts(1) | | | | | 9 | | | | | | 9 | | | | | | 2026 | | |
Michigan(1) | | | | | 16 | | | | | | 14 | | | | | | 2030 | | |
Nevada
|
| | | | 2 | | | | | | 2 | | | | | | 2024 | | |
New York
|
| | | | 3 | | | | | | 3 | | | | | | 2030 | | |
Ohio(1) | | | | | 6 | | | | | | 6 | | | | | | 2029 | | |
Pennsylvania
|
| | | | 11 | | | | | | 11 | | | | | | 2024 | | |
Canada(1) | | | | | 26 | | | | | | 2 | | | | | | 2031 | | |
Jurisdiction
|
| |
不。註冊申請
Submitted |
| |
No. Registration Awarded
as of May 24, 2022 |
| ||||||
美國專利商標局(1)
|
| | | | 3 | | | | | | 2 | | |
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cresco Labs, LLC
|
| |
提前批准成人用培植中心許可證
License Number: 1503060739-EA |
| |
Kankakee
|
| |
03/31/2022
|
| |
早期批准的成人使用培養中心的經營許可證
|
|
|
提前批准成人用培植中心許可證
License Number: 1503060740-EA |
| |
Lincoln
|
| |
03/31/2022
|
| |
早期批准的成人使用培養中心的經營許可證
|
| ||
|
提前批准成人用培植中心許可證
License Number: 1503060741-EA |
| |
Joliet
|
| |
03/31/2022
|
| |
早期批准的成人使用培養中心的經營許可證
|
| ||
|
醫用大麻種植中心經營許可證
License Number: 1503060739 |
| |
Kankakee
|
| |
05/18/2022
|
| |
經營醫用大麻種植中心許可證
|
| ||
|
醫用大麻種植中心經營許可證
License Number: 1503060740 |
| |
Lincoln
|
| |
03/09/2023
|
| |
經營醫用大麻種植中心許可證
|
| ||
|
醫用大麻種植中心經營許可證
License Number: 1503060741 |
| |
Joliet
|
| |
03/09/2023
|
| |
經營醫用大麻種植中心許可證
|
| ||
|
Industrial Hemp
Processor License License Number: 1204-301 |
| |
Kankakee
|
| |
12/31/2022
|
| |
工業大麻加工許可證
|
| ||
|
Industrial Hemp
Processor License License Number: 1204-302 |
| |
Joliet
|
| |
12/31/2022
|
| |
工業大麻加工許可證
|
| ||
|
Industrial Hemp
Processor License License Number: 1204-303 |
| |
Lincoln
|
| |
12/31/2022
|
| |
工業大麻加工許可證
|
| ||
|
Transporter License1503060741-TR
|
| |
Joliet
|
| |
07/14/2022
|
| |
運輸大麻許可證
|
| ||
|
Transporter License1503060740-TR
|
| |
Lincoln
|
| |
07/14/2022
|
| |
運輸大麻許可證
|
| ||
|
Transporter License1503060739-TR
|
| |
Kankakee
|
| |
07/14/2022
|
| |
運輸大麻許可證
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Phoenix Farms of
Illinois, LLC |
| |
註冊醫用大麻配藥組織證書
License: 280:000035 |
| |
Champaign
|
| |
04/26/2022
|
| |
經營醫用大麻藥房的許可證
|
|
|
註冊醫用大麻配藥組織證書
License: 284:000006 |
| |
Champaign
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
| ||
|
註冊成人配藥組織證書
License: 284:000056 |
| |
Danville
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
| ||
PDI Medical III,
LLC |
| |
註冊醫用大麻配藥組織證書
License: 280:000016 |
| |
Buffalo Grove
|
| |
12/07/2022
|
| |
經營醫用大麻藥房的許可證
|
|
|
註冊成人配藥組織證書
License: 284:000009 |
| |
Buffalo Grove
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
| ||
|
註冊成人配藥組織證書
License: 284:000080 |
| |
Naperville
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
| ||
FloraMedex, LLC
|
| |
註冊醫用大麻配藥組織證書
License: 280:000034 |
| |
Elmwood Park
|
| |
04/18/2022
|
| |
經營醫用大麻藥房的許可證
|
|
|
註冊成人配藥組織證書
License: 284:000010 |
| |
Elmwood Park
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
| ||
|
註冊成人配藥組織證書
License: 284:000061 |
| |
Schaumburg
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
| ||
MedMar Lakeview,
LLC |
| |
註冊成人配藥組織證書
License: 284:000053 |
| |
Chicago
|
| |
01/13/2023
|
| |
經營醫用大麻藥房的許可證
|
|
|
註冊成人配藥組織證書
License: 284:000008 |
| |
Chicago
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
| ||
|
註冊成人配藥組織證書
License: 284:000053 |
| |
Chicago
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
MedMar Rockford,
LLC |
| |
註冊醫用大麻配藥組織證書
License: 280:000013 |
| |
Rockford
|
| |
11/24/2022
|
| |
經營醫用大麻藥房的許可證
|
|
|
註冊成人配藥組織證書
License: 284:000007 |
| |
Rockford
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
| ||
|
註冊成人配藥組織證書
License: 284:000059 |
| |
South Beloit
|
| |
03/31/2022
|
| |
經營娛樂性大麻藥房許可證
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cresco Yeltrah, LLC
|
| |
Medical Marijuana
Grower/ Processor Permit Applicant ID: GP-6012-17 |
| |
Brookville
|
| |
06/20/2022
|
| |
種植和加工醫用大麻許可證
|
|
|
醫用大麻藥房許可證申請者ID:D-5016-17
|
| |
Butler
|
| |
06/29/2022
|
| |
經營醫用大麻藥房的許可證
|
| ||
|
醫用大麻藥房許可證申請者ID:D-5016-17
|
| |
Pittsburgh
|
| |
06/29/2022
|
| |
經營醫用大麻藥房的許可證
|
| ||
|
醫用大麻藥房許可證申請者ID:D-5016-17
|
| |
New Kensington
|
| |
06/29/2022
|
| |
經營醫用大麻藥房的許可證
|
| ||
|
醫用大麻藥房許可證申請者ID:D-18-1007
|
| |
Wyomissing
|
| |
12/18/2022
|
| |
經營醫用大麻藥房的許可證
|
| ||
|
醫用大麻藥房許可證申請者ID:D-18-1007
|
| |
Philadelphia
|
| |
12/18/2022
|
| |
經營醫用大麻藥房的許可證
|
| ||
|
醫用大麻藥房許可證申請者ID:D-18-1007
|
| |
Ambler
|
| |
12/18/2022
|
| |
經營醫用大麻藥房的許可證
|
| ||
Bay, LLC
|
| |
醫用大麻藥房許可證申請者ID:D-1069-17
|
| |
Lancaster
|
| |
06/29/2022
|
| |
經營醫用大麻藥房的許可證
|
|
|
醫用大麻藥房許可證申請者ID:D-1069-17
|
| |
Philadelphia
|
| |
06/29/2022
|
| |
經營醫用大麻藥房的許可證
|
| ||
|
醫用大麻藥房許可證申請者ID:D-1069-17
|
| |
Phoenixville
|
| |
06/29/2022
|
| |
經營醫用大麻藥房的許可證
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Laurel Harvest
Labs, LLC |
| |
醫用大麻種植者/加工商許可證申請者ID:CR02-GP20-1202
|
| |
Mount Joy
|
| |
02/20/2023
|
| |
種植和加工醫用大麻許可證
|
|
|
醫用大麻藥房許可證申請者ID:CR02-D20-2202
|
| |
Montgomeryville
|
| |
02/20/2023
|
| |
種植和加工醫用大麻許可證
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cresco Labs Ohio,
LLC |
| |
MMCPC00017
|
| |
Yellow Springs
|
| |
09/13/2022
|
| |
Cultivation License
|
|
| | |
MMD 0700002
|
| |
Wintersville
|
| |
07/01/2023
|
| |
Dispensary License
|
|
| | |
MMCP00041
|
| |
Yellow Springs
|
| |
06/10/2022
|
| |
醫用大麻加工商許可證
|
|
Verdant Creations
Newark, LLC |
| |
MMD.0700061
|
| |
Newark
|
| |
12/04/2022
|
| |
Dispensary License
|
|
Verdant Creation
Marion, LLC |
| |
MMD.0700062
|
| |
Marion
|
| |
12/04/2022
|
| |
Dispensary License
|
|
Care Med
Associates, LLC |
| |
MMD.0700063
|
| |
Cincinnati
|
| |
12/04/2022
|
| |
Dispensary License
|
|
Verdant Creations
Chillicothe, LLC |
| |
MMD.0700064
|
| |
Chillicothe
|
| |
12/04/2022
|
| |
Dispensary License
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
SLO Cultivation Inc.
|
| |
臨時製造編號:cdph-10003334
|
| |
Mendota
|
| |
05/31/2022
|
| |
醫療和成人用製造
|
|
|
Provisional License Number: C11-0000193-LIC
|
| |
Mendota
|
| |
05/28/2022
|
| |
醫療和成人用製造
|
| ||
|
Provisional License Number: CCL18-0002726
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002733
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002727
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002728
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002729
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002731
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002765
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002764
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002763
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002762
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002761
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002760
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002759
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002757
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002756
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002755
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002754
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002753
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002752
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002766
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
Provisional License Number: CCL18-0002751
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
臨時苗圃許可證編號:CCL18-0002750
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
| ||
|
臨時處理器許可證號:CCL18-0002749
|
| |
Carpinteria
|
| |
05/28/2022
|
| |
種植小混光,第1級
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
| | |
臨時處理器許可證號:CCL18-0002816
|
| |
Carpinteria
|
| |
05/31/2022
|
| |
Nursery
|
|
| | |
臨時處理器許可證號:CCL18-0002817
|
| |
Carpinteria
|
| |
05/31/2022
|
| |
Processor
|
|
FloraCal Farms | | |
栽培基質(暫定)CCL18-0002186
|
| |
Santa Rosa
|
| |
03/21/2023
|
| |
栽培:醫用介質室內:
|
|
| | |
Processor (Provisional) CCL19-0000639
|
| |
Santa Rosa
|
| |
06/27/2022
|
| |
Processor
|
|
| | |
Distribution (Provisional) C11-0001222-LIC
|
| |
Santa Rosa
|
| |
06/25/2022
|
| |
Distribution
|
|
Cub City, LLC | | |
小型室內栽培(暫定)CCL18-0002062
|
| |
Santa Rosa
|
| |
03/21/2023
|
| |
種植:醫用小型室內
|
|
River Distributing
Co., LLC |
| |
Distribution (Provisional) C11-0000933-LIC
|
| |
Sacramento
|
| |
07/29/2022
|
| |
Distribution
|
|
| | |
Distribution (Provisional) C11-0000608-LIC
|
| |
La Habra
|
| |
07/01/2022
|
| |
Distribution
|
|
Holding Entity
|
| |
Permit/License
|
| |
Registration Number
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Encanto
Green Cross Dispensary |
| |
醫用大麻藥房和種植場所登記證;批准經營
|
| |
00000080DCQI00709964
|
| |
Phoenix
|
| |
08/07/2022
|
| |
批准種植和分發醫用大麻
|
|
Encanto
Green Cross Dispensary |
| |
醫用大麻藥房登記證;批准經營
|
| |
00000080DCQI00709964
|
| |
Salome
|
| |
08/07/2022
|
| |
批准種植醫用大麻
|
|
Encanto
Green Cross Dispensary |
| |
成人使用大麻藥房現場登記證;批准經營
|
| |
00000101ESZO30906924
|
| |
Phoenix
|
| |
01/28/2023
|
| |
批准發放成人用大麻
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
山谷農業有限責任公司
|
| |
Certificate of
Registration Number: MM0801M |
| |
Middletown
|
| |
07/31/2023
|
| |
Acquiring,
possession, manufacture, sale, transporting and distributing medical marijuana |
|
|
Certificate of
Registration Number: MM0802D |
| |
Brooklyn
|
| |
07/31/2023
|
| |
Acquiring,
possession, sale, transporting, distributing, and dispensing medical marijuana |
| ||
|
Certificate of
Registration Number: MM0803D |
| |
Huntington
|
| |
07/31/2023
|
| |
Acquiring,
possession, sale, transporting, distributing, and dispensing medical marijuana |
| ||
|
Certificate of
Registration Number: MM0804D |
| |
Bardonia
|
| |
07/31/2023
|
| |
Acquiring,
possession, sale, transporting, cutting, and dispensing medical marijuana |
| ||
|
Certificate of
Registration Number: MM0805D |
| |
New Hartford
|
| |
07/31/2023
|
| |
Acquiring,
possession, sale, transporting, distributing, and dispensing medical marijuana |
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cresco HHH, LLC
|
| |
RMD-686
|
| |
Fall River
|
| |
11/20/2022
|
| |
Medical cultivation,
manufacturing and processing and it establishes and allows for dispensary operations |
|
|
MC281478
|
| |
Fall River
|
| |
06/08/2022
|
| |
Marijuana
Cultivator-Tier 4 |
| ||
|
MP281361
|
| |
Fall River
|
| |
06/18/2022
|
| |
Marijuana Product
Manufacturer |
| ||
Cultivate
Cultivation, LLC |
| |
MP281305
|
| |
Leicester
|
| |
09/24/2022
|
| |
Marijuana Product
Manufacturer |
|
| | |
MC281266
|
| |
Leicester
|
| |
09/26/2022
|
| |
Marijuana
Cultivator |
|
| | |
MR282522
|
| |
Framingham
|
| |
02/10/2023
|
| |
Marijuana Retailer
|
|
| | |
RMD-3193
|
| |
Framingham
|
| |
10/14/2022
|
| |
Medical cultivation,
manufacturing and processing and it establishes and allows for dispensary operations |
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
Cultivate Leicester,
Inc |
| |
MC282053
|
| |
Uxbridge
|
| |
03/12/2023
|
| |
Marijuana
Cultivator |
|
|
MP281742
|
| |
Uxbridge
|
| |
03/12/2023
|
| |
Marijuana Product
Manufacturer |
| ||
| | |
MR281843
|
| |
Worcester
|
| |
05/05/2022
|
| |
Marijuana Retailer
|
|
| | |
MR28126
|
| |
Leicester
|
| |
09/26/2022
|
| |
Marijuana Retailer
|
|
| | |
RMD-485
|
| |
Leicester
|
| |
11/18/2022
|
| |
Medical cultivation,
manufacturing and processing and it establishes and allows for dispensary operations |
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
| ||||||
Cresco Labs
Michigan, LLC |
| |
PR-000067
|
| | | | 馬歇爾 | | | | | | 03/04/2023 | | | |
醫療加工證
|
|
|
AU-P-000127
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
成人使用處理器許可證
|
| ||
|
AU-G-C-000351
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
| ||
| | |
AU-G-C-000352
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-C-000353
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-C-000354
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-C-000355
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
GR-C-21-001012
|
| | | | 馬歇爾 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001013
|
| | | | 馬歇爾 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001014
|
| | | | 馬歇爾 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001015
|
| | | | 馬歇爾 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001016
|
| | | | 馬歇爾 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001017
|
| | | | 馬歇爾 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001018
|
| | | | 馬歇爾 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-21-001019
|
| | | | 馬歇爾 | | | | | | 11/24/2022 | | | |
Medical Cultivation
|
|
| | |
GR-C-000726
|
| | | | 馬歇爾 | | | | | | 03/04/2023 | | | |
Medical Cultivation
|
|
| | |
GR-C-000727
|
| | | | 馬歇爾 | | | | | | 03/04/2023 | | | |
Medical Cultivation
|
|
| | |
AU-G-EX-000239
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000240
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000241
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000242
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000243
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000244
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
| | |
AU-G-EX-000245
|
| | | | 馬歇爾 | | | | | | 06/22/2022 | | | |
Adult-Use Cultivation
|
|
Holding Entity
|
| |
Permit/License
|
| |
City
|
| |
Expiration Date
|
| |
Description
|
|
3 Boys Farms, LLC | | |
MMTC-2017-0008
|
| |
Vertically-
integrated State License for all activities and locations |
| |
06/02/2022
|
| |
Cultivation,
manufacturing and processing and it establishes and allows for dispensary operations |
|
| 通知權和投票權 | | |
Cresco股票持有人將有權獲得Cresco任何股東大會的通知並出席該會議,但只有Cresco其他特定類別或系列股票的持有人才有權在該會議上投票。在每次這樣的會議上,Cresco股票的持有者將有權就所持有的每股Cresco股票投一票。
|
|
| 階級權利和優先購買權 | | |
只要任何Cresco股票仍未發行,Cresco將不會損害或幹擾Cresco股票附帶的任何權利,除非Cresco股票持有人通過單獨的特別決議同意。Cresco股票的持有者現在或將來將無權認購、購買或接收任何發行的Cresco股票或Cresco的債券、債券或其他證券的任何部分。
|
|
| Dividends | | |
Cresco股票的持有者將有權在Cresco董事宣佈時獲得Cresco的現金或財產股息。
|
|
| Participation | | |
如果Cresco發生清算、解散或清盤,無論是自願或非自願的,或Cresco的資產在股東之間進行任何其他分配以清盤其事務,Cresco股份的持有人應有權與Cresco股份、SSVS(按轉換為Cresco股份的基準)和PVS(按轉換為Cresco股份的基準)的所有其他持有人一起按比例參與,但須遵守Cresco股份(包括但不限於MVS)的任何股份持有人的優先權利。
|
|
| Changes | | |
Cresco股份不得拆分或合併,除非同時以相同方式拆分或合併Cresco股份、SSVS、PVS及MVS,或作出該等其他調整,以維持及保留上述各類別股份持有人的相對權利。
|
|
| Conversion | | |
如果提出購買PVS的要約,並且根據適用的證券法或PVS隨後上市的證券交易所的上市規則或條件,該要約必須向這些要求適用的加拿大給定省份或地區的所有或幾乎所有PVS持有者提出,在要約生效期間的任何時間,每股Cresco股份應根據持有人的選擇按當時有效的轉換比率的倒數轉換為PVS,直至適用證券法例規定要約人認購併支付根據要約收購的股份的時間後一天為止。換股權利只能就Cresco股份行使,目的是根據要約存入所產生的PVS,而不是出於其他原因。在這種情況下,Cresco的轉讓代理人應代表持有人存入由此產生的PVS。如果轉換時發行並響應要約而投標的PVS被股東撤回或未被要約人接受,或要約被放棄或撤回,則轉換產生的PVS應自動按當時有效的轉換比率重新轉換為Cresco股票,而Cresco方面或持有人方面不會進一步幹預。
|
|
| Right to Vote | | |
PVS的持有人將有權獲得Cresco的任何股東大會的通知並出席,但只有Cresco的另一特定類別或系列股票的持有人才有權在該會議上投票。在每次此類會議上,PVS的持有人將有權就該PVS最終可轉換為的每股Cresco股份投一票,為了更好地確定,該投票權最初應等於每PVS 200票(可由Cresco董事會酌情調整,取決於保持外國私人發行人地位所需的比率)。
|
|
| Class Rights | | |
只要任何PVS仍未結清,Cresco將不會在未經PVS和MVS持有人通過單獨的特別決議同意的情況下,損害或幹擾PVS附帶的任何權利或特別權利。任何授權或設立優先於已發行PVS或與PVS平價的任何類別股份的行動,均須徵得已發行PVS及MVS的過半數持有人同意。就行使上述投票權而言,每名自願書持有人對所持有的每一份自願書有一票投票權。
|
|
| 認購權;優先購買權 | | |
PVS的持有人無權認購、購買或接收任何發行的Cresco股票或Cresco的債券、債券或其他證券的任何部分。
|
|
| Dividends | | |
PVS的持有人有權從任何可合法獲得的現金或其他資產中收取股息,因此,就股息和任何宣佈或支付Cresco股份的任何股息而言,同等權益(按折算基準,假設所有PVS轉換為Cresco股份)。除非Cresco同時宣佈或支付(如適用)Cresco股份的等值股息(按轉換為Cresco股份的基準),否則不會在PVS上宣佈或支付股息。
|
|
| Participation | | |
如果Cresco發生清算、解散或清盤,無論是自願的還是非自願的,或者如果Cresco的資產在股東之間進行了任何其他分配以了結其事務,則PVS的持有人將有權與PVS(以轉換為Cresco股份的基準)和Cresco股份的所有其他持有人一起按比例參與,但須受優先於PVS的任何Cresco股份(包括但不限於MVS)持有人的優先權利的限制。
|
|
| Changes | | |
除非同時以相同方式拆分或合併Cresco股份、PVS及MVS,或作出其他調整以維持及保留上述各類別股份持有人的相對權利,否則不得拆分或合併PVS。
|
|
| Conversion | | |
PVS各自擁有轉換為200股Cresco股票的受限權利(“轉換比率”),但須根據某些慣常的公司變動和外國私人發行人的考慮進行調整。轉換PVS的能力受Cresco股票、PVS和MV總數的限制
|
|
| | | |
由美國居民直接或間接持有的(根據1934年證券交易法(修訂本)第3B-4和12G3-2(A)規則確定的)不得超過Cresco股份、PVS和MV在實施該等轉換後已發行和發行的股份總數的40%(40%)(視調整而定),並受超過某些水平的Cresco股份實益所有權的限制。此外,在某些情況下,Cresco有權將PVS轉換為Cresco股票,包括在Cresco股票根據修訂後的1933年美國證券法登記時。
|
|
| Right to Vote | | |
MVS的持有人有權獲得通知並出席Cresco的任何股東大會,但只有Cresco的另一特定類別或系列股票的持有人才有權在該會議上投票。在每次會議上,MVS持有人有權就所持有的每一MVS投2,000票,但如在任何時間,(I)Cresco資本中的Cresco可贖回股份(如適用)及(Ii)Cresco資本中的Cresco可贖回單位(或Cresco Corp或Cresco的任何繼承人不時存在的證券)直接或間接由MVS持有人(“持有人”)及持有人的前身或轉讓人、準許受讓人及準許繼承人實益擁有,及任何先前轉讓人的轉讓人及任何先前核準受讓人的許可受讓人(“持有人集團”)除以(I)Cresco可贖回股份(如適用)及(Ii)持有人及持有人集團於涉及Cresco、Cresco Corp及Cresco(其中包括)的企業合併交易完成日期直接或間接實益擁有的Cresco可贖回單位總數少於50%(“觸發事件”),則持有人自該日起有權就所持有的每一MVS享有50票。應Cresco的要求,MVS的持有人應不時向Cresco提供有關持有人對Cresco可贖回股份(如適用)和Cresco可贖回單位的直接和間接實益所有權(及其允許受讓人和允許繼承人的所有權)的證據,以便Cresco能夠確定MVS的投票權。就這些計算而言, 持有人應被視為實益擁有由中間公司或基金持有的Cresco可贖回股票(如果適用),比例為他們在該公司或基金的股權。
|
|
| Class Rights | | |
只要任何MVS仍未解決,Cresco將不會在未經MVS持有人通過單獨的特別決議同意的情況下,損害或幹擾MVS附帶的任何權利或特別權利。任何授權或設立任何類別股份的行動,均須徵得已發行MVS的過半數持有人同意,而該等股份的優先程度高於MVS或與MVS相同。在行使該等投票權時,每名持票人可就持有的每一張票投一票。
|
|
| 認購權;優先購買權 | | |
MVS的持有人無權認購、購買或接收任何發行的Cresco股票、或Cresco的債券、債權證或其他不可在現在或將來轉換為MVS的證券的任何部分。
|
|
| Dividends | | | MVS的持有者無權獲得股息。 | |
| Participation | | |
如果Cresco發生清算、解散或清盤,無論是自願的還是非自願的,或者如果Cresco的資產在股東之間進行了任何其他分配,以了結其事務,Cresco將首先分配其資產,並優先於Cresco任何其他類別股份的持有人(包括Cresco股票和PVS的持有人)向其持有人返還MVS的發行價的權利,如果沒有足夠的資產將MVS的發行價全額返還給MVS的持有人,該等持有人將收到
|
|
| | | |
相當於其MVS與所有其他MVS持有者的發行價比例的比例份額的金額。MVS的持有人無權作為MVS的持有人直接或間接獲得Cresco的任何其他資產或財產,他們的唯一權利將是根據本款返還該MVS的發行價。
|
|
| Changes | | |
除非同時以同樣的方式拆分或合併MVS、PVS和Cresco股份,以維護和維護上述每一類別股份持有人的相對權利,否則不得對MVS進行拆分或合併。
|
|
| Conversion | | | MVS的持有者無權轉換。 | |
| Redemption Rights | | |
一旦觸發事件發生,Cresco有權贖回導致觸發事件發生的持有人及持有人集團的全部或部分MV,方法是提前兩天向該MV的持有人及持有人集團發出書面通知,金額相當於每一MV的發行價,並以現金支付給如此贖回的MV的持有人。Cresco不需要在持有人或持有人集團之間按比例贖回MV。將由Cresco贖回的MVS的持有人應將代表該MVS的一張或多張證書交回Cresco的檔案處,以便轉讓給Cresco(或隨附與此相關的妥為籤立的股份轉讓)。
每張已交回的股票將被註銷,此後Cresco將以保兑支票、銀行匯票或電匯向該股票的登記持有人支付適用的贖回金額;但如果被贖回的股票所代表的MV少於所有MV,則應以被註銷股票的適用登記持有人的名義發行代表該證書所代表的MV未贖回餘額的新股票。如在適用的贖回日期,任何MVS的贖回價格已就任何MVS支付(或提交付款),則在該日期,如此贖回及支付或投標的MVS的持有人在該MVS上的所有權利將終止,而該等已贖回MVS的持有人將不再被視為已發行及尚未贖回,不論該MVS的持有人是否已向Cresco交付代表該等證券的證書,而自該日期起及之後,先前代表撤回的MVS的證書只證明該MVS的前持有人有權收取該持有人有權獲得的贖回價格。
|
|
| Transfer | | |
MVS的持有人不得轉讓任何MVS,除非此類轉讓是轉讓給直系親屬,或轉讓給由該持有人或其直系親屬全資實益擁有的公司或個人,或該持有人或其直系親屬是其唯一受益人。為使轉讓生效,任何轉讓必須事先獲得Cresco的書面同意。
|
|
|
Investment
Agreement |
| |
為補充MVS附帶的權利、特權、限制和條件,作為MVS的初始持有人,Cresco和創辦人簽訂了一項投資協議,自企業合併完成時生效,其中規定:(I)每個MVS只能轉讓給持有者的直系親屬或關聯實體,或轉讓給其他創始人或與其他創始人關聯的實體,以及(Ii)在將MVS出售給第(I)款中未列出的第三方購買者時,此類MV將立即由Cresco以其發行價贖回。
|
|
| Right to Vote | | | SSVS的持有人有權獲得通知並出席Cresco的任何股東大會,但只有Cresco的另一特定類別或系列股票的持有人才有權在該會議上投票。在每次會議上,SSV的持有人將有權就該SSV最終可轉換為的每股Cresco股份投一票,為提高確定性,該投票權最初應等於每個SSVS的0.00001的投票權。 | |
| Class Rights | | |
只要任何SSV仍未解決,Cresco將不會損害或幹擾SSV附帶的任何權利或特殊權利,除非SSV持有人通過單獨的特別決議同意。在行使這些投票權時,每名社會保障計劃持有人可就每一份社會保障計劃投一票。
|
|
| 認購權;優先購買權 | | |
SSVS的持有人無權認購、購買或接收現在或將來發行的任何Cresco股票、債券、債權證或其他證券的任何部分。
|
|
| Dividends | | |
因此,SSVS的持有人有權從任何現金或其他合法可用資產中收取股息(假設所有SSVS按特別換股比率轉換為Cresco股份),並有權就Cresco股份的任何股息及任何宣佈或支付股息。除非Cresco同時宣佈或支付(如適用)Cresco股份及PVS的等值股息(按轉換為Cresco股份的基準),否則不會在SSVS上宣派或支付股息。
|
|
| Participation | | |
如果Cresco發生清算、解散或清盤,無論是自願的還是非自願的,或者如果Cresco的資產在股東之間進行任何其他分配以結束其事務,SSVS的持有人將有權與Cresco股票的所有其他持有人(在轉換為Cresco股票的基礎上)享有優先於SSVS的任何Cresco股份(包括但不限於MVS)的優先權利,PVS(在轉換為Cresco股票的基礎上)和Cresco股票。
|
|
| Changes | | |
可通過董事(或其委員會)的決議將SSV拆分或合併,而無需以相同方式同時拆分或合併Cresco股份、PVS和MVS,前提是相應地調整特別換股比率,並相應調整SSV的投票權,使所有SSV持有人在拆分或合併前持有的總投票權等於拆分或合併後所有SSVS持有人持有的總投票數。
|
|
| 所有權限制 | | |
SSVS只能由一名或多名非指定的美國人直接或間接實益擁有或控制。
|
|
| 轉移限制 | | |
未經Cresco董事會(或其委員會)事先書面同意,SSV或其中的任何權利或權益不得由SSV持有人以合法、實益或任何其他方式轉讓,Cresco董事會(或其委員會)可全權酌情予以扣留。
|
|
| Redemption Rights | | |
Cresco有權隨時通過向任何持有人提供提前兩天的書面通知(“贖回通知”)贖回全部或部分SSV:(I)現金,其價格等於特別換股比率(可根據其條款調整)乘以緊接贖回通知日期前10個交易日Cresco股票在CSE(或該等其他證券交易所或報價系統)的平均成交量加權平均交易價;或(Ii)按可根據其條款調整的特別換股比率購入Cresco股份。Cresco不需要在SSVS持有人中按比例贖回SSVS。
|
|
| Conversion | | |
SSV的持有者有權轉換為每股SSV 0.00001的Cresco股票(“特別換股比率”),但須受某些公司變動的慣例調整所限。轉換SSV的能力須事先獲得Cresco董事會或其委員會的書面同意。Cresco可要求每個SSV持有人按適用的特殊轉換比率轉換所有SSV,前提是在任何時間滿足以下所有條件(或SSV持有人的特別決議以其他方式放棄):(A)Cresco不再是“外國私人發行人”(根據美國交易所法案3b-4規則確定);或(B)Cresco董事會(或其委員會)確定不再需要或不再需要SSV。
|
|
CSE
|
| ||||||||||||||||||
Period
|
| |
High Trading Price (C$)
|
| |
Low Trading Price (C$)
|
| |
Volume
|
| |||||||||
May 2021
|
| | | | 16.7600 | | | | | | 13.3000 | | | | | | 6,764,181 | | |
June 2021
|
| | | | 14.9400 | | | | | | 12.4400 | | | | | | 5,371,470 | | |
July 2021
|
| | | | 14.9700 | | | | | | 12.6800 | | | | | | 6,498,345 | | |
August 2021
|
| | | | 14.3700 | | | | | | 12.1200 | | | | | | 4,185,734 | | |
September 2021
|
| | | | 12.5100 | | | | | | 10.1400 | | | | | | 5,857,624 | | |
October 2021
|
| | | | 11.7700 | | | | | | 9.2200 | | | | | | 3,951,944 | | |
November 2021
|
| | | | 13.0400 | | | | | | 9.3900 | | | | | | 8,826,438 | | |
December 2021
|
| | | | 11.0500 | | | | | | 7.8000 | | | | | | 7,844,152 | | |
January 2022
|
| | | | 9.2500 | | | | | | 6.5200 | | | | | | 5,390,428 | | |
February 2022
|
| | | | 10.3600 | | | | | | 7.8400 | | | | | | 6,961,238 | | |
March 2022
|
| | | | 8.7900 | | | | | | 6.7400 | | | | | | 7,690,492 | | |
April 2022
|
| | | | 7.9000 | | | | | | 5.6000 | | | | | | 6,020,478 | | |
May 1 – •
|
| | |
|
•
|
| | | |
|
•
|
| | | |
|
•
|
| |
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
對價的性質
|
| |||||||||
May 10, 2021
|
| | | | 159,259 | | | | | $ | 11.64 | | | | | $ | 1,854,005 | | | |
Cash (exercise of warrants)
|
|
May 10, 2021
|
| | | | 100,000 | | | | | $ | 12.79 | | | | | $ | 1,279,041 | | | |
換股(可贖回股份)
|
|
May 10, 2021
|
| | | | 4,620 | | | | | $ | 6.00 | | | | | $ | 27,720 | | | |
股票發行(行使限制性股票單位)
|
|
May 10, 2021
|
| | | | 61,700 | | | | | $ | 11.25 | | | | | $ | 694,125 | | | |
股票發行(與認購協議有關)
|
|
May 28, 2021
|
| | | | 945.00 | | | | | $ | 11.25 | | | | | $ | 10,631 | | | |
Cash (exercise of options)
|
|
May 28, 2021
|
| | | | 25,770.00 | | | | | $ | 11.64 | | | | | $ | 300,000 | | | |
Cash (exercise of warrants)
|
|
May 28, 2021
|
| | | | 2,900,000.00 | | | | | $ | 12.24 | | | | | $ | 35,488,168 | | | |
換股(可贖回股份)
|
|
May 28, 2021
|
| | | | 58,233 | | | | | $ | 6.00 | | | | | $ | 349,398 | | | |
股票發行(行使限制性股票單位)
|
|
May 28, 2021
|
| | | | 232 | | | | | $ | 5.96 | | | | | $ | 1,383 | | | |
股票發行(行使限制性股票單位)
|
|
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
對價的性質
|
| |||||||||
June 01, 2021
|
| | | | 136,340 | | | | | $ | 6.00 | | | | | $ | 818,040 | | | |
股票發行(行使限制性股票單位)
|
|
June 03, 2021
|
| | | | 500,000 | | | | | $ | 11.71 | | | | | $ | 5,853,921 | | | |
換股(可贖回股份)
|
|
June 08, 2021
|
| | | | 50,000 | | | | | $ | 2.25 | | | | | $ | 112,500 | | | |
Cash (exercise of options)
|
|
June 10, 2021
|
| | | | 11,500 | | | | | $ | 1.14 | | | | | $ | 13,062 | | | |
Cash (exercise of options)
|
|
June 10, 2021
|
| | | | 760,000 | | | | | $ | 11.63 | | | | | $ | 8,835,456 | | | |
換股(可贖回股份)
|
|
June 17, 2021
|
| | | | 4,500 | | | | | $ | 2.99 | | | | | $ | 13,455 | | | |
Cash (exercise of options)
|
|
June 18, 2021
|
| | | | 179,250 | | | | | $ | 1 – $2.99 | | | | | $ | 207,968 | | | |
Cash (exercise of options)
|
|
June 22, 2021
|
| | | | 5,000 | | | | | $ | 2.25 | | | | | $ | 11,250 | | | |
Cash (exercise of options)
|
|
June 25, 2021
|
| | | | 3,000,000 | | | | | $ | 11.29 | | | | | $ | 33,870,181 | | | |
換股(可贖回股份)
|
|
July 05, 2021
|
| | | | 1,000 | | | | | $ | 2.99 | | | | | $ | 2,990 | | | |
Cash (exercise of options)
|
|
July 08, 2021
|
| | | | 2,000 | | | | | $ | 2.99 | | | | | $ | 5,980 | | | |
Cash (exercise of options)
|
|
July 08, 2021
|
| | | | 65,626 | | | | | $ | 2.25 | | | | | $ | 147,659 | | | |
Cash (exercise of options)
|
|
July 12, 2021
|
| | | | 100,000 | | | | | $ | 1.14 | | | | | $ | 114,000 | | | |
Cash (exercise of options)
|
|
July 12, 2021
|
| | | | 360,000 | | | | | $ | 11.38 | | | | | $ | 4,096,223 | | | |
換股(可贖回股份)
|
|
July 12, 2021
|
| | | | 17,084 | | | | | $ | 12.17 | | | | | $ | 207,876 | | | |
股票發行(行使與Bluma有關的限制性股票單位)
|
|
July 12, 2021
|
| | | | 2,993 | | | | | $ | 11.40 | | | | | $ | 34,120 | | | |
股票發行(行使限制性股票單位)
|
|
July 13, 2021
|
| | | | 1,000 | | | | | $ | 1.00 | | | | | $ | 1,000 | | | |
Cash (exercise of options)
|
|
July 14, 2021
|
| | | | 42,500 | | | | | $ | 6.5 – $6.86 | | | | | $ | 278,950 | | | |
Cash (exercise of options)
|
|
July 16, 2021
|
| | | | 13,662 | | | | | $ | 3.75 | | | | | $ | 51,233 | | | |
Cash (exercise of options)
|
|
July 16, 2021
|
| | | | 132,357 | | | | | $ | 12.17 | | | | | $ | 1,610,504 | | | |
股票發行(行使與Bluma有關的限制性股票單位)
|
|
July 16, 2021
|
| | | | 3,688 | | | | | $ | 5.96 | | | | | $ | 21,980 | | | |
股票發行(與收購Origin House有關)
|
|
July 26, 2021
|
| | | | 1,000 | | | | | $ | 3.75 | | | | | $ | 3,750 | | | |
Cash (exercise of options)
|
|
August 03, 2021
|
| | | | 2,500 | | | | | $ | 2.99 | | | | | $ | 7,475 | | | |
Cash (exercise of options)
|
|
August 05, 2021
|
| | | | 6,000 | | | | | $ | 4.24 | | | | | $ | 25,440 | | | |
Cash (exercise of warrants)
|
|
August 05, 2021
|
| | | | 3,870 | | | | | $ | 2.51 | | | | | $ | 9,714 | | | |
股票發行(行使限制性股票單位)
|
|
August 05, 2021
|
| | | | 7,661 | | | | | $ | 6.86 | | | | | $ | 52,554 | | | |
股票發行(行使限制性股票單位)
|
|
August 10, 2021
|
| | | | 3,000 | | | | | $ | 2.25 | | | | | $ | 6,750 | | | |
Cash (exercise of options)
|
|
August 13, 2021
|
| | | | 25,000 | | | | | $ | 3.75 | | | | | $ | 93,750 | | | |
Cash (exercise of options)
|
|
August 17, 2021
|
| | | | 1,000 | | | | | $ | 1.00 | | | | | $ | 1,000 | | | |
Cash (exercise of options)
|
|
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
對價的性質
|
| |||||||||
September 02, 2021
|
| | | | 1,750 | | | | | $ | 2.99 | | | | | $ | 5,233 | | | |
Cash (exercise of options)
|
|
September 02, 2021
|
| | | | 4,818,472 | | | | | $ | 9.68 | | | | | $ | 46,642,896 | | | |
購買考慮事項(在
中
connection with Cultivate) |
|
September 09, 2021
|
| | | | 80,000 | | | | | $ | 1.14 | | | | | $ | 91,200 | | | |
Cash (exercise of options)
|
|
September 09, 2021
|
| | | | 100,000 | | | | | $ | 8.52 | | | | | $ | 851,905 | | | |
換股(可贖回股份)
|
|
September 09, 2021
|
| | | | 500,000 | | | | | $ | 8.52 | | | | | $ | 4,259,523 | | | |
換股(可贖回股份)
|
|
September 10, 2021
|
| | | | 10,000 | | | | | $ | 3.75 | | | | | $ | 37,500 | | | |
Cash (exercise of options)
|
|
September 10, 2021
|
| | | | 10,500 | | | | | $ | 1.13 – $2.25 | | | | | $ | 12,425 | | | |
Cash (exercise of options)
|
|
September 14, 2021
|
| | | | 500 | | | | | $ | 2.25 | | | | | $ | 1,125 | | | |
Cash (exercise of options)
|
|
September 27, 2021
|
| | | | 15,000 | | | | | $ | 2.99 | | | | | $ | 44,850 | | | |
Cash (exercise of options)
|
|
September 29, 2021
|
| | | | 3,750 | | | | | $ | 2.99 | | | | | $ | 11,213 | | | |
Cash (exercise of options)
|
|
September 30, 2021
|
| | | | 1,000 | | | | | $ | 1.14 | | | | | $ | 1,136 | | | |
Cash (exercise of options)
|
|
October 04, 2021
|
| | | | 2,500 | | | | | $ | 3.75 | | | | | $ | 9,375 | | | |
Cash (exercise of options)
|
|
October 05, 2021
|
| | | | 1,000 | | | | | $ | 1.00 | | | | | $ | 1,000 | | | |
Cash (exercise of options)
|
|
October 13, 2021
|
| | | | 100,000 | | | | | $ | 3.75 | | | | | $ | 375,000 | | | |
Cash (exercise of options)
|
|
October 18, 2021
|
| | | | 2,000 | | | | | $ | 2.25 | | | | | $ | 4,500 | | | |
Cash (exercise of options)
|
|
October 25, 2021
|
| | | | 2,000 | | | | | $ | 1.00 | | | | | $ | 2,000 | | | |
Cash (exercise of options)
|
|
October 28, 2021
|
| | | | 5,000 | | | | | $ | 1 – $2.25 | | | | | $ | 7,500 | | | |
Cash (exercise of options)
|
|
November 08, 2021
|
| | | | 10,000 | | | | | $ | 1.14 | | | | | $ | 11,400 | | | |
Cash (exercise of options)
|
|
November 09, 2021
|
| | | | 4,169 | | | | | $ | 8.86 | | | | | $ | 36,937 | | | |
股票發行(行使限制性股票單位)
|
|
November 10, 2021
|
| | | | 18,750 | | | | | $ | 3.75 | | | | | $ | 70,313 | | | |
Cash (exercise of options)
|
|
November 12, 2021
|
| | | | 10,000 | | | | | $ | 2.25 | | | | | $ | 22,500 | | | |
Cash (exercise of options)
|
|
November 12, 2021
|
| | | | 241,430 | | | | | $ | 1.14 – $6 | | | | | $ | 365,495 | | | |
Cash (exercise of options)
|
|
November 12, 2021
|
| | | | 400,000 | | | | | $ | 9.57 | | | | | $ | 3,826,502 | | | |
換股(可贖回股份)
|
|
November 12, 2021
|
| | | | 74,899 | | | | | $ | 11.42 – $12.17 | | | | | $ | 908,850 | | | |
股票發行(行使限制性股票單位)
|
|
November 15, 2021
|
| | | | 1,000,000 | | | | | $ | 9.13 | | | | | $ | 9,131,581 | | | |
換股(可贖回股份)
|
|
November 16, 2021
|
| | | | 50,000 | | | | | $ | 3.75 | | | | | $ | 187,500 | | | |
Cash (exercise of options)
|
|
November 17, 2021
|
| | | | 5,000 | | | | | $ | 5.90 | | | | | $ | 29,500 | | | |
Cash (exercise of options)
|
|
November 18, 2021
|
| | | | 11,000 | | | | | $ | 3.75 – $5.9 | | | | | $ | 62,750 | | | |
Cash (exercise of options)
|
|
November 19, 2021
|
| | | | 9,050 | | | | | $ | 1 – $3.75 | | | | | $ | 20,188 | | | |
Cash (exercise of options)
|
|
November 22, 2021
|
| | | | 3,250 | | | | | $ | 2.99 | | | | | $ | 9,718 | | | |
Cash (exercise of options)
|
|
November 23, 2021
|
| | | | 2,500 | | | | | $ | 2.99 | | | | | $ | 7,475 | | | |
Cash (exercise of options)
|
|
November 24, 2021
|
| | | | 1,555 | | | | | $ | 3.75 | | | | | $ | 5,831 | | | |
Cash (exercise of options)
|
|
November 24, 2021
|
| | | | 6,166,861 | | | | | $ | 8.80 | | | | | $ | 54,240,357 | | | |
購買考慮事項(在
中
connection with Cure Penn) |
|
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
對價的性質
|
| |||||||||
November 26, 2021
|
| | | | 25,000 | | | | | $ | 6.86 | | | | | $ | 171,500 | | | |
Cash (exercise of options)
|
|
December 01, 2021
|
| | | | 125,000 | | | | | $ | 1.14 | | | | | $ | 142,500 | | | |
Cash (exercise of options)
|
|
December 02, 2021
|
| | | | 12,500 | | | | | $ | 1.14 | | | | | $ | 14,198 | | | |
Cash (exercise of options)
|
|
December 02, 2021
|
| | | | 418 | | | | | $ | 9.13 | | | | | $ | 3,816 | | | |
股票發行(行使限制性股票單位)
|
|
December 02, 2021
|
| | | | 177 | | | | | $ | 9.13 | | | | | $ | 1,616 | | | |
股票發行(行使限制性股票單位)
|
|
December 06, 2021
|
| | | | 1,170 | | | | | $ | 3.75 | | | | | $ | 4,388 | | | |
Cash (exercise of options)
|
|
December 07, 2021
|
| | | | 18,500 | | | | | $ | 2.25 – $2.99 | | | | | $ | 54,575 | | | |
Cash (exercise of options)
|
|
December 09, 2021
|
| | | | 182,358 | | | | | $ | 7.88 | | | | | $ | 1,437,323 | | | |
購買考慮事項(在
中
connection with Laurel Harvest) |
|
December 13, 2021
|
| | | | 12,000 | | | | | $ | 4.24 | | | | | $ | 50,880 | | | |
Cash (exercise of warrants)
|
|
December 14, 2021
|
| | | | 35,000 | | | | | $ | 2.25 | | | | | $ | 78,750 | | | |
Cash (exercise of options)
|
|
December 14, 2021
|
| | | | 7,526,270 | | | | | $ | 7.88 | | | | | $ | 59,321,112 | | | |
購買考慮事項(在
中
connection with Laurel Harvest) |
|
December 20, 2021
|
| | | | 77,899 | | | | | $ | 2.25 – $3.75 | | | | | $ | 183,371 | | | |
Cash (exercise of options)
|
|
December 24, 2021
|
| | | | 10,000 | | | | | $ | 2.25 | | | | | $ | 22,500 | | | |
Cash (exercise of options)
|
|
December 28, 2021
|
| | | | 645,161 | | | | | $ | 7.88 | | | | | $ | 5,085,078 | | | |
購買考慮事項(在
中
connection with Laurel Harvest) |
|
January 03, 2022
|
| | | | 10,000 | | | | | $ | 2.25 | | | | | $ | 22,500 | | | |
Cash (exercise of options)
|
|
January 04, 2022
|
| | | | 55,000 | | | | | $ | 2.25 | | | | | $ | 123,750 | | | |
Cash (exercise of options)
|
|
January 05, 2022
|
| | | | 12,500 | | | | | $ | 2.99 | | | | | $ | 37,375 | | | |
Cash (exercise of options)
|
|
January 10, 2022
|
| | | | 12,000 | | | | | $ | 4.24 | | | | | $ | 50,880 | | | |
Cash (exercise of warrants)
|
|
January 11, 2022
|
| | | | 62,500 | | | | | $ | 1.14 | | | | | $ | 71,250 | | | |
Cash (exercise of options)
|
|
January 13, 2022
|
| | | | 10,000 | | | | | $ | 2.25 | | | | | $ | 22,500 | | | |
Cash (exercise of options)
|
|
January 14, 2022
|
| | | | 37,000 | | | | | $ | 1.00 | | | | | $ | 37,000 | | | |
Cash (exercise of options)
|
|
January 14, 2022
|
| | | | 195,000 | | | | | $ | 1.00 | | | | | $ | 195,000 | | | |
Cash (exercise of options)
|
|
January 15, 2022
|
| | | | 25,000 | | | | | $ | 2.99 | | | | | $ | 74,750 | | | |
Cash (exercise of options)
|
|
January 17, 2022
|
| | | | 10,000 | | | | | $ | 2.25 | | | | | $ | 22,500 | | | |
Cash (exercise of options)
|
|
January 18, 2022
|
| | | | 16,320 | | | | | $ | 11.92 | | | | | $ | 194,534 | | | |
股票發行(行使限制性股票單位)
|
|
January 19, 2022
|
| | | | 10,000 | | | | | $ | 2.25 | | | | | $ | 22,500 | | | |
Cash (exercise of options)
|
|
January 24, 2022
|
| | | | 20,000 | | | | | $ | 2.25 | | | | | $ | 45,000 | | | |
Cash (exercise of options)
|
|
January 25, 2022
|
| | | | 20,000 | | | | | $ | 2.25 | | | | | $ | 45,000 | | | |
Cash (exercise of options)
|
|
January 26, 2022
|
| | | | 30,000 | | | | | $ | 2.25 | | | | | $ | 67,500 | | | |
Cash (exercise of options)
|
|
February 1, 2022
|
| | | | 1,720 | | | | | $ | 5.96 | | | | | $ | 10,251 | | | |
股票發行(與收購Origin House有關)
|
|
February 3, 2022
|
| | | | 16,334 | | | | | $ | 11.42 | | | | | $ | 186,534 | | | |
股票發行(行使限制性股票單位)
|
|
Date Issued
|
| |
Number of
Cresco Securities |
| |
Issue Price
per Unit ($) |
| |
Aggregate
Issue Price ($) |
| |
對價的性質
|
| |||||||||
February 4, 2022
|
| | | | 75,562 | | | | | $ | 6.86 | | | | | $ | 518,355 | | | |
股票發行(行使限制性股票單位)
|
|
February 10, 2022
|
| | | | 1,000,000 | | | | | $ | 7.52 | | | | | $ | 7,520,000 | | | |
換股(可贖回股份)
|
|
February 10, 2022
|
| | | | 6,250 | | | | | $ | 5.90 | | | | | $ | 36,875 | | | |
Cash (exercise of options)
|
|
February 21, 2022
|
| | | | 37,500 | | | | | $ | 6.86 | | | | | $ | 257,250 | | | |
股票發行(行使限制性股票單位)
|
|
March 7, 2022
|
| | | | 10,000 | | | | | $ | 3.75 | | | | | $ | 37,500 | | | |
Cash (exercise of options)
|
|
March 9, 2022
|
| | | | 7,500 | | | | | $ | 3.75 | | | | | $ | 28,125 | | | |
Cash (exercise of options)
|
|
March 15, 2022
|
| | | | 1,253 | | | | | $ | 13.41 | | | | | $ | 16,803 | | | |
股票發行(行使限制性股票單位)
|
|
March 23, 2022
|
| | | | 700,000 | | | | | $ | 6.51 | | | | | $ | 4,557,000 | | | |
換股(可贖回股份)
|
|
April 4, 2022
|
| | | | 115,000 | | | | | $ | 6.00 | | | | | | 690,000 | | | |
股票發行(行使限制性股票單位)
|
|
April 7, 2022
|
| | | | 2,388 | | | | | $ | 9.39 | | | | | | 22,423 | | | |
股票發行(行使限制性股票單位)
|
|
April 18, 2022
|
| | | | 27,500 | | | | | $ | 3.75 | | | | | | 103,125 | | | |
Cash (exercise of options)
|
|
April 27, 2022
|
| | | | 50,000 | | | |
$ 1.14 – $3.75
|
| | | | 122,500 | | | |
Cash (exercise of options)
|
|
Options Issued
|
| |||||||||||||||||||||
Date Issued
|
| |
Number of
Units |
| |
Exercise Price
per Unit ($) |
| |
Total Aggregate
Proceeds Assuming the Exercise of all Options |
| |
Nature of
Consideration |
| |||||||||
April 28, 2021
|
| |
200,000 Options to
purchase Subordinate Voting Shares |
| | | $ | 12.26 | | | | | $ | 2,452,000 | | | | | | 現金 | | |
June 30, 2021
|
| |
1,144,355 Options to
purchase Subordinate Voting Shares |
| | | $ | 11.42 | | | | | $ | 13,068,534 | | | | | | 現金 | | |
September 30, 2021
|
| |
511,100 Options to
purchase Subordinate Voting Shares |
| | | $ | 9.41 | | | | | $ | 4,809,451 | | | | | | 現金 | | |
December 31, 2021
|
| |
453,750 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.62 | | | | | $ | 3,003,825 | | | | | | 現金 | | |
January 4, 2022
|
| |
1,293,073 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.49 | | | | | $ | 8,392,044 | | | | | | 現金 | | |
Options Issued
|
| |||||||||||||||||||||
Date Issued
|
| |
Number of
Units |
| |
Exercise Price
per Unit ($) |
| |
Total Aggregate
Proceeds Assuming the Exercise of all Options |
| |
Nature of
Consideration |
| |||||||||
January 15, 2022
|
| |
250,000 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.91 | | | | | $ | 1,727,500 | | | | | | 現金 | | |
March 15, 2022
|
| |
284,971 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.62 | | | | | $ | 1,886,508 | | | | | | 現金 | | |
March 31, 2022
|
| |
441,204 Options to
purchase Subordinate Voting Shares |
| | | $ | 6.03 | | | | | $ | 2,660,460 | | | | | | 現金 | | |
PVS轉換為Cresco股票
|
| ||||||||||||
Date Issued
|
| |
Number of PVS
|
| |
轉換時發行的Cresco股票數量
|
| ||||||
• – • | | | |
|
•
|
| | | |
|
•
|
| |
Industry Involvement
|
| |
公平地披露必要的具體信息
展示所有重要事實、風險和 Uncertainties |
| |
附錄J對照參考
|
|
所有從事美國大麻相關活動的發行商
|
| | 描述發行人參與美國大麻行業的性質,幷包括下表所示的至少一種直接、間接和輔助行業參與類型的披露。 | | |
業務總體發展
Description of the
商業 - 州級美國大麻業務 |
|
| | | 突出表示,根據美國聯邦法律,大麻是非法的,執行相關法律是一個重大風險。 | | |
Risk Factors
|
|
| | |
討論聯邦當局或檢察官就發行者進行美國大麻相關活動的任何司法管轄區的執法行動風險所作的任何聲明和其他可用的指導。概述相關風險,其中包括第三方服務提供商可能暫停或撤回服務的風險,以及監管機構可能對發行人在美國的運營能力施加某些限制的風險。
|
| |
風險因素 - 美國聯邦法規
危險因素 - 食品和藥物管理局或煙酒槍械和爆炸物管理局法規
風險因素國家規定的 - 變化
風險因素 - 反洗錢法律法規
Risk Factors — Access to Banks
風險因素 - 在美國的投資可能會受到
|
|
Industry Involvement
|
| |
公平地披露必要的具體信息
展示所有重要事實、風險和 Uncertainties |
| |
附錄J對照參考
|
|
| | | | | |
Heightened Scrutiny
營銷產品的風險因素 - 約束
風險因素 - 知識產權
風險因素 - 無法獲得美國破產保護
風險因素合同的 - 合法性
民事資產沒收的風險因素 - 風險
|
|
| | | 鑑於根據美國聯邦法律,大麻是非法的,討論發行人獲得公共和私人資本的能力,並指出為了支持持續運營,可以/不可以使用哪些融資選擇。 | | |
風險因素法律、監管或政治變革的 - 風險
Risk Factors — Access to Banks
|
|
| | | 量化發行人對美國大麻相關活動的資產負債表和經營報表敞口。 | | | 注:Cresco的主要業務僅在美國。 | |
| | | 披露是否未以法律意見或其他形式獲得關於(A)遵守適用的州監管框架和(B)美國聯邦法律可能產生的風險和影響的法律意見。 | | | 已獲得法律諮詢。 | |
直接參與種植或分銷的美國大麻發行商
|
| | 概述發行人所在的美國各州的法規,並確認發行人如何遵守適用的許可要求以及適用的美國州制定的監管框架。 | | |
商業 - 州級美國大麻業務説明
|
|
| | | 討論發行人持續監測美國州法律合規性的計劃,概述內部合規程序,並提供積極的聲明,表明發行人遵守美國州法律和相關的許可框架。及時披露任何可能影響發行人的違規行為、傳票或違規通知 | | |
商業 - 美國行業背景和趨勢的總體發展
商業 - 州級美國大麻業務説明
風險因素 - 美國州監管不確定性
|
|
Industry Involvement
|
| |
公平地披露必要的具體信息
展示所有重要事實、風險和 Uncertainties |
| |
附錄J對照參考
|
|
| | | 許可證、業務活動或運營。 | | | | |
間接參與種植或分銷的美國大麻發行商
|
| | 概述發行人投資對象所在的美國各州的法規。 | | | Not applicable. | |
| | | 通過正面或負面聲明提供合理保證,確保被投資方的業務符合適用的許可要求和適用的美國州制定的監管框架。 | | | Cresco不知道有任何違規行為。 | |
有重大輔助參與的美國大麻發行商
|
| | 通過正面或負面聲明提供合理保證,即適用客户或被投資人的業務符合適用的許可要求和適用的美國州制定的監管框架。 | | | Not applicable. | |
| | |
As at
March 31, 2022 (before Arrangement) |
| |
Pro Forma
Adjustment |
| |
Pro Forma as
at March 31, 2022 (after Arrangement) |
| |||||||||
Indebtedness | | | | | | | | | | | | | | | | | | | |
長期應付票據和應付貸款合計(美元)
|
| | | | 466,076,000 | | | | | | | | | | | | 466,076,000 | | |
股東權益 | | | | | | | | | | | | | | | | | | | |
MVS(1) | | | | | 500,000 | | | | | | | | | | | | 500,000 | | |
Cresco Shares(2)
|
| | | | 272,635,721 | | | | | | 235,087,248(3) | | | | | | 507,722,969 | | |
PVS(4) | | | | | 20,472,294 | | | | | | | | | | | | 20,472,294 | | |
Cresco Redeemable Units(5)
|
| | | | 107,740,164 | | | | | | | | | | | | 107,740,164 | | |
SSVS
(以轉換為Cresco股票的方式列報) |
| | | | 639 | | | | | | | | | | | | 639 | | |
Cresco股票未償還
(按轉換後的Cresco股票計算) |
| | | | 401,348,818 | | | | | | | | | | | | 636,436,066 | | |
Options
|
| | | | 24,840,979 | | | | | | | | | | | | 24,840,979 | | |
Warrants(6) | | | | | 9,519,554 | | | | | | | | | | | | 9,519,554 | | |
Restricted share units
|
| | | | 4,167,648 | | | | | | | | | | | | 4,167,648 | | |
完全稀釋的未償還股份(7)
|
| | | | 439,876,999 | | | | | | | | | | | | 674,964,247 | | |
| 未經審計的簡明中期合併財務報表: | | | | | | | |
|
未經審計的簡明中期合併資產負債表
|
| | | | J-136 | | |
|
未經審計的簡明中期合併經營報表
|
| | | | J-137 | | |
|
未經審計的全面虧損簡併中期合併報表
|
| | | | J-138 | | |
|
未經審計的簡明中期合併股東權益變動表
|
| | | | J-139 | | |
|
未經審計的現金流量簡略中期合併報表
|
| | | | J-140 | | |
|
未經審計的簡明中期合併財務報表附註
|
| | | | J-142 | | |
| | |
March 31,
2022 |
| |
December 31,
2021 |
| ||||||
ASSETS | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 179,320 | | | | | $ | 223,543 | | |
受限現金
|
| | | | 2,600 | | | | | | 2,559 | | |
應收賬款,淨額
|
| | | | 48,691 | | | | | | 43,379 | | |
Inventory, net
|
| | | | 156,432 | | | | | | 136,643 | | |
短期應收貸款
|
| | | | — | | | | | | 1,312 | | |
其他流動資產
|
| | | | 12,757 | | | | | | 14,319 | | |
流動資產總額
|
| | | | 399,800 | | | | | | 421,755 | | |
Non-current assets: | | | | | | | | | | | | | |
財產和設備,淨額
|
| | | | 394,994 | | | | | | 369,092 | | |
使用權資產
|
| | | | 90,150 | | | | | | 88,017 | | |
無形資產,淨額
|
| | | | 435,930 | | | | | | 437,644 | | |
長期應收貸款
|
| | | | 1,234 | | | | | | 505 | | |
Investments
|
| | | | 4,288 | | | | | | 5,912 | | |
Goodwill
|
| | | | 448,336 | | | | | | 446,767 | | |
遞延納税資產
|
| | | | 5,997 | | | | | | 6,561 | | |
其他非流動資產
|
| | | | 4,208 | | | | | | 4,210 | | |
非流動資產合計
|
| | | | 1,385,137 | | | | | | 1,358,708 | | |
TOTAL ASSETS
|
| | | $ | 1,784,937 | | | | | $ | 1,780,463 | | |
負債和股東權益 | | | | | | | | | | | | | |
LIABILITIES | | | | | | | | | | | | | |
流動負債: | | | | | | | | | | | | | |
應付賬款
|
| | | $ | 33,285 | | | | | $ | 32,278 | | |
應計負債
|
| | | | 95,962 | | | | | | 95,442 | | |
短期借款
|
| | | | 29,202 | | | | | | 19,928 | | |
應付所得税
|
| | | | 64,180 | | | | | | 46,949 | | |
租賃負債的當期部分
|
| | | | 21,137 | | | | | | 20,792 | | |
延期對價、或有對價和其他短期應付款項
|
| | | | 86,619 | | | | | | 71,833 | | |
短期衍生負債
|
| | | | 809 | | | | | | 1,172 | | |
流動負債總額
|
| | | | 331,194 | | | | | | 288,394 | | |
非流動負債: | | | | | | | | | | | | | |
長期應付票據和應付貸款
|
| | | | 466,076 | | | | | | 465,079 | | |
租賃負債
|
| | | | 124,104 | | | | | | 118,936 | | |
遞延納税義務
|
| | | | 84,206 | | | | | | 85,666 | | |
延期考慮,長期考慮
|
| | | | 8,607 | | | | | | 17,651 | | |
其他長期負債
|
| | | | 7,005 | | | | | | 7,001 | | |
非流動負債合計
|
| | | | 689,998 | | | | | | 694,333 | | |
總負債
|
| | | | 1,021,192 | | | | | | 982,727 | | |
承付款和或有事項(附註15) | | | | | | | | | | | | | |
SHAREHOLDERS’ EQUITY | | | | | | | | | | | | | |
超級投票權股份,無面值;500,000股分別於2022年3月31日和2021年12月31日授權、發行和發行
|
| | | | | | | | | | | | |
次表決權股份,無面值;授權無限股份;分別於2022年3月31日和2021年12月31日發行和發行272,629,692股和270,033,270股
|
| | | | | | | | | | | | |
比例投票權份額1,無面值;授權無限股份,分別於2022年3月31日和2021年12月31日發行和發行20,472,294股和20,667,206股
|
| | | | | | | | | | | | |
特殊從屬投票股份2,無面值;639股分別於2022年3月31日和2021年12月31日授權、發行和發行
|
| | | | | | | | | | | | |
股本
|
| | | | 1,607,452 | | | | | | 1,597,715 | | |
累計其他綜合損失
|
| | | | (444) | | | | | | (254) | | |
累計赤字
|
| | | | (880,395) | | | | | | (841,907) | | |
Cresco Labs Inc.的股權
|
| | | | 726,613 | | | | | | 755,554 | | |
非控股權益
|
| | | | 37,132 | | | | | | 42,182 | | |
股東權益總額
|
| | | | 763,745 | | | | | | 797,736 | | |
總負債和股東權益
|
| | | $ | 1,784,937 | | | | | $ | 1,780,463 | | |
| | |
Three Months Ended March 31,
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
Revenue, net
|
| | | $ | 214,391 | | | | | $ | 178,437 | | |
銷售商品的成本
|
| | | | 107,018 | | | | | | 91,414 | | |
Gross profit
|
| | | | 107,373 | | | | | | 87,023 | | |
Operating expenses: | | | | | | | | | | | | | |
銷售、一般和行政
|
| | | | 87,106 | | | | | | 70,785 | | |
總運營費用
|
| | | | 87,106 | | | | | | 70,785 | | |
營業收入
|
| | | | 20,267 | | | | | | 16,238 | | |
Other expense: | | | | | | | | | | | | | |
利息支出,淨額
|
| | | | (14,363) | | | | | | (11,302) | | |
其他費用,淨額
|
| | | | (6,772) | | | | | | (12,340) | | |
權益法投資虧損
|
| | | | — | | | | | | (1,196) | | |
其他費用合計,淨額
|
| | | | (21,135) | | | | | | (24,838) | | |
所得税前虧損
|
| | | | (868) | | | | | | (8,600) | | |
所得税費用
|
| | | | (22,807) | | | | | | (15,524) | | |
Net loss
|
| | | | (23,675) | | | | | | (24,124) | | |
可歸因於非控股權益的税後淨收入
|
| | | | 3,706 | | | | | | 5,269 | | |
Cresco Labs Inc.的淨虧損。
|
| | | $ | (27,381) | | | | | $ | (29,393) | | |
可歸因於克雷斯科實驗室公司股東的每股淨虧損 - : | | | | | | | | | | | | | |
每股基本和攤薄虧損
|
| | | $ | (0.09) | | | | | $ | (0.12) | | |
基本和稀釋加權平均流通股數量
|
| | | | 292,719,359 | | | | | | 237,701,059 | | |
| | |
Three Months Ended March 31,
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
Net loss
|
| | | $ | (23,675) | | | | | $ | (24,124) | | |
扣除税後的外幣折算差額
|
| | | | (190) | | | | | | 354 | | |
本期綜合虧損合計
|
| | | | (23,865) | | | | | | (23,770) | | |
非控股權益應佔綜合收益,税後淨額
|
| | | | 3,706 | | | | | | 5,269 | | |
可歸因於Cresco Labs Inc.的全面損失總額。
|
| | | $ | (27,571) | | | | | $ | (29,039) | | |
| | |
Share capital
|
| |
Accumulated
Deficit |
| |
Accumulated
other comprehensive loss, net of tax |
| |
Non-controlling
interests |
| |
Total
|
| |||||||||||||||
Balance as of January 1, 2021
|
| | | $ | 802,264 | | | | | $ | (328,380) | | | | | $ | (647) | | | | | $ | 102,095 | | | | | $ | 575,332 | | |
行使期權和認股權證
|
| | | | 1,956 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,956 | | |
股權薪酬
|
| | | | 6,207 | | | | | | — | | | | | | — | | | | | | — | | | | | | 6,207 | | |
某些基於股份的支付安排的員工税
|
| | | | 13,139 | | | | | | — | | | | | | — | | | | | | — | | | | | | 13,139 | | |
所得税準備金
|
| | | | — | | | | | | 80 | | | | | | — | | | | | | — | | | | | | 80 | | |
與收購相關的股票發行
|
| | | | 2,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,000 | | |
私募發行,扣除成本
|
| | | | 123,469 | | | | | | — | | | | | | — | | | | | | — | | | | | | 123,469 | | |
股票發行
|
| | | | 15,790 | | | | | | — | | | | | | — | | | | | | — | | | | | | 15,790 | | |
分配給非控股股東
|
| | | | (2,165) | | | | | | — | | | | | | — | | | | | | (3,980) | | | | | | (6,145) | | |
Cresco LLC股票贖回和其他調整
|
| | | | 93,264 | | | | | | (85,538) | | | | | | — | | | | | | (5,403) | | | | | | 2,323 | | |
外幣折算
|
| | | | — | | | | | | — | | | | | | 354 | | | | | | — | | | | | | 354 | | |
Net income (loss)
|
| | | | — | | | | | | (29,393) | | | | | | — | | | | | | 5,269 | | | | | | (24,124) | | |
Balance as of March 31, 2021
|
| | | $ | 1,055,924 | | | | | $ | (443,231) | | | | | $ | (293) | | | | | $ | 97,981 | | | | | $ | 710,381 | | |
Balance as of January 1, 2022
|
| | | $ | 1,597,715 | | | | | $ | (841,907) | | | | | $ | (254) | | | | | $ | 42,182 | | | | | | 797,736 | | |
行使期權和認股權證
|
| | | | 358 | | | | | | — | | | | | | — | | | | | | — | | | | | | 358 | | |
股權薪酬
|
| | | | 7,727 | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,727 | | |
某些基於股份的支付安排的員工税
|
| | | | (87) | | | | | | — | | | | | | — | | | | | | — | | | | | | (87) | | |
所得税準備金
|
| | | | — | | | | | | 78 | | | | | | — | | | | | | — | | | | | | 78 | | |
根據應收税金協議應付
|
| | | | (163) | | | | | | — | | | | | | — | | | | | | — | | | | | | (163) | | |
股東贖回帶來的税收優惠
|
| | | | 186 | | | | | | — | | | | | | — | | | | | | — | | | | | | 186 | | |
分配給非控股股東
|
| | | | (9,992) | | | | | | — | | | | | | — | | | | | | (8,233) | | | | | | (18,225) | | |
Cresco LLC股票贖回和其他調整
|
| | | | 11,708 | | | | | | (11,185) | | | | | | — | | | | | | (523) | | | | | | — | | |
外幣折算
|
| | | | — | | | | | | — | | | | | | (190) | | | | | | — | | | | | | (190) | | |
Net income (loss)
|
| | | | — | | | | | | (27,381) | | | | | | — | | | | | | 3,706 | | | | | | (23,675) | | |
Balance as of March 31, 2022
|
| | | $ | 1,607,452 | | | | | $ | (880,395) | | | | | $ | (444) | | | | | $ | 37,132 | | | | | $ | 763,745 | | |
| | |
Three Months Ended March 31,
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
經營活動現金流: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (23,675) | | | | | $ | (24,124) | | |
將淨虧損與經營活動中使用的現金淨額進行調整:
|
| | | | | | | | | | | | |
折舊和攤銷
|
| | | | 10,960 | | | | | | 10,151 | | |
經營性租賃資產攤銷
|
| | | | 1,116 | | | | | | 1,845 | | |
壞賬費用和預期信貸損失準備費用
|
| | | | (518) | | | | | | 158 | | |
基於股份的薪酬費用
|
| | | | 7,506 | | | | | | 6,280 | | |
投資的損益
|
| | | | 1,693 | | | | | | (6,812) | | |
遞延和或有對價的公允價值變動損失
|
| | | | 5,667 | | | | | | 11,111 | | |
衍生工具和權證的(收益)損失
|
| | | | (375) | | | | | | 7,654 | | |
庫存核銷和撥備損失
|
| | | | 902 | | | | | | — | | |
遞延税金變動
|
| | | | (208) | | | | | | (3,492) | | |
債務的貼現和遞延融資成本增加
安排 |
| | | | 934 | | | | | | 1,420 | | |
外幣(收益)損失
|
| | | | (69) | | | | | | 406 | | |
(收益)淨虧損,對淨收入的其他調整
|
| | | | — | | | | | | (1,828) | | |
結算收益
|
| | | | — | | | | | | (810) | | |
資產剝離虧損
|
| | | | — | | | | | | 3,634 | | |
經營性資產和負債的變化:
|
| | | | | | | | | | | | |
應收賬款
|
| | | | (6,624) | | | | | | (6,052) | | |
Inventory
|
| | | | (19,762) | | | | | | (6,664) | | |
Other assets
|
| | | | 528 | | | | | | 45 | | |
應付賬款和其他應計費用
|
| | | | 7,073 | | | | | | 6,013 | | |
經營租賃負債
|
| | | | (4,688) | | | | | | (3,931) | | |
其他流動負債
|
| | | | — | | | | | | (185) | | |
應付所得税
|
| | | | 16,122 | | | | | | 18,131 | | |
經營活動提供的現金淨額(已用)
|
| | | | (3,418) | | | | | | 12,950 | | |
投資活動的現金流: | | | | | | | | | | | | | |
購置房產和設備
|
| | | | (35,588) | | | | | | (21,410) | | |
購買無形資產
|
| | | | (1,886) | | | | | | (1,459) | | |
售後回租交易收益和租户改善津貼
|
| | | | 2,886 | | | | | | 5,382 | | |
支付收購對價,扣除收購現金
|
| | | | (1,085) | | | | | | (140) | | |
資產剝離收益,扣除轉賬現金後的淨額
|
| | | | — | | | | | | 69 | | |
收取貸款和墊款的收據
|
| | | | 2,654 | | | | | | — | | |
擬收購實體的貸款和墊款
|
| | | | (1,200) | | | | | | (9,232) | | |
用於投資活動的現金淨額
|
| | | | (34,219) | | | | | | (26,790) | | |
| | |
Three Months Ended March 31,
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
融資活動的現金流: | | | | | | | | | | | | | |
1月發售的收益
|
| | | | — | | | | | | 124,105 | | |
償還債務、融資發行成本和非延期貸款費
|
| | | | — | | | | | | (3,488) | | |
行使股票期權、認股權證和認股權證所得收益
|
| | | | 2,424 | | | | | | 14,991 | | |
與限制性股票單位股票淨結算相關的税款支付
|
| | | | — | | | | | | (140) | | |
分配給非控股權益可贖回單位持有人
|
| | | | (8,233) | | | | | | (2,790) | | |
融資租賃債務本金支付
|
| | | | (556) | | | | | | (472) | | |
融資活動提供的現金淨額(單位:
|
| | | | (6,365) | | | | | | 132,206 | | |
外幣匯率變動對現金的影響
|
| | | | (180) | | | | | | (169) | | |
現金和現金等價物淨(減)增
|
| | | | (44,182) | | | | | | 118,197 | | |
期初現金和現金等價物以及限制性現金
|
| | | | 226,102 | | | | | | 140,774 | | |
現金和現金等價物,期末
|
| | | | 179,320 | | | | | | 255,503 | | |
受限現金,期末
|
| | | | 2,600 | | | | | | 3,468 | | |
現金及現金等價物和受限現金,期末
|
| | | $ | 181,920 | | | | | $ | 258,971 | | |
補充披露現金流信息: | | | | | | | | | | | | | |
期間支付的現金: | | | | | | | | | | | | | |
Income tax, net
|
| | | $ | 6,893 | | | | | $ | 833 | | |
Interest
|
| | | | 4,763 | | | | | | 9,402 | | |
非現金投融資交易: | | | | | | | | | | | | | |
企業合併的非現金對價
|
| | | $ | — | | | | | $ | 25,564 | | |
贖回股權的非控股權益
|
| | | | 612 | | | | | | 5,402 | | |
增加租賃淨負債
|
| | | | 3,508 | | | | | | 2,503 | | |
購買財產、設備和無形資產所產生的責任
|
| | | | 4,791 | | | | | | 16,297 | | |
無現金行使股票期權和認股權證
|
| | | | 470 | | | | | | 951 | | |
未向非控股權益可贖回單位持有人申報的分配
|
| | | | 13,386 | | | | | | 2,174 | | |
融資租賃業務應收賬款
|
| | | | 1,086 | | | | | | — | | |
根據應收税金協議承擔的債務
|
| | | | 163 | | | | | | — | | |
非徵集無形資產股份發行
|
| | | | — | | | | | | 3,000 | | |
發行結算用股票
|
| | | | — | | | | | | 12,790 | | |
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs Inc. | | |
British Columbia, Canada
|
| | Parent Company | | | | |
CannaRoyalty Corp.(原產地)
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Cali-AntiFragile Corp.
|
| | California | | | Holding Company | | |
100%
|
|
Alta Supply Inc. (Continuum)
|
| | California | | | Distribution | | |
100%
|
|
Kaya Management Inc.
|
| | California | | | Production | | |
100%
|
|
River Distributing Co., LLC
|
| | California | | | Distribution | | |
100%
|
|
FloraCal Farms
|
| | California | | | Cultivation | | |
100%
|
|
Cub City, LLC
|
| | California | | | Cultivation | | |
100%
|
|
CRHC Holdings Corp.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Laurel Harvest Labs, LLC
|
| | Pennsylvania | | | 種植和配給設施 | | |
100%
|
|
JDRC Mount Joy, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
JDRC Scranton, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bluma Wellness Inc.
|
| |
British Columbia, Canada
|
| | Holding Company | | |
100%
|
|
CannCure Investments Inc.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
大麻治癒投資有限責任公司
|
| | Florida | | | Holding Company | | |
100%
|
|
3 Boys Farm,LLC(佛羅裏達州一家工廠)
|
| | Florida | | |
種植、生產和配給設施
|
| |
100%
|
|
Farm to Fresh Holdings, LLC
|
| | Florida | | | 種植、生產和配給設施 | | |
100%
|
|
Cresco U.S. Corp.
|
| | Illinois | | | Cresco Labs LLC經理 | | |
100%
|
|
MedMar Inc.
|
| | Illinois | | | Holding Company | | |
100%
|
|
MedMar Lakeview, LLC
|
| | Illinois | | | Dispensary | | |
88%
|
|
MedMar Rockford, LLC
|
| | Illinois | | | Dispensary | | |
75%
|
|
Gloucester Street Capital,LLC
|
| | New York | | | Holding Company | | |
100%
|
|
山谷農業有限責任公司
|
| | New York | | | Operating Entity | | |
100%
|
|
JDRC Ellenville, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
CMA Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BL Real Estate, LLC
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培育許可有限責任公司
|
| | Massachusetts | | | 種植、生產和配給 | | |
100%
|
|
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
| | | | | | Facility | | | | |
Cultivate Worcester, Inc
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Leicester, Inc
|
| | Massachusetts | | | 種植、生產和配給設施 | | |
100%
|
|
培育Framingham,Inc.
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Burncoat, Inc
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培植公司
|
| | Massachusetts | | | 種植和生產實體 | | |
100%
|
|
Good News Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Wonder Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BW Maryland Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
JDRC Seed, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
CP賓夕法尼亞控股有限責任公司
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bay, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Bay Asset Management, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Ridgeback, LLC
|
| | Colorado | | | Holding Company | | |
100%
|
|
Cresco Labs, LLC
|
| | Illinois | | | Operating Entity | | |
57%
|
|
Cresco Labs Notes Issuer,LLC
|
| | Illinois | | | Holding Company | | | | |
Cresco Labs Ohio, LLC
|
| | Ohio | | | 種植、生產和配給設施 | | |
99%
|
|
Wellbeings, LLC
|
| | Delaware | | | CBD健康產品開發 | | |
100%
|
|
Cresco Labs SLO, LLC
|
| | California | | | Holding Company | | |
100%
|
|
SLO Cultivation Inc.
|
| | California | | | 種植和生產設施 | | |
80%
|
|
Cresco Labs Joliet, LLC
|
| | Illinois | | | 種植和生產設施 | | |
100%
|
|
Cresco Labs Kankakee, LLC
|
| | Illinois | | | 種植和生產設施 | | |
100%
|
|
Cresco Labs Logan, LLC
|
| | Illinois | | | 種植和生產設施 | | |
100%
|
|
Cresco Labs PA, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Cresco Yeltrah, LLC
|
| | Pennsylvania | | | 種植、生產和配給設施 | | |
100%
|
|
JDC Newark, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
紐瓦克綠地創造有限責任公司
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Marion, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Marion,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Chillicothe, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Chillicothe,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Columbus, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Care Med Associates, LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
Cresco Labs Arizona, LLC
|
| | Arizona | | | Holding Company | | |
100%
|
|
亞利桑那州設施供應有限責任公司
|
| | Arizona/Maryland | | | 種植、生產和配給設施 | | |
100%
|
|
Cresco Labs Tinad, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
PDI Medical III, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
克雷斯科實驗室鳳凰農場有限責任公司
|
| | Illinois | | | Holding Company | | |
100%
|
|
伊利諾伊州鳳凰農場有限責任公司
|
| | Illinois | | | Dispensary | | |
100%
|
|
JDC Elmwood, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
FloraMedex, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
Cresco Edibles, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
TSC Cresco, LLC
|
| | Illinois | | | Licensing | | |
75%
|
|
Cresco HHH, LLC
|
| | Massachusetts | | | 種植、生產和配給設施 | | |
100%
|
|
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs Michigan, LLC(a)
|
| | Michigan | | | 種植和生產設施 | | |
85%
|
|
| | |
Three Months Ended
March 31, |
| |||||||||
(In thousands)
|
| |
2022
|
| |
2021
|
| ||||||
可贖回股票
|
| | | | 108,833 | | | | | | 121,927 | | |
Options
|
| | | | 24,842 | | | | | | 14,482 | | |
Warrants
|
| | | | 9,520 | | | | | | 2,185 | | |
RSUs
|
| | | | 4,085 | | | | | | 631 | | |
潛在稀釋股份總數
|
| | | | 147,280 | | | | | | 139,225 | | |
($ in thousands)
|
| |
March 31,
2022 |
| |
December 31,
2021 |
| ||||||
原材料
|
| | | $ | 38,771 | | | | | $ | 38,618 | | |
原料 - 非大麻
|
| | | | 37,603 | | | | | | 22,260 | | |
在製品
|
| | | | 28,088 | | | | | | 26,561 | | |
成品
|
| | | | 51,970 | | | | | | 49,204 | | |
總庫存
|
| | | $ | 156,432 | | | | | $ | 136,643 | | |
($ in thousands)
|
| |
Land and
Buildings |
| |
Machinery
and Equipment |
| |
Furniture
and Fixtures |
| |
Leasehold
Improvements |
| |
Website,
Computer Equipment and Software |
| |
Vehicles
|
| |
Construction
In Progress |
| |
Total
|
| ||||||||||||||||||||||||
Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2022
|
| | | $ | 146,884 | | | | | $ | 38,968 | | | | | $ | 26,227 | | | | | $ | 152,778 | | | | | $ | 8,148 | | | | | $ | 3,258 | | | | | $ | 42,847 | | | | | $ | 419,110 | | |
Additions
|
| | | | 21,168 | | | | | | 800 | | | | | | 994 | | | | | | 1,202 | | | | | | 413 | | | | | | 9 | | | | | | 8,625 | | | | | | 33,211 | | |
Transfers
|
| | | | 10 | | | | | | 137 | | | | | | 156 | | | | | | 645 | | | | | | 371 | | | | | | — | | | | | | (1,319) | | | | | | — | | |
Disposals
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
測算期調整
|
| | | | 1,829 | | | | | | (210) | | | | | | 929 | | | | | | (1,348) | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,200 | | |
外匯和其他調整的影響
|
| | | | 252 | | | | | | — | | | | | | (86) | | | | | | (277) | | | | | | 1 | | | | | | (20) | | | | | | 20 | | | | | | (110) | | |
As of March 31, 2022
|
| | | $ | 170,143 | | | | | $ | 39,695 | | | | | $ | 28,220 | | | | | $ | 153,000 | | | | | $ | 8,933 | | | | | $ | 3,247 | | | | | $ | 50,173 | | | | | $ | 453,411 | | |
累計折舊 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2022
|
| | | $ | (7,498) | | | | | $ | (6,821) | | | | | $ | (7,579) | | | | | $ | (23,149) | | | | | $ | (3,927) | | | | | $ | (1,044) | | | | | $ | — | | | | | $ | (50,018) | | |
折舊
|
| | | | (1,404) | | | | | | (1,300) | | | | | | (1,433) | | | | | | (3,588) | | | | | | (508) | | | | | | (168) | | | | | | — | | | | | | (8,401) | | |
Disposals
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Adjustments
|
| | | | | | | | | | | | | | | | 3 | | | | | | — | | | | | | (1) | | | | | | — | | | | |
|
—
|
| | | | | 2 | | |
As of March 31, 2022
|
| | | $ | (8,902) | | | | | $ | (8,121) | | | | | $ | (9,009) | | | | | $ | (26,737) | | | | | $ | (4,436) | | | | | $ | (1,212) | | | | | $ | — | | | | | $ | (58,417) | | |
Net book value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
As of December 31, 2021
|
| | | $ | 139,386 | | | | | $ | 32,147 | | | | | $ | 18,648 | | | | | $ | 129,629 | | | | | $ | 4,221 | | | | | $ | 2,214 | | | | | $ | 42,847 | | | | | $ | 369,092 | | |
As of March 31, 2022
|
| | | $ | 161,241 | | | | | $ | 31,574 | | | | | $ | 19,211 | | | | | $ | 126,263 | | | | | $ | 4,497 | | | | | $ | 2,035 | | | | | $ | 50,173 | | | | | $ | 394,994 | | |
($ in thousands)
|
| |
March 31,
2022 |
| |
December 31,
2021 |
| ||||||
420 Capital
|
| | | $ | 68 | | | | | $ | 68 | | |
Lighthouse
|
| | | | 627 | | | | | | 542 | | |
Old Pal
|
| | | | 592 | | | | | | 592 | | |
IMC
|
| | | | 3,001 | | | | | | 4,710 | | |
總投資
|
| | | $ | 4,288 | | | | | $ | 5,912 | | |
($ in thousands)
|
| |
Customer
Relationships |
| |
Trade
Names |
| |
Permit
Application Costs |
| |
Licenses
|
| |
Other
Intangibles(a) |
| |
Goodwill
|
| |
Total
|
| |||||||||||||||||||||
Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at January 1, 2022
|
| | | $ | 31,879 | | | | | $ | 2,100 | | | | | $ | 11,921 | | | | | $ | 404,307 | | | | | $ | 6,284 | | | | | $ | 446,767 | | | | | $ | 903,258 | | |
Additions
|
| | | | — | | | | | | — | | | | | | 1,886 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,886 | | |
測算期調整
|
| | | | — | | | | | | — | | | | | | — | | | | | | (1,000) | | | | | | — | | | | | | 1,569 | | | | | | 569 | | |
Disposals
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Balance at March 31, 2022
|
| | | $ | 31,879 | | | | | $ | 2,100 | | | | | $ | 13,807 | | | | | $ | 403,307 | | | | | $ | 6,284 | | | | | $ | 448,336 | | | | | $ | 905,713 | | |
累計攤銷 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at January 1, 2022
|
| | | $ | (4,197) | | | | | $ | (695) | | | | | $ | (10,448) | | | | | $ | — | | | | | $ | (3,507) | | | | | $ | — | | | | | $ | (18,847) | | |
攤銷
|
| | | | (924) | | | | | | (438) | | | | | | (674) | | | | | | — | | | | | | (564) | | | | | | — | | | | | | (2,600) | | |
Balance at March 31, 2022
|
| | | $ | (5,121) | | | | | $ | (1,133) | | | | | $ | (11,122) | | | | | $ | — | | | | | $ | (4,071) | | | | | $ | — | | | | | $ | (21,447) | | |
Net book value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
December 31, 2021
|
| | | $ | 27,682 | | | | | $ | 1,405 | | | | | $ | 1,473 | | | | | $ | 404,307 | | | | | $ | 2,777 | | | | | $ | 446,767 | | | | | $ | 884,411 | | |
March 31, 2022
|
| | | $ | 26,758 | | | | | $ | 967 | | | | | $ | 2,685 | | | | | $ | 403,307 | | | | | $ | 2,213 | | | | | $ | 448,336 | | | | | $ | 884,266 | | |
($ in thousands)
|
| | | | | | |
2022
|
| | | $ | 7,334 | | |
2023
|
| | | | 5,068 | | |
2024
|
| | | | 4,226 | | |
2025
|
| | | | 4,092 | | |
2026
|
| | | | 3,966 | | |
Thereafter
|
| | | | 7,937 | | |
預計攤銷總額
|
| | | $ | 32,623 | | |
(In thousands)
|
| |
Redeemable
Units |
| |
SVS*
|
| |
PVS**
|
| |
MVS
|
| |
SSVS***
|
| |||||||||||||||
期初餘額,2022年1月1日
|
| | | | 109,441 | | | | | | 269,971 | | | | | | 20,667 | | | | | | 500 | | | | | | 1 | | |
行使期權和認股權證
|
| | | | — | | | | | | 465 | | | | | | — | | | | | | — | | | | | | — | | |
RSUs issued
|
| | | | — | | | | | | 225 | | | | | | — | | | | | | — | | | | | | — | | |
Cresco LLC贖回
|
| | | | (1,701) | | | | | | 1,701 | | | | | | — | | | | | | — | | | | | | — | | |
PVS轉換為SVS
|
| | | | — | | | | | | 195 | | | | | | (195) | | | | | | — | | | | | | — | | |
與某些基於股份的支付安排的員工税有關的問題
|
| | | | — | | | | | | 79 | | | | | | — | | | | | | — | | | | | | — | | |
Ending balance, March 31, 2022
|
| | | | 107,740 | | | | | | 272,636 | | | | | | 20,472 | | | | | | 500 | | | | | | 1 | | |
(In thousands)
|
| |
Redeemable
Units |
| |
SVS*
|
| |
PVS**
|
| |
MVS
|
| |
SSVS***
|
| |||||||||||||||
期初餘額,2021年1月1日
|
| | | | 126,338 | | | | | | 194,231 | | | | | | 29,311 | | | | | | 500 | | | | | | 1 | | |
行使期權和認股權證
|
| | | | — | | | | | | 1,297 | | | | | | — | | | | | | — | | | | | | — | | |
RSUs issued
|
| | | | — | | | | | | 37 | | | | | | — | | | | | | — | | | | | | — | | |
與收購相關的股票發行
|
| | | | — | | | | | | 206 | | | | | | — | | | | | | — | | | | | | — | | |
Cresco LLC贖回
|
| | | | (6,977) | | | | | | 6,977 | | | | | | — | | | | | | — | | | | | | — | | |
PVS轉換為SVS
|
| | | | — | | | | | | 6,630 | | | | | | (6,630) | | | | | | — | | | | | | — | | |
股票發行
|
| | | | — | | | | | | 11,159 | | | | | | — | | | | | | — | | | | | | — | | |
Ending balance, March 31, 2021
|
| | | | 119,361 | | | | | | 220,537 | | | | | | 22,681 | | | | | | 500 | | | | | | 1 | | |
| | |
Number of warrants*
(In thousands) |
| |
Weighted-average
exercise price |
| ||||||
Balance as of January 1, 2022
|
| | | | 9,842 | | | | | $ | 9.63 | | |
Exercised
|
| | | | (12) | | | | | | 4.24 | | |
Forfeited
|
| | | | (310) | | | | | | 11.64 | | |
Balance as of March 31, 2022
|
| | | | 9,520 | | | | | $ | 9.82 | | |
| | |
Number of warrants*
(In thousands) |
| |
Weighted-average
exercise price |
| ||||||
Balance as of January 1, 2021
|
| | | | 6,183 | | | | | $ | 7.80 | | |
Exercised
|
| | | | (518) | | | | | | 4.25 | | |
Balance as of March 31, 2021
|
| | | | 5,665 | | | | | $ | 8.12 | | |
($ in thousands)
|
| |
TSC
Cresco, LLC |
| |
MedMar
Inc. (Lakeview) |
| |
MedMar
Inc. (Rockford) |
| |
Cresco
Labs Ohio, LLC |
| |
SLO
Cultivation Inc. |
| |
Other
entities including Cresco Labs, LLC(1),(3) |
| |
Eliminations
|
| |
Total
|
| ||||||||||||||||||||||||
非流動資產
|
| | | $ | 5,215 | | | | | $ | 35,241 | | | | | $ | 20,563 | | | | | $ | 15,861 | | | | | $ | 22,822 | | | | | $ | 1,285,435 | | | | | $ | — | | | | | $ | 1,385,137 | | |
流動資產
|
| | | | 61,717 | | | | | | 111,494 | | | | | | 171,804 | | | | | | 68,048 | | | | | | 95,882 | | | | | | 196,640 | | | | | | (305,785) | | | | | | 399,800 | | |
非流動負債
|
| | | | — | | | | | | (12,007) | | | | | | (3,476) | | | | | | (12,311) | | | | | | (14,255) | | | | | | (647,949) | | | | | | — | | | | | | (689,998) | | |
流動負債
|
| | | | (56,191) | | | | | | (104,492) | | | | | | (130,319) | | | | | | (77,427) | | | | | | (148,460) | | | | | | (131,458) | | | | | | 317,153 | | | | | | (331,194) | | |
淨資產(負債)
|
| | | $ | 10,741 | | | | | $ | 30,236 | | | | | $ | 58,572 | | | | | $ | (5,829) | | | | | $ | (44,011) | | | | | $ | 702,668 | | | | | $ | 11,368 | | | | | $ | 763,745 | | |
可歸屬淨資產(負債)
to NCI |
| | | $ | 3,750 | | | | | $ | 4,313 | | | | | $ | 9,281 | | | | | $ | 9 | | | | | $ | (9,604) | | | | | $ | 29,383 | | | | | $ | — | | | | | $ | 37,132 | | |
Revenue
|
| | | $ | 7,060 | | | | | $ | 11,947 | | | | | $ | 22,048 | | | | | $ | 4,104 | | | | | $ | 680 | | | | | $ | 174,036 | | | | | $ | (5,484) | | | | | $ | 214,391 | | |
Gross profit
|
| | | | 3,889 | | | | | | 8,802 | | | | | | 16,756 | | | | | | 465 | | | | | | (1,243) | | | | | | 77,388 | | | | | | 1,316 | | | | | | 107,373 | | |
Net income (loss)
|
| | | $ | 3,651 | | | | | $ | 3,253 | | | | | $ | 12,635 | | | | | $ | (876) | | | | | $ | (2,308) | | | | | $ | (40,030) | | | | | $ | — | | | | | $ | (23,675) | | |
分配給NCI的淨收益(虧損)
|
| | | $ | 913 | | | | | $ | 403 | | | | | $ | 3,159 | | | | | $ | (9) | | | | | $ | (462) | | | | | $ | (298) | | | | | $ | — | | | | | $ | 3,706 | | |
NCI percentage as of March 31,
2022 |
| | | | 25.0%(1) | | | | | | 12.4%(2) | | | | | | 25.0%(2) | | | | | | 1.0%(1) | | | | | | 20.0%(1) | | | | | | 42.7% | | | | | | | | | | | | | | |
($ in thousands)
|
| |
TSC
Cresco, LLC |
| |
MedMar
Inc. (Lakeview) |
| |
MedMar
Inc. (Rockford) |
| |
Cresco
Labs Ohio, LLC |
| |
SLO
Cultivation Inc. |
| |
Other
entities including Cresco Labs, LLC(1),(3) |
| |
Eliminations
|
| |
Total
|
| ||||||||||||||||||||||||
非流動資產
|
| | | $ | 5,208 | | | | | $ | 33,698 | | | | | $ | 22,934 | | | | | $ | 16,093 | | | | | $ | 23,422 | | | | | $ | 1,257,353 | | | | | $ | — | | | | | $ | 1,358,708 | | |
流動資產
|
| | | | 54,506 | | | | | | 95,522 | | | | | | 154,929 | | | | | | 64,897 | | | | | | 97,276 | | | | | | 250,029 | | | | | | (295,404) | | | | | | 421,755 | | |
非流動負債
|
| | | | — | | | | | | (11,213) | | | | | | (3,443) | | | | | | (12,286) | | | | | | (14,071) | | | | | | (653,320) | | | | | | — | | | | | | (694,333) | | |
流動負債
|
| | | | (49,726) | | | | | | (92,049) | | | | | | (124,597) | | | | | | (73,441) | | | | | | (147,993) | | | | | | (107,143) | | | | | | 306,555 | | | | | | (288,394) | | |
淨資產(負債)
|
| | | $ | 9,988 | | | | | $ | 25,958 | | | | | $ | 49,823 | | | | | $ | (4,737) | | | | | $ | (41,366) | | | | | $ | 746,919 | | | | | $ | 11,151 | | | | | $ | 797,736 | | |
歸屬於NCI的淨資產(負債)
|
| | | $ | 2,850 | | | | | $ | 3,910 | | | | | $ | 6,123 | | | | | $ | 18 | | | | | $ | (9,143) | | | | | $ | 38,424 | | | | | $ | — | | | | | $ | 42,182 | | |
截至2021年12月31日的NCI百分比
|
| | | | 25.0%(1) | | | | | | 12.4%(2) | | | | | | 25.0%(2) | | | | | | 1.0%(1) | | | | | | 20.0%(1) | | | | | | 43.3% | | | | | | | | | | | | | | |
(Shares in thousands)
|
| |
Number of
stock options outstanding |
| |
Weighted-average
exercise price |
| |
Weighted-average
remaining contractual life (years) |
| |
Aggregate
intrinsic value |
| ||||||||||||
Outstanding – January 1, 2022
|
| | | | 23,610 | | | | | $ | 5.54 | | | | | | 7.70 | | | | | $ | 53,455 | | |
Granted
|
| | | | 2,301 | | | | | | 6.38 | | | | | | | | | | | | | | |
Exercised
|
| | | | (453) | | | | | | 1.61 | | | | | | | | | | | | | | |
Forfeited
|
| | | | (617) | | | | | | 8.46 | | | | | | | | | | | | | | |
Outstanding – March 31, 2022
|
| | | | 24,841 | | | | | | 5.63 | | | | | | 7.72 | | | | | | 41,652 | | |
Exercisable – March 31, 2022
|
| | | | 14,216 | | | | | $ | 2.81 | | | | | | 7.04 | | | | | $ | 36,366 | | |
(千美元,每股數據除外)
|
| |
Three Months Ended
March 31, 2022 |
| |||
加權平均授予日期授予的股票期權單位的公允價值(每股)
|
| | | $ | 4.31 | | |
行使股票期權單位的內在價值,按行權日的市場價格計算
|
| | | $ | 2,225 | | |
| | |
March 31, 2022
|
|
無風險年利率
|
| |
1.4% – 1.9%
|
|
預期年度股息收益率
|
| |
0%
|
|
預期股價波動
|
| |
77.0% to 78.9%
|
|
股票期權的預期壽命
|
| |
5.5 to 7 years
|
|
罰沒率
|
| |
9.4% – 21.3%
|
|
授予日的公允價值
|
| |
$3.51 to $4.90
|
|
授權日的股價
|
| |
$5.59 to $6.91
|
|
行權價格區間
|
| |
$6.03 to $6.91
|
|
(Shares in thousands)
|
| |
Number of
RSUs outstanding |
| |
Weighted-
average fair value |
| |
Weighted-
average remaining contractual life (years) |
| |
Aggregate
intrinsic value |
| ||||||||||||
Outstanding – January 1, 2022
|
| | | | 1,093 | | | | | $ | 8.83 | | | | | | 3.50 | | | | | $ | 9,657 | | |
Granted
|
| | | | 3,324 | | | | | | 6.33 | | | | | | | | | | | | | | |
已歸屬並已結算
|
| | | | (169) | | | | | | 6.53 | | | | | | | | | | | | | | |
Forfeited
|
| | | | (80) | | | | | | 7.36 | | | | | | | | | | | | | | |
Outstanding – March 31, 2022
|
| | | | 4,168 | | | | | $ | 6.83 | | | | | | 4.00 | | | | | | 28,451 | | |
($ in thousands)
|
| |
Three Months Ended
March 31, 2022 |
| |||
已發行限制性股票單位的加權平均授予日公允價值(每股)
|
| | | $ | 9.53 | | |
歸屬的RSU的總公允價值,按歸屬日期的市場價格計算
|
| | | $ | 1,101 | | |
($ in thousands)
|
| |
March 31,
2022 |
| |
December 31,
2021 |
| ||||||
培養或有對價
|
| | | $ | 39,636 | | | | | $ | 33,969 | | |
桂冠收穫延期對價
|
| | | | 46,968 | | | | | | 37,847 | | |
短期遞延和或有對價總額
|
| | | $ | 86,604 | | | | | $ | 71,816 | | |
($ in thousands)
|
| |
March 31,
2022 |
| |
December 31,
2021 |
| ||||||
谷銀營運現金流遞延對價
|
| | | $ | 8,607 | | | | | $ | 8,577 | | |
桂冠收穫延期對價
|
| | | | — | | | | | | 9,074 | | |
總延期對價,長期
|
| | | $ | 8,607 | | | | | $ | 17,651 | | |
($ in thousands)
|
| |
March 31, 2022
|
| |
December 31, 2021
|
| ||||||
高級貸款,扣除未攤銷債務發行成本
|
| | | $ | 400,000 | | | | | $ | 400,000 | | |
應付利息
|
| | | | 19,211 | | | | | | 9,711 | | |
融資負債 - 租賃
|
| | | | 97,633 | | | | | | 97,797 | | |
減去:未攤銷債務發行成本
|
| | | | (21,566) | | | | | | (22,501) | | |
借款總額和應付利息
|
| | | $ | 495,278 | | | | | $ | 485,007 | | |
減:短期借款和應付利息
|
| | | | (19,211) | | | | | | (9,711) | | |
減去: - 租賃融資負債的當前部分
|
| | | | (9,991) | | | | | | (10,217) | | |
長期票據和應付貸款總額
|
| | | $ | 466,076 | | | | | $ | 465,079 | | |
| | |
Three Months Ended
March 31, |
| |||||||||
($ in thousands)
|
| |
2022
|
| |
2021
|
| ||||||
Wholesale
|
| | | $ | 95,109 | | | | | $ | 95,634 | | |
Dispensary
|
| | | | 119,282 | | | | | | 82,803 | | |
總收入
|
| | | $ | 214,391 | | | | | $ | 178,437 | | |
| | |
Three Months Ended
March 31, |
| |||||||||
($ in thousands)
|
| |
2022
|
| |
2021
|
| ||||||
衍生品負債的未實現收益(虧損) - 權證
|
| | | $ | 375 | | | | | $ | (7,649) | | |
衍生工具虧損
|
| | | | (5,667) | | | | | | (11,106) | | |
撥備 - 應收貸款收益
|
| | | | 738 | | | | | | 273 | | |
按公允價值持有的投資的未實現虧損
|
| | | | (1,670) | | | | | | (1,305) | | |
處置損失
|
| | | | — | | | | | | (3,343) | | |
投資轉換收益
|
| | | | — | | | | | | 9,324 | | |
外幣損益
|
| | | | 68 | | | | | | (636) | | |
其他(虧損)收入
|
| | | | (616) | | | | | | 2,102 | | |
其他費用合計,淨額
|
| | | $ | (6,772) | | | | | $ | (12,340) | | |
| | | | | |
Three Months Ended
March 31, |
| |||||||||
($ in thousands)
|
| |
Classification
|
| |
2022
|
| |
2021
|
| ||||||
Operating Leases | | | | | | | | | | | | | | | | |
出租人擁有SLO的少數股權
|
| |
Rent expense
|
| | | $ | 379 | | | | | $ | 400 | | |
出租人擁有MedMar的少數股權
|
| |
Rent expense
|
| | | | 73 | | | | | | 57 | | |
出租人是MVS的股東
|
| |
Rent expense
|
| | | | 296 | | | | | | 277 | | |
Finance Leases | | | | | | | | | | | | | | | | |
出租人擁有MedMar的少數股權
|
| |
Depreciation expense
|
| | | $ | 76 | | | | | $ | 66 | | |
出租人擁有MedMar的少數股權
|
| |
Interest expense
|
| | | | 69 | | | | | | 71 | | |
出租人是MVS的股東
|
| |
Depreciation expense
|
| | | | 19 | | | | | | 18 | | |
出租人是MVS的股東
|
| |
Interest expense
|
| | | | 34 | | | | | | 21 | | |
| | |
As of March 31, 2022
|
| |
As of December 31, 2021
|
| ||||||||||||||||||
($ in thousands)
|
| |
ROU Asset
|
| |
Lease Liability
|
| |
ROU Asset
|
| |
Lease Liability
|
| ||||||||||||
Operating Leases | | | | | | | | | | | | | | | | | | | | | | | | | |
出租人擁有SLO的少數股權
|
| | | $ | 6,936 | | | | | $ | 12,193 | | | | | $ | 6,996 | | | | | $ | 11,938 | | |
出租人擁有MedMar的少數股權
|
| | | | 1,498 | | | | | | 1,527 | | | | | | 1,525 | | | | | | 1,549 | | |
出租人是MVS的股東
|
| | | | 6,205 | | | | | | 6,208 | | | | | | 6,314 | | | | | | 4,867 | | |
Finance Leases | | | | | | | | | | | | | | | | | | | | | | | | | |
出租人擁有MedMar的少數股權
|
| | | $ | 2,263 | | | | | $ | 2,610 | | | | | $ | 2,137 | | | | | $ | 2,457 | | |
出租人是MVS的股東
|
| | | | 597 | | | | | | 1,049 | | | | | | 616 | | | | | | 1,063 | | |
| | |
March 31, 2022
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized
Cost |
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 179,320 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 179,320 | | |
受限現金(1)
|
| | | | 2,600 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,600 | | |
保證金
|
| | | | 3,942 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,942 | | |
應收賬款,淨額
|
| | | | 48,691 | | | | | | — | | | | | | — | | | | | | — | | | | | | 48,691 | | |
長期應收貸款
|
| | | | 1,234 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,234 | | |
Investments
|
| | | | — | | | | | | 3,001 | | | | | | 627 | | | | | | 660 | | | | | | 4,288 | | |
財務負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
應付賬款
|
| | | $ | 33,285 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 33,285 | | |
應計負債
|
| | | | 95,962 | | | | | | — | | | | | | — | | | | | | — | | | | | | 95,962 | | |
短期借款
|
| | | | 29,202 | | | | | | — | | | | | | — | | | | | | — | | | | | | 29,202 | | |
租賃負債的當期部分
|
| | | | 21,137 | | | | | | — | | | | | | — | | | | | | — | | | | | | 21,137 | | |
延期對價、或有對價和其他短期應付款項
|
| | | | 5 | | | | | | 10 | | | | | | — | | | | | | 86,604 | | | | | | 86,619 | | |
短期衍生負債
|
| | | | — | | | | | | — | | | | | | — | | | | | | 809 | | | | | | 809 | | |
租賃負債
|
| | | | 124,104 | | | | | | — | | | | | | — | | | | | | — | | | | | | 124,104 | | |
延期對價和或有對價,長期對價
|
| | | | — | | | | | | — | | | | | | — | | | | | | 8,607 | | | | | | 8,607 | | |
長期應付票據和應付貸款
|
| | | | 466,076 | | | | | | — | | | | | | — | | | | | | — | | | | | | 466,076 | | |
| | |
December 31, 2021
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized
Cost |
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 223,543 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 223,543 | | |
受限現金(1)
|
| | | | 2,559 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,559 | | |
保證金
|
| | | | 3,941 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,941 | | |
應收賬款,淨額
|
| | | | 43,379 | | | | | | — | | | | | | — | | | | | | — | | | | | | 43,379 | | |
短期應收貸款
|
| | | | 747 | | | | | | — | | | | | | — | | | | | | 565 | | | | | | 1,312 | | |
長期應收貸款
|
| | | | 505 | | | | | | — | | | | | | — | | | | | | — | | | | | | 505 | | |
Investments
|
| | | | — | | | | | | 4,710 | | | | | | 542 | | | | | | 660 | | | | | | 5,912 | | |
財務負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
應付賬款
|
| | | $ | 32,278 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,278 | | |
應計負債
|
| | | | 95,442 | | | | | | — | | | | | | — | | | | | | — | | | | | | 95,442 | | |
短期借款
|
| | | | 19,928 | | | | | | — | | | | | | — | | | | | | — | | | | | | 19,928 | | |
租賃負債的當期部分
|
| | | | 20,792 | | | | | | — | | | | | | — | | | | | | — | | | | | | 20,792 | | |
延期對價、或有對價和其他短期應付款項
|
| | | | 5 | | | | | | 12 | | | | | | — | | | | | | 71,816 | | | | | | 71,833 | | |
短期衍生負債
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,172 | | | | | | 1,172 | | |
租賃負債
|
| | | | 118,936 | | | | | | — | | | | | | — | | | | | | — | | | | | | 118,936 | | |
延期對價和或有對價,長期對價
|
| | | | — | | | | | | — | | | | | | — | | | | | | 17,651 | | | | | | 17,651 | | |
長期應付票據和應付貸款
|
| | | | 465,079 | | | | | | — | | | | | | — | | | | | | — | | | | | | 465,079 | | |
($ in thousands)
|
| |
Valuation
classification |
| |
March 31,
2022 |
| |
December 31,
2021 |
| ||||||
短期應收貸款 - 燈塔,淨額ECL(1)
|
| |
Fair value
|
| | | $ | — | | | | | $ | 565 | | |
應收利息
|
| |
Amortized cost
|
| | | | — | | | | | | 747 | | |
短期應收貸款總額
|
| | | | | | $ | — | | | | | $ | 1,312 | | |
($ in thousands)
|
| |
Valuation
classification |
| |
March 31,
2022 |
| |
December 31,
2021 |
| ||||||
長期應收貸款 - 伊利諾伊州孵化器,淨額
|
| |
Amortized cost
|
| | | | 819 | | | | | | 100 | | |
長期應收貸款 - Other,淨額
|
| |
Amortized cost
|
| | | | 415 | | | | | | 405 | | |
長期應收貸款總額
|
| | | | | | $ | 1,234 | | | | | $ | 505 | | |
| | |
March 31,
2022 |
| |
December 31,
2021 |
|
無風險年利率
|
| |
0.62%
|
| |
0.15%
|
|
預期年度股息收益率
|
| |
0%
|
| |
0%
|
|
預期股價波動
|
| |
59.4%
|
| |
47.3%
|
|
認股權證的預期壽命
|
| |
|
| |
|
|
罰沒率
|
| |
0%
|
| |
0%
|
|
期末股價
|
| |
$6.03
|
| |
$6.62
|
|
期末執行價
|
| |
$10.00
|
| |
$9.86
|
|
($ in thousands)
|
| |
March 31,
2022 |
| |
December 31,
2021 |
| ||||||
0 to 60 days
|
| | | $ | 42,952 | | | | | $ | 37,750 | | |
61 to 120 days
|
| | | | 4,622 | | | | | | 4,309 | | |
120 days +
|
| | | | 3,506 | | | | | | 3,540 | | |
應收賬款總額,毛額
|
| | | $ | 51,080 | | | | | $ | 45,599 | | |
壞賬準備
|
| | | | 2,389 | | | | | | 2,220 | | |
應收賬款總額,淨額
|
| | | $ | 48,691 | | | | | $ | 43,379 | | |
($ in thousands)
|
| |
|
| |
1 to 3 Years
|
| |
3 to 5 Years
|
| |
Total
|
| ||||||||||||
應付賬款和應計負債
|
| | | $ | 129,247 | | | | | $ | — | | | | | $ | — | | | | | $ | 129,247 | | |
延期對價、或有對價和其他應付款
|
| | | | 86,619 | | | | | | — | | | | | | — | | | | | | 86,619 | | |
延期對價和或有對價
|
| | | | — | | | | | | 8,607 | | | | | | — | | | | | | 8,607 | | |
長期應付票據和應付貸款及短期借款
|
| | | | 29,202 | | | | | | — | | | | | | 466,076 | | | | | | 495,278 | | |
截至2022年3月31日的總債務
|
| | | $ | 245,068 | | | | | $ | 8,607 | | | | | $ | 466,076 | | | | | $ | 719,751 | | |
| | |
March 31, 2022
|
| |
December 31, 2021
|
| ||||||
($ in thousands)
|
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs
Michigan, LLC |
| ||||||
流動資產
|
| | | $ | 38,781 | | | | | $ | 36,850 | | |
非流動資產
|
| | | | 36,562 | | | | | | 36,320 | | |
流動負債
|
| | | | (77,961) | | | | | | (72,476) | | |
非流動負債
|
| | | | (23,222) | | | | | | (23,124) | | |
Cresco Labs Inc.的股權。
|
| | | | (25,840) | | | | | | (22,430) | | |
| | |
March 31, 2022
|
| |
March 31, 2021
|
| ||||||
($ in thousands)
|
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs
Michigan, LLC |
| ||||||
Revenue
|
| | | $ | 1,032 | | | | | $ | 1,108 | | |
Cresco Labs Inc.的淨虧損。
|
| | | | (2,378) | | | | | | (1,442) | | |
Net loss
|
| | | | (2,378) | | | | | | (1,442) | | |
| | |
Three Months Ended
March 31, |
| |||||||||
($ in thousands)
|
| |
2022
|
| |
2021
|
| ||||||
利息支出 - 租賃
|
| | | $ | (994) | | | | | $ | (937) | | |
利息支出 - 應付票據和貸款
|
| | | | (9,500) | | | | | | (6,021) | | |
債務貼現和遞延融資費用攤銷
|
| | | | (934) | | | | | | (1,420) | | |
利息支出 - 融資活動以及銷售和回租
|
| | | | (2,981) | | | | | | (2,836) | | |
其他利息支出
|
| | | | (99) | | | | | | (333) | | |
利息收入
|
| | | | 145 | | | | | | 245 | | |
總利息支出,淨額
|
| | | $ | (14,363) | | | | | $ | (11,302) | | |
| | |
Three Months Ended
March 31, |
| |||||||||
($ in thousands)
|
| |
2022
|
| |
2021
|
| ||||||
所得税前虧損
|
| | | $ | (868) | | | | | $ | (8,600) | | |
所得税費用
|
| | | | 22,807 | | | | | | 15,524 | | |
實際税率
|
| | | | (2,627.5)% | | | | | | (180.5)% | | |
| | |
Three Months Ended
March 31, |
| |||||||||
($ in thousands)
|
| |
2022
|
| |
2021
|
| ||||||
工資和員工成本
|
| | | $ | 39,487 | | | | | $ | 30,474 | | |
銷售和營銷費用
|
| | | | 3,025 | | | | | | 7,250 | | |
基於股份的薪酬
|
| | | | 6,506 | | | | | | 5,595 | | |
折舊和攤銷
|
| | | | 4,552 | | | | | | 5,642 | | |
Excise taxes
|
| | | | 4,912 | | | | | | 3,950 | | |
設施費用
|
| | | | 7,750 | | | | | | 3,821 | | |
諮詢費和專業費
|
| | | | 4,412 | | | | | | 2,806 | | |
計算機和軟件費用
|
| | | | 2,650 | | | | | | 2,721 | | |
商業保險
|
| | | | 2,443 | | | | | | 2,130 | | |
Rental fees
|
| | | | 1,962 | | | | | | 1,608 | | |
Accounting
|
| | | | 2,540 | | | | | | 1,991 | | |
Legal
|
| | | | 3,843 | | | | | | 1,537 | | |
差旅和員工費用
|
| | | | 1,120 | | | | | | 622 | | |
訴訟應計調整
|
| | | | 513 | | | | | | 237 | | |
其他費用
|
| | | | 1,391 | | | | | | 401 | | |
銷售、一般和管理費用合計
|
| | | $ | 87,106 | | | | | $ | 70,785 | | |
| | |
Three Months Ended
|
| |||||||||
| | |
March 31,
|
| |||||||||
($ in thousands)
|
| |
2022
|
| |
2021
|
| ||||||
衍生品負債的未實現收益(虧損) - 權證
|
| | | $ | 375 | | | | | $ | (7,649) | | |
衍生工具虧損
|
| | | | (5,667) | | | | | | (11,106) | | |
撥備 - 應收貸款收益
|
| | | | 738 | | | | | | 273 | | |
按公允價值持有的投資的未實現虧損
|
| | | | (1,670) | | | | | | (1,305) | | |
處置損失
|
| | | | — | | | | | | (3,343) | | |
投資轉換收益
|
| | | | — | | | | | | 9,324 | | |
外幣損益
|
| | | | 68 | | | | | | (636) | | |
其他(虧損)收入
|
| | | | (616) | | | | | | 2,102 | | |
其他費用合計,淨額
|
| | | $ | (6,772) | | | | | $ | (12,340) | | |
($ in thousands)
|
| |
2022
|
| |
2021
|
| |
2020
|
| |||||||||||||||||||||||||||||||||||||||
| | |
Q1
|
| |
Q4
|
| |
Q3
|
| |
Q2
|
| |
Q1
|
| |
Q4
|
| |
Q3
|
| |
Q2
|
| ||||||||||||||||||||||||
Revenue, net
|
| | | $ | 214,391 | | | | | $ | 217,787 | | | | | $ | 215,483 | | | | | $ | 209,975 | | | | | $ | 178,437 | | | | | $ | 162,317 | | | | | $ | 153,298 | | | | | $ | 94,256 | | |
營業利潤(虧損)
|
| | | | 20,267 | | | | | | 15,557 | | | | | | (264,018) | | | | | | 14,872 | | | | | | 16,238 | | | | | | 329 | | | | | | 24,935 | | | | | | (20,938) | | |
Cresco Labs Inc.的淨(虧損)收入。
|
| | | | (27,381) | | | | | | (14,732) | | | | | | (270,645) | | | | | | (4,827) | | | | | | (29,393) | | | | | | (54,636) | | | | | | 15,457 | | | | | | (36,433) | | |
Basic EPS
|
| | | $ | (0.09) | | | | | $ | (0.08) | | | | | $ | (1.00) | | | | | $ | (0.02) | | | | | $ | (0.12) | | | | | $ | (0.25) | | | | | $ | 0.07 | | | | | $ | (0.18) | | |
Diluted EPS
|
| | | $ | (0.09) | | | | | $ | (0.08) | | | | | $ | (1.00) | | | | | $ | (0.02) | | | | | $ | (0.12) | | | | | $ | (0.22) | | | | | $ | 0.04 | | | | | $ | (0.18) | | |
| | |
Three Months Ended March 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2022
|
| |
2021
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
Revenue
|
| | | $ | 214,391 | | | | | $ | 178,437 | | | | | $ | 35,954 | | | | | | 20.1% | | |
銷貨成本
|
| | | | 107,018 | | | | | | 91,414 | | | | | | 15,604 | | | | | | 17.1% | | |
Gross profit
|
| | | | 107,373 | | | | | | 87,023 | | | | | | 20,350 | | | | | | 23.4% | | |
總運營費用
|
| | | | 87,106 | | | | | | 70,785 | | | | | | 16,321 | | | | | | 23.1% | | |
其他費用合計,淨額
|
| | | | (21,135) | | | | | | (24,838) | | | | | | 3,703 | | | | | | (14.9)% | | |
所得税費用
|
| | | | (22,807) | | | | | | (15,524) | | | | | | (7,283) | | | | | | 46.9% | | |
Net loss(1)
|
| | | $ | (23,675) | | | | | $ | (24,124) | | | | | $ | 449 | | | | |
|
(1.9)%
|
| |
| | |
Three Months Ended March 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2022
|
| |
2021
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
Net loss(1)
|
| | | $ | (23,675) | | | | | $ | (24,124) | | | | | $ | 449 | | | | | | (1.9)% | | |
折舊和攤銷
|
| | | | 10,960 | | | | | | 10,151 | | | | | | 809 | | | | | | 8.0% | | |
利息支出,淨額
|
| | | | 14,363 | | | | | | 11,302 | | | | | | 3,061 | | | | | | 27.1% | | |
所得税費用
|
| | | | 22,807 | | | | | | 15,524 | | | | | | 7,283 | | | | | | 46.9% | | |
EBITDA (non-GAAP)
|
| | | $ | 24,455 | | | | | $ | 12,853 | | | | | $ | 11,602 | | | | |
|
90.3%
|
| |
其他費用,淨額
|
| | | | 6,772 | | | | | | 12,340 | | | | | | (5,568) | | | | | | (45.1)% | | |
權益法投資虧損
|
| | | | — | | | | | | 1,196 | | | | | | (1,196) | | | | | | 100.0% | | |
收購存貨的公允價值加價
|
| | | | 5,322 | | | | | | 585 | | | | | | 4,737 | | | | | | 平方毫米 | | |
購置和其他非核心成本的調整
|
| | | | 6,694 | | | | | | 1,738 | | | | | | 4,956 | | | | | | 285.2% | | |
基於股份的薪酬
|
| | | | 7,506 | | | | | | 6,280 | | | | | | 1,226 | | | | | | 19.5% | | |
調整後的EBITDA(非GAAP)
|
| | | $ | 50,749 | | | | | $ | 34,992 | | | | | $ | 15,757 | | | | | | 45.0% | | |
($ in thousands)
|
| |
Total
|
| |
Operating Leases
|
| |
Finance Leases
|
| |||||||||
2022
|
| | | $ | 18,733 | | | | | $ | 14,752 | | | | | $ | 3,981 | | |
2023
|
| | | | 24,798 | | | | | | 19,367 | | | | | | 5,431 | | |
2024
|
| | | | 25,136 | | | | | | 19,530 | | | | | | 5,606 | | |
2025
|
| | | | 26,654 | | | | | | 20,897 | | | | | | 5,757 | | |
2026
|
| | | | 26,984 | | | | | | 21,086 | | | | | | 5,898 | | |
Thereafter
|
| | | | 210,390 | | | | | | 177,234 | | | | | | 33,156 | | |
租賃支付總額
|
| | | $ | 332,695 | | | | | $ | 272,866 | | | | | $ | 59,829 | | |
減去:計入利息
|
| | | | (181,874) | | | | | | (153,114) | | | | | | (28,760) | | |
少:租户改善津貼
|
| | | | (5,580) | | | | | | (4,935) | | | | | | (645) | | |
租賃負債現值
|
| | | | 145,241 | | | | | | 114,817 | | | | | | 30,424 | | |
減去:短期租賃負債
|
| | | | (21,137) | | | | | | (16,897) | | | | | | (4,240) | | |
長期租賃負債現值
|
| | | $ | 124,104 | | | | | $ | 97,920 | | | | | $ | 26,184 | | |
($ in thousands)
|
| |
|
| |
1 to 3 Years
|
| |
3 to 5 Years
|
| |
Total
|
| ||||||||||||
應付賬款和應計負債
|
| | | $ | 129,247 | | | | | $ | — | | | | | $ | — | | | | | $ | 129,247 | | |
延期對價、或有對價等
payables |
| | | | 86,619 | | | | | | — | | | | | | — | | | | | | 86,619 | | |
延期對價和或有對價
|
| | | | — | | | | | | 8,607 | | | | | | — | | | | | | 8,607 | | |
長期應付票據和應付貸款及短期
borrowings |
| | | | 29,202 | | | | | | — | | | | | | 466,076 | | | | | | 495,278 | | |
截至2022年3月31日的總債務
|
| | | $ | 245,068 | | | | | $ | 8,607 | | | | | $ | 466,076 | | | | | $ | 719,751 | | |
| | | | | |
Three Months Ended
March 31, |
| |||||||||
($ in thousands)
|
| |
Classification
|
| |
2022
|
| |
2021
|
| ||||||
Operating Leases | | | | | | | | | | | | | | | | |
出租人擁有SLO的少數股權
|
| | Rent expense | | | | $ | 379 | | | | | $ | 400 | | |
出租人擁有MedMar的少數股權
|
| | Rent expense | | | | | 73 | | | | | | 57 | | |
出租人是MVS的股東
|
| | Rent expense | | | | | 296 | | | | | | 277 | | |
Finance Leases | | | | | | | | | | | | | | | | |
出租人擁有MedMar的少數股權
|
| |
Depreciation expense
|
| | | $ | 76 | | | | | $ | 66 | | |
出租人擁有MedMar的少數股權
|
| | Interest expense | | | | | 69 | | | | | | 71 | | |
出租人是MVS的股東
|
| |
Depreciation expense
|
| | | | 19 | | | | | | 18 | | |
出租人是MVS的股東
|
| | Interest expense | | | | | 34 | | | | | | 21 | | |
| | |
As of March 31, 2022
|
| |
As of December 31, 2021
|
| ||||||||||||||||||
($ in thousands)
|
| |
ROU Asset
|
| |
Lease Liability
|
| |
ROU Asset
|
| |
Lease Liability
|
| ||||||||||||
Operating Leases | | | | | | | | | | | | | | | | | | | | | | | | | |
出租人擁有SLO的少數股權
|
| | | $ | 6,936 | | | | | $ | 12,193 | | | | | $ | 6,996 | | | | | $ | 11,938 | | |
出租人擁有MedMar的少數股權
|
| | | | 1,498 | | | | | | 1,527 | | | | | | 1,525 | | | | | | 1,549 | | |
出租人是MVS的股東
|
| | | | 6,205 | | | | | | 6,208 | | | | | | 6,314 | | | | | | 4,867 | | |
Finance Leases | | | | | | | | | | | | | | | | | | | | | | | | | |
出租人擁有MedMar的少數股權
|
| | | $ | 2,263 | | | | | $ | 2,610 | | | | | $ | 2,137 | | | | | $ | 2,457 | | |
出租人是MVS的股東
|
| | | | 597 | | | | | | 1,049 | | | | | | 616 | | | | | | 1,063 | | |
| | |
March 31, 2022
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized Cost
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 179,320 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 179,320 | | |
受限現金(1)
|
| | | | 2,600 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,600 | | |
保證金
|
| | | | 3,942 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,942 | | |
應收賬款,淨額
|
| | | | 48,691 | | | | | | — | | | | | | — | | | | | | — | | | | | | 48,691 | | |
長期應收貸款
|
| | | | 1,234 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,234 | | |
Investments
|
| | | | — | | | | | | 3,001 | | | | | | 627 | | | | | | 660 | | | | | | 4,288 | | |
財務負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
應付賬款
|
| | | $ | 33,285 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 33,285 | | |
應計負債
|
| | | | 95,962 | | | | | | — | | | | | | — | | | | | | — | | | | | | 95,962 | | |
短期借款
|
| | | | 29,202 | | | | | | — | | | | | | — | | | | | | — | | | | | | 29,202 | | |
租賃負債的當期部分
|
| | | | 21,137 | | | | | | — | | | | | | — | | | | | | — | | | | | | 21,137 | | |
延期對價、或有對價和其他短期應付款項
|
| | | | 5 | | | | | | 10 | | | | | | — | | | | | | 86,604 | | | | | | 86,619 | | |
短期衍生負債
|
| | | | — | | | | | | — | | | | | | — | | | | | | 809 | | | | | | 809 | | |
租賃負債
|
| | | | 124,104 | | | | | | — | | | | | | — | | | | | | — | | | | | | 124,104 | | |
延期對價和或有對價,長期對價
|
| | | | — | | | | | | — | | | | | | — | | | | | | 8,607 | | | | | | 8,607 | | |
長期應付票據和應付貸款
|
| | | | 466,076 | | | | | | — | | | | | | — | | | | | | — | | | | | | 466,076 | | |
| | |
December 31, 2021
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized Cost
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 223,543 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 223,543 | | |
受限現金(1)
|
| | | | 2,559 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,559 | | |
保證金
|
| | | | 3,941 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,941 | | |
應收賬款,淨額
|
| | | | 43,379 | | | | | | — | | | | | | — | | | | | | — | | | | | | 43,379 | | |
短期應收貸款
|
| | | | 747 | | | | | | — | | | | | | — | | | | | | 565 | | | | | | 1,312 | | |
長期應收貸款
|
| | | | 505 | | | | | | — | | | | | | — | | | | | | — | | | | | | 505 | | |
Investments
|
| | | | — | | | | | | 4,710 | | | | | | 542 | | | | | | 660 | | | | | | 5,912 | | |
財務負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
應付賬款
|
| | | $ | 32,278 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,278 | | |
應計負債
|
| | | | 95,442 | | | | | | — | | | | | | — | | | | | | — | | | | | | 95,442 | | |
短期借款
|
| | | | 19,928 | | | | | | — | | | | | | — | | | | | | — | | | | | | 19,928 | | |
租賃負債的當期部分
|
| | | | 20,792 | | | | | | — | | | | | | — | | | | | | — | | | | | | 20,792 | | |
延期對價、或有對價和其他短期應付款項
|
| | | | 5 | | | | | | 12 | | | | | | — | | | | | | 71,816 | | | | | | 71,833 | | |
短期衍生負債
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,172 | | | | | | 1,172 | | |
租賃負債
|
| | | | 118,936 | | | | | | — | | | | | | — | | | | | | — | | | | | | 118,936 | | |
延期對價和或有對價,長期對價
|
| | | | — | | | | | | — | | | | | | — | | | | | | 17,651 | | | | | | 17,651 | | |
長期應付票據和應付貸款
|
| | | | 465,079 | | | | | | — | | | | | | — | | | | | | — | | | | | | 465,079 | | |
Securities
|
| |
Number of Shares
(in thousands) |
| |||
已發行且未償還的 | | | | | | | |
超級投票股份
|
| | | | 500 | | |
從屬表決權股份(1)
|
| | | | 272,636 | | |
比例投票權股份(2)
|
| | | | 20,472 | | |
特殊從屬表決權股份(3)
|
| | | | 1 | | |
可贖回股票
|
| | | | 107,740 | | |
Warrants
|
| | | | 9,520 | | |
股票期權
|
| | | | 24,841 | | |
受限股票單位
|
| | | | 4,168 | | |
|
獨立註冊會計師事務所報告
|
| | | | J-203 | | |
| 合併財務報表: | | | | | | | |
|
合併資產負債表
|
| | | | J-204 | | |
|
合併業務報表
|
| | | | J-205 | | |
|
全面虧損合併報表
|
| | | | J-206 | | |
|
股東權益變動合併報表
|
| | | | J-207 | | |
|
現金流量表合併報表
|
| | | | J-208 | | |
|
合併財務報表附註
|
| | | | J-210 | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
ASSETS | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 223,543 | | | | | $ | 136,339 | | |
Restricted cash
|
| | | | 2,559 | | | | | | 4,435 | | |
Accounts receivable, net
|
| | | | 43,379 | | | | | | 29,943 | | |
Inventory, net
|
| | | | 136,643 | | | | | | 67,183 | | |
短期應收貸款
|
| | | | 1,312 | | | | | | 2,438 | | |
Other current assets
|
| | | | 14,319 | | | | | | 9,129 | | |
Total current assets
|
| | | | 421,755 | | | | | | 249,467 | | |
Non-current assets: | | | | | | | | | | | | | |
財產和設備,淨額
|
| | | | 369,092 | | | | | | 228,804 | | |
Right-of-use assets
|
| | | | 88,017 | | | | | | 71,794 | | |
Intangible assets, net
|
| | | | 437,644 | | | | | | 195,541 | | |
長期應收貸款
|
| | | | 505 | | | | | | 21,223 | | |
Investments
|
| | | | 5,912 | | | | | | 4,360 | | |
Goodwill
|
| | | | 446,767 | | | | | | 450,569 | | |
Deferred tax asset
|
| | | | 6,561 | | | | | | 7,130 | | |
Other non-current assets
|
| | | | 4,210 | | | | | | 3,708 | | |
Total non-current assets
|
| | | | 1,358,708 | | | | | | 983,129 | | |
TOTAL ASSETS
|
| | | $ | 1,780,463 | | | | | $ | 1,232,596 | | |
負債和股東權益 | | | | | | | | | | | | | |
流動負債: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 32,278 | | | | | $ | 23,231 | | |
Accrued liabilities
|
| | | | 95,442 | | | | | | 130,469 | | |
Short-term borrowings
|
| | | | 19,928 | | | | | | 25,924 | | |
Income tax payable
|
| | | | 46,949 | | | | | | 36,067 | | |
租賃負債的當期部分
|
| | | | 20,792 | | | | | | 18,040 | | |
延期對價、或有對價和其他應付款項,短期
|
| | | | 71,833 | | | | | | 19,115 | | |
短期衍生負債
|
| | | | 1,172 | | | | | | — | | |
流動負債總額
|
| | | | 288,394 | | | | | | 252,846 | | |
非流動負債: | | | | | | | | | | | | | |
長期應付票據和應付貸款
|
| | | | 465,079 | | | | | | 255,439 | | |
長期衍生負債
|
| | | | — | | | | | | 17,505 | | |
Lease liabilities
|
| | | | 118,936 | | | | | | 74,468 | | |
Deferred tax liability
|
| | | | 85,666 | | | | | | 41,202 | | |
延期對價和或有對價、長期對價
|
| | | | 17,651 | | | | | | 7,247 | | |
其他長期負債
|
| | | | 7,001 | | | | | | 8,557 | | |
非流動負債合計
|
| | | | 694,333 | | | | | | 404,418 | | |
TOTAL LIABILITIES
|
| | | $ | 982,727 | | | | | $ | 657,264 | | |
承付款和或有事項(附註15) | | | | | | | | | | | | | |
SHAREHOLDERS’ EQUITY | | | | | | | | | | | | | |
超級投票權股份,無面值;500,000股分別於2021年12月31日和2020年12月31日授權、發行和發行
|
| | | | | | | | | | | | |
次表決權股份,無面值;授權無限股份;分別於2021年12月31日和2020年12月31日發行和發行270,033,270和194,085,616股
|
| | | | | | | | | | | | |
比例投票權股份(1),無面值;授權無限股份;分別於2021年12月31日和2020年12月31日發行和發行20,667,206股和29,311,088股
|
| | | | | | | | | | | | |
特殊從屬表決權股份(2股),無面值;639股分別於2021年12月31日和2020年12月31日授權、發行和發行
|
| | | | | | | | | | | | |
Share capital
|
| | | | 1,597,715 | | | | | | 802,264 | | |
累計其他綜合損失
|
| | | | (254) | | | | | | (647) | | |
Accumulated deficit
|
| | | | (841,907) | | | | | | (328,380) | | |
Equity of Cresco Labs Inc.
|
| | | | 755,554 | | | | | | 473,237 | | |
非控股權益
|
| | | | 42,182 | | | | | | 102,095 | | |
股東權益總額
|
| | | | 797,736 | | | | | | 575,332 | | |
總負債和股東權益
|
| | | $ | 1,780,463 | | | | | $ | 1,232,596 | | |
| | |
Year ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Revenue, net
|
| | | $ | 821,682 | | | | | $ | 476,251 | | |
Costs of goods sold
|
| | | | 415,335 | | | | | | 269,550 | | |
Gross profit
|
| | | | 406,347 | | | | | | 206,701 | | |
Operating expenses: | | | | | | | | | | | | | |
銷售、一般和行政管理
|
| | | | 317,804 | | | | | | 228,946 | | |
Impairment loss
|
| | | | 305,894 | | | | | | 1,217 | | |
總運營費用
|
| | | | 623,698 | | | | | | 230,163 | | |
Loss from operations
|
| | | | (217,351) | | | | | | (23,462) | | |
Other (expense) income: | | | | | | | | | | | | | |
Interest expense, net
|
| | | | (51,211) | | | | | | (31,229) | | |
Other income (expense), net
|
| | | | 13,031 | | | | | | (8,295) | | |
權益法投資(虧損)
|
| | | | (1,196) | | | | | | (1,181) | | |
Total other (expense), net
|
| | | | (39,376) | | | | | | (40,705) | | |
所得税前虧損
|
| | | | (256,727) | | | | | | (64,167) | | |
Income tax (expense)
|
| | | | (40,107) | | | | | | (28,604) | | |
Net (loss)
|
| | | $ | (296,834) | | | | | $ | (92,771) | | |
可歸因於非控股權益的税後淨收入
|
| | | | 22,763 | | | | | | 9,386 | | |
可歸因於Cresco Labs Inc.的淨(虧損)
|
| | | $ | (319,597) | | | | | $ | (102,157) | | |
可歸因於Cresco Labs Inc.股東的每股淨(虧損) - : | | | | | | | | | | | | | |
每股基本和攤薄(虧損)
|
| | | $ | (1.22) | | | | | $ | (0.49) | | |
基本和稀釋後的加權平均流通股數量
|
| | | | 262,326,138 | | | | | | 210,465,988 | | |
| | |
Year ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Net (loss)
|
| | | $ | (296,834) | | | | | $ | (92,771) | | |
外幣折算差額,税後淨額
|
| | | | 393 | | | | | | (647) | | |
該期間的全面(虧損)總額
|
| | | $ | (296,441) | | | | | $ | (93,418) | | |
可歸因於非控股權益的税後淨額綜合收入
|
| | | | 22,763 | | | | | | 9,386 | | |
可歸因於Cresco Labs Inc.的全面(損失)總額
|
| | | $ | (319,204) | | | | | $ | (102,804) | | |
| | |
Share capital
|
| |
Accumulated
deficit |
| |
Accumulated
other comprehensive loss, net of tax |
| |
Non-controlling
interests |
| |
Total
|
| |||||||||||||||
Balance as of January 1, 2020
|
| | | $ | 291,723 | | | | | $ | (132,474) | | | | | $ | — | | | | | $ | 119,266 | | | | | $ | 278,515 | | |
行使期權和認股權證
|
| | | | 3,238 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,238 | | |
股權薪酬
|
| | | | 8,565 | | | | | | — | | | | | | — | | | | | | — | | | | | | 8,565 | | |
某些股份支付安排的員工税
|
| | | | 2,825 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,825 | | |
所有權權益變更
|
| | | | — | | | | | | — | | | | | | — | | | | | | (249) | | | | | | (249) | | |
Income tax reserve
|
| | | | — | | | | | | (115) | | | | | | — | | | | | | — | | | | | | (115) | | |
應收税金應付
agreements |
| | | | (823) | | | | | | — | | | | | | — | | | | | | — | | | | | | (823) | | |
股東贖回帶來的税收優惠
|
| | | | 967 | | | | | | — | | | | | | — | | | | | | — | | | | | | 967 | | |
與收購相關的股權發行
|
| | | | 436,168 | | | | | | — | | | | | | — | | | | | | — | | | | | | 436,168 | | |
對非控股股東的分配
|
| | | | (49,602) | | | | | | — | | | | | | — | | | | | | (16,793) | | | | | | (66,395) | | |
Equity issuances
|
| | | | 6,054 | | | | | | — | | | | | | — | | | | | | — | | | | | | 6,054 | | |
Cresco LLC股票已贖回
|
| | | | 103,149 | | | | | | (93,634) | | | | | | — | | | | | | (9,515) | | | | | | — | | |
外幣折算
|
| | | | — | | | | | | — | | | | | | (647) | | | | | | — | | | | | | (647) | | |
Net income (loss)
|
| | | | — | | | | | | (102,157) | | | | | | — | | | | | | 9,386 | | | | | | (92,771) | | |
Ending Balance as of December 31, 2020
|
| | | $ | 802,264 | | | | | $ | (328,380) | | | | | $ | (647) | | | | | $ | 102,095 | | | | | $ | 575,332 | | |
行使期權和認股權證
|
| | | | 6,947 | | | | | | — | | | | | | — | | | | | | — | | | | | | 6,947 | | |
股權薪酬
|
| | | | 28,215 | | | | | | — | | | | | | — | | | | | | — | | | | | | 28,215 | | |
某些股份支付安排的員工税
|
| | | | 11,458 | | | | | | — | | | | | | — | | | | | | — | | | | | | 11,458 | | |
Income tax reserve
|
| | | | — | | | | | | 311 | | | | | | — | | | | | | — | | | | | | 311 | | |
應收税金應付
agreements |
| | | | (1,803) | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,803) | | |
股東贖回帶來的税收優惠
|
| | | | 1,983 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,983 | | |
與收購相關的股權發行
|
| | | | 380,452 | | | | | | — | | | | | | — | | | | | | — | | | | | | 380,452 | | |
私募發行,扣除成本
|
| | | | 123,469 | | | | | | — | | | | | | — | | | | | | — | | | | | | 123,469 | | |
Equity issuances
|
| | | | 15,521 | | | | | | — | | | | | | — | | | | | | — | | | | | | 15,521 | | |
對非控股股東的分配
|
| | | | 25,877 | | | | | | (1,985) | | | | | | — | | | | | | (71,600) | | | | | | (47,708) | | |
Cresco LLC股票已贖回
|
| | | | 203,332 | | | | | | (192,256) | | | | | | — | | | | | | (11,076) | | | | | | — | | |
外幣折算
|
| | | | — | | | | | | — | | | | | | 393 | | | | | | — | | | | | | 393 | | |
Net income (loss)
|
| | | | — | | | | | | (319,597) | | | | | | — | | | | | | 22,763 | | | | | | (296,834) | | |
Ending Balance as of December 31, 2021
|
| | | $ | 1,597,715 | | | | | $ | (841,907) | | | | | $ | (254) | | | | | $ | 42,182 | | | | | $ | 797,736 | | |
| | |
Year ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
經營活動現金流: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (296,834) | | | | | $ | (92,771) | | |
將淨虧損與經營活動提供(用於)的現金淨額進行調整:
|
| | | | | | | | | | | | |
折舊及攤銷
|
| | | | 38,640 | | | | | | 31,788 | | |
經營性租賃資產攤銷
|
| | | | 6,309 | | | | | | 4,967 | | |
壞賬費用和預期信貸損失撥備費用
|
| | | | 3,544 | | | | | | 1,747 | | |
基於共享的薪酬費用
|
| | | | 27,536 | | | | | | 18,839 | | |
(Gain) loss on investments
|
| | | | (930) | | | | | | 2,117 | | |
(收益)遞延和或有對價的公允價值變動
|
| | | | (14,775) | | | | | | (2,029) | | |
衍生工具和權證的(收益)損失
|
| | | | (16,663) | | | | | | 8,500 | | |
(收益),淨虧損,應收貸款
|
| | | | — | | | | | | (921) | | |
Impairment loss
|
| | | | 305,894 | | | | | | 1,194 | | |
庫存核銷和撥備損失
|
| | | | 2,669 | | | | | | 3,259 | | |
Change in deferred taxes
|
| | | | (34,931) | | | | | | (11,152) | | |
債務安排的貼現和遞延融資成本增加
|
| | | | 11,304 | | | | | | 4,619 | | |
債務清償損失
|
| | | | 10,342 | | | | | | — | | |
Foreign currency loss
|
| | | | 730 | | | | | | 1,521 | | |
Other losses, net of gains
|
| | | | 721 | | | | | | 15,246 | | |
經營性資產和負債變動:
|
| | | | | | | | | | | | |
Accounts receivable
|
| | | | (10,964) | | | | | | (6,602) | | |
Inventory
|
| | | | (18,420) | | | | | | (17,063) | | |
Other assets
|
| | | | (6,215) | | | | | | (507) | | |
應付賬款和應計費用
|
| | | | 21,155 | | | | | | 15,351 | | |
經營性租賃負債
|
| | | | (16,436) | | | | | | (12,312) | | |
Other liabilities
|
| | | | (90) | | | | | | 278 | | |
Income tax payable
|
| | | | 1,901 | | | | | | 26,083 | | |
經營活動提供(用於)的現金淨額
|
| | | | 14,487 | | | | | | (7,848) | | |
投資活動的現金流: | | | | | | | | | | | | | |
購置房產和設備
|
| | | | (93,875) | | | | | | (87,154) | | |
購買無形資產
|
| | | | (3,178) | | | | | | (2,105) | | |
銷售和回租交易收益以及租户改善津貼
|
| | | | 33,157 | | | | | | 45,945 | | |
收購對價的支付,扣除收購現金的淨額
|
| | | | (75,814) | | | | | | (14,768) | | |
資產剝離收益,扣除轉賬現金後的淨額
|
| | | | 69 | | | | | | — | | |
貸款和墊款收款收據
|
| | | | 2,000 | | | | | | — | | |
擬收購實體的貸款和墊款
|
| | | | (26,292) | | | | | | (6,667) | | |
淨現金(用於)投資活動
|
| | | | (163,933) | | | | | | (64,749) | | |
| | |
Year ended December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
融資活動的現金流: | | | | | | | | | | | | | |
從1月發售開始的收益
|
| | | | 124,105 | | | | | | — | | |
行使股票期權、認股權證和認股權證的收益
|
| | | | 20,096 | | | | | | 6,200 | | |
在市場上發行的收益
|
| | | | — | | | | | | 3,521 | | |
發行長期債務的收益
|
| | | | 387,000 | | | | | | 186,000 | | |
償還債務、融資發行成本和非延期貸款費
|
| | | | (6,461) | | | | | | (7,605) | | |
支付債務預付款和清償債務費用
|
| | | | (16,202) | | | | | | — | | |
Repayment of debt
|
| | | | (200,000) | | | | | | (10,340) | | |
支付與收購相關的或有對價
|
| | | | — | | | | | | (1,719) | | |
收購非控股權益
|
| | | | — | | | | | | (203) | | |
分配給非控股權益可贖回單位持有人和其他成員
|
| | | | (69,803) | | | | | | (16,372) | | |
與限制性股票單位股票淨結算相關的税款支付
|
| | | | (143) | | | | | | (8,672) | | |
融資租賃交易收益
|
| | | | — | | | | | | 11,754 | | |
融資租賃債務本金支付
|
| | | | (3,587) | | | | | | (1,078) | | |
融資活動提供的現金淨額
|
| | | | 235,005 | | | | | | 161,486 | | |
匯率變動對現金和現金等價物的影響
|
| | | | (231) | | | | | | (1,124) | | |
現金和現金等價物淨增長
|
| | | | 85,328 | | | | | | 87,765 | | |
年初現金和現金等價物以及受限現金
|
| | | | 140,774 | | | | | | 53,009 | | |
現金和現金等價物,年終
|
| | | | 223,543 | | | | | | 136,339 | | |
受限現金,年終
|
| | | | 2,559 | | | | | | 4,435 | | |
現金和現金等價物以及受限現金,年終
|
| | | $ | 226,102 | | | | | $ | 140,774 | | |
補充披露現金流信息: | | | | | | | | | | | | | |
本年度已支付現金: | | | | | | | | | | | | | |
Income tax, net
|
| | | $ | 73,955 | | | | | $ | 13,491 | | |
Interest
|
| | | | 39,118 | | | | | | 29,183 | | |
非現金交易: | | | | | | | | | | | | | |
根據企業合併和
發行股票、股票期權和認股權證
acquisitions |
| | | $ | 380,452 | | | | | $ | 435,705 | | |
企業合併的非現金對價
|
| | | | 47,921 | | | | | | — | | |
贖回股權的非控股權益
|
| | | | 11,074 | | | | | | 11,389 | | |
增加租賃淨負債
|
| | | | 28,143 | | | | | | 53,444 | | |
購買財產、設備和無形資產所產生的責任
|
| | | | 7,207 | | | | | | 11,155 | | |
無現金行使股票期權和認股權證
|
| | | | 3,879 | | | | | | 2,784 | | |
未向非控股權益可贖回單位申報的分配
holders |
| | | | 36,450 | | | | | | 63,994 | | |
債務、融資發行成本和非延期貸款費的負債
|
| | | | 7,000 | | | | | | 8,570 | | |
非徵集無形資產發行股份
|
| | | | 3,000 | | | | | | — | | |
發行股票結算
|
| | | | 12,790 | | | | | | — | | |
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs Inc. | | |
British Columbia, Canada
|
| | Parent Company | | | | |
CannaRoyalty Corp.(原產地)
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Cali-AntiFragile Corp.
|
| | California | | | Holding Company | | |
100%
|
|
Alta Supply Inc. (Continuum)
|
| | California | | | Distribution | | |
100%
|
|
Kaya Management Inc.
|
| | California | | | Production | | |
100%
|
|
River Distributing Co., LLC
|
| | California | | | Distribution | | |
100%
|
|
FloraCal Farms
|
| | California | | | Cultivation | | |
100%
|
|
Cub City, LLC
|
| | California | | | Cultivation | | |
100%
|
|
CRHC Holdings Corp.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
Laurel Harvest Labs, LLC
|
| | Pennsylvania | | | 種植和配給設施 | | |
100%
|
|
JDRC Mount Joy, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
JDRC Scranton, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bluma Wellness Inc.
|
| |
British Columbia, Canada
|
| | Holding Company | | |
100%
|
|
CannCure Investments Inc.
|
| | Ontario, Canada | | | Holding Company | | |
100%
|
|
大麻治癒投資有限責任公司
|
| | Florida | | | Holding Company | | |
100%
|
|
3 Boys Farm,LLC(佛羅裏達州一家工廠)
|
| | Florida | | |
種植、生產和配給設施
|
| |
100%
|
|
Farm to Fresh Holdings, LLC
|
| | Florida | | |
種植、生產和配給設施
|
| |
100%
|
|
Cresco U.S. Corp.
|
| | Illinois | | | Cresco Labs LLC經理 | | |
100%
|
|
MedMar Inc.
|
| | Illinois | | | Holding Company | | |
100%
|
|
MedMar Lakeview, LLC
|
| | Illinois | | | Dispensary | | |
88%
|
|
MedMar Rockford, LLC
|
| | Illinois | | | Dispensary | | |
75%
|
|
Gloucester Street Capital,LLC
|
| | New York | | | Holding Company | | |
100%
|
|
山谷農業有限責任公司
|
| | New York | | | Operating Entity | | |
100%
|
|
CMA Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BL Real Estate, LLC
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培育許可有限責任公司
|
| | Massachusetts | | | 種植、生產和配給設施 | | |
100%
|
|
Cultivate Worcester, Inc
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Leicester, Inc
|
| | Massachusetts | | | 種植、生產和配給設施 | | |
100%
|
|
培育Framingham,Inc.
|
| | Massachusetts | | | Dispensary | | |
100%
|
|
Cultivate Burncoat, Inc
|
| | Massachusetts | | | Holding Company | | |
100%
|
|
培植公司
|
| | Massachusetts | | | 種植和生產實體 | | |
100%
|
|
Good News Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Wonder Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
BW Maryland Holdings, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
CP賓夕法尼亞控股有限責任公司
|
| | Illinois | | | Holding Company | | |
100%
|
|
Bay, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Bay Asset Management, LLC
|
| | Pennsylvania | | | Holding Company | | |
100%
|
|
Ridgeback, LLC
|
| | Colorado | | | Holding Company | | |
100%
|
|
Cresco Labs, LLC
|
| | Illinois | | | Operating Entity | | |
57%
|
|
Entity
|
| |
Location
|
| |
Purpose
|
| |
Percentage
Held |
|
Cresco Labs Notes Issuer,LLC
|
| | Illinois | | | Holding Company | | | | |
Cresco Labs Ohio, LLC
|
| | Ohio | | | 種植、生產和配給設施 | | |
99%
|
|
Wellbeings, LLC
|
| | Delaware | | | CBD健康產品開發 | | |
100%
|
|
Cresco Labs SLO, LLC
|
| | California | | | Holding Company | | |
100%
|
|
SLO Cultivation Inc.
|
| | California | | | 種植和生產設施 | | |
80%
|
|
Cresco Labs Joliet, LLC
|
| | Illinois | | | 種植和生產設施 | | |
100%
|
|
Cresco Labs Kankakee, LLC
|
| | Illinois | | | 種植和生產設施 | | |
100%
|
|
Cresco Labs Logan, LLC
|
| | Illinois | | | 種植和生產設施 | | |
100%
|
|
Cresco Labs PA, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
Cresco Yeltrah, LLC
|
| | Pennsylvania | | |
種植、生產和配給設施
|
| |
100%
|
|
JDC Newark, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
紐瓦克綠地創造有限責任公司
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Marion, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Marion,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Chillicothe, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Verdant Creations Chillicothe,LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
JDC Columbus, LLC
|
| | Ohio | | | Holding Company | | |
100%
|
|
Care Med Associates, LLC
|
| | Ohio | | | Dispensary | | |
100%
|
|
Cresco Labs Arizona, LLC
|
| | Arizona | | | Holding Company | | |
100%
|
|
亞利桑那州設施供應有限責任公司
|
| | Arizona/Maryland | | | 種植、生產和配給設施 | | |
100%
|
|
Cresco Labs Tinad, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
PDI Medical III, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
克雷斯科實驗室鳳凰農場有限責任公司
|
| | Illinois | | | Holding Company | | |
100%
|
|
伊利諾伊州鳳凰農場有限責任公司
|
| | Illinois | | | Dispensary | | |
100%
|
|
JDC Elmwood, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
FloraMedex, LLC
|
| | Illinois | | | Dispensary | | |
100%
|
|
Cresco Edibles, LLC
|
| | Illinois | | | Holding Company | | |
100%
|
|
TSC Cresco, LLC
|
| | Illinois | | | Licensing | | |
75%
|
|
Cresco HHH, LLC
|
| | Massachusetts | | | 種植、生產和配給設施 | | |
100%
|
|
Cresco Labs Michigan, LLC(a)
|
| | Michigan | | | 種植和生產設施 | | |
85%
|
|
Category
|
| |
Methodology
|
| |
Estimated
Useful Life |
|
租賃改進
|
| | 按租賃年限或改善工程的預計使用年限中較短的時間攤銷 | | | 1 – 15 years | |
機械設備
|
| | 資產的預計使用壽命 | | | 5 – 15 years | |
Furniture and Fixtures
|
| | 資產的預計使用壽命 | | | 3 – 8 years | |
Vehicles | | | 資產的預計使用壽命 | | | 5 years | |
Website and Software
|
| | 資產的預計使用壽命 | | | 3 – 7 years | |
Computer Equipment
|
| | 資產的預計使用壽命 | | | 3 – 7 years | |
建築和建築改進
|
| | 資產的預計使用壽命 | | | 5 – 39 years | |
Category
|
| |
Estimated
Useful Life |
|
客户關係
|
| | 7 – 19 years | |
Non-Compete Agreements
|
| | 4 – 5 years | |
Trade Names
|
| | 10 years | |
許可證申請費
|
| | 1 – 2 years | |
非招標協議
|
| | 1 – 2 years | |
(in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Redeemable shares
|
| | | | 115,136 | | | | | | 136,077 | | |
Options
|
| | | | 23,609 | | | | | | 9,402 | | |
Warrants
|
| | | | 9,842 | | | | | | 532 | | |
RSUs
|
| | | | 999 | | | | | | 145 | | |
潛在稀釋股份總數
|
| | | | 149,586 | | | | | | 146,156 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Raw materials
|
| | | $ | 38,618 | | | | | $ | 23,203 | | |
Raw materials – non-cannabis
|
| | | | 22,260 | | | | | | 15,288 | | |
Work-in-process
|
| | | | 26,561 | | | | | | 7,530 | | |
Finished goods
|
| | | | 49,204 | | | | | | 21,162 | | |
Total Inventory
|
| | | $ | 136,643 | | | | | $ | 67,183 | | |
($ in thousands)
|
| |
Land and
Buildings |
| |
Machinery
and Equipment |
| |
Furniture
and Fixtures |
| |
Leasehold
Improvements |
| |
Website,
Computer Equipment and Software |
| |
Vehicles
|
| |
Construction
In Progress |
| |
Total
|
| ||||||||||||||||||||||||
Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2020
|
| | | $ | 72,803 | | | | | $ | 15,650 | | | | | $ | 10,458 | | | | | $ | 41,638 | | | | | $ | 2,715 | | | | | $ | 715 | | | | | $ | 42,048 | | | | |
$
|
186,027
|
| |
Additions
|
| | | | 6,278 | | | | | | 5,915 | | | | | | 4,820 | | | | | | 5,198 | | | | | | 2,414 | | | | | | 879 | | | | | | 45,193 | | | | | | 70,697 | | |
Transfers
|
| | | | 27,581 | | | | | | 1,290 | | | | | | 2,191 | | | | | | 30,548 | | | | | | 125 | | | | | | 21 | | | | | | (61,756) | | | | | | — | | |
Disposals
|
| | | | — | | | | | | (110) | | | | | | (33) | | | | | | (214) | | | | | | (24) | | | | | | — | | | | | | — | | | | | | (381) | | |
與銷售和回租交易相關的銷售
|
| | | | (10,136) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (11,403) | | | | | | (21,539) | | |
收購帶來的額外收益
|
| | | | — | | | | | | 455 | | | | | | 473 | | | | | | 11,069 | | | | | | 585 | | | | | | 331 | | | | | | 5,166 | | | | | | 18,079 | | |
外匯和其他調整的影響
|
| | |
|
—
|
| | | | | 6 | | | | | | (273) | | | | | | 130 | | | | | | (43) | | | | | | — | | | | | | (51) | | | | | | (231) | | |
As of December 31, 2020
|
| | | $ | 96,526 | | | | | $ | 23,206 | | | | | $ | 17,636 | | | | | $ | 88,369 | | | | | $ | 5,772 | | | | | $ | 1,946 | | | | | $ | 19,197 | | | | | $ | 252,652 | | |
Additions
|
| | | | 7,873 | | | | | | 5,772 | | | | | | 4,484 | | | | | | 12,339 | | | | | | 1,650 | | | | | | 921 | | | | | | 63,413 | | | | | | 96,452 | | |
Transfers
|
| | | | 4,021 | | | | | | 4,923 | | | | | | 3,560 | | | | | | 39,494 | | | | | | 580 | | | | | | 65 | | | | | | (52,646) | | | | | | (3) | | |
Disposals
|
| | | | — | | | | | | (130) | | | | | | (407) | | | | | | (811) | | | | | | (23) | | | | | | (30) | | | | | | — | | | | | | (1,401) | | |
收購帶來的額外收益
|
| | | | 39,106 | | | | | | 5,279 | | | | | | 834 | | | | | | 12,448 | | | | | | 111 | | | | | | 377 | | | | | | 12,839 | | | | | | 70,994 | | |
外匯和其他調整的影響
|
| | | | (642) | | | | | | (82) | | | | | | 120 | | | | | | 939 | | | | | | 58 | | | | | | (21) | | | | | | 44 | | | | | | 416 | | |
As of December 31, 2021
|
| | | $ | 146,884 | | | | | $ | 38,968 | | | | | $ | 26,227 | | | | | $ | 152,778 | | | | | $ | 8,148 | | | | | $ | 3,258 | | | | | $ | 42,847 | | | | | $ | 419,110 | | |
累計折舊 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2020
|
| | | $ | (511) | | | | | $ | (1,248) | | | | | $ | (994) | | | | | $ | (3,142) | | | | | $ | (743) | | | | | $ | (160) | | | | | $ | — | | | | | $ | (6,798) | | |
Depreciation
|
| | | | (1,522) | | | | | | (1,987) | | | | | | (2,205) | | | | | | (10,197) | | | | | | (1,263) | | | | | | (333) | | | | | | — | | | | | | (17,507) | | |
與銷售和回租交易相關的銷售
|
| | | | — | | | | | | — | | | | | | — | | | | | | 457 | | | | | | — | | | | | | — | | | | | | — | | | | | | 457 | | |
As of December 31, 2020
|
| | | $ | (2,033) | | | | | $ | (3,235) | | | | | $ | (3,199) | | | | | $ | (12,882) | | | | | $ | (2,006) | | | | | $ | (493) | | | | | $ | — | | | | | $ | (23,848) | | |
($ in thousands)
|
| |
Land and
Buildings |
| |
Machinery
and Equipment |
| |
Furniture
and Fixtures |
| |
Leasehold
Improvements |
| |
Website,
Computer Equipment and Software |
| |
Vehicles
|
| |
Construction
In Progress |
| |
Total
|
| ||||||||||||||||||||||||
Depreciation
|
| | | | (5,465) | | | | | | (3,603) | | | | | | (4,387) | | | | | | (10,358) | | | | | | (1,882) | | | | | | (588) | | | | | | — | | | | | | (26,283) | | |
Disposals
|
| | | | — | | | | | | 74 | | | | | | 140 | | | | | | 297 | | | | | | 13 | | | | | | 19 | | | | | | — | | | | | | 543 | | |
Adjustments
|
| | | | — | | | | | | (57) | | | | | | (133) | | | | | | (206) | | | | | | (52) | | | | | | 18 | | | | | | — | | | | | | (430) | | |
As of December 31, 2021
|
| | | $ | (7,498) | | | | | $ | (6,821) | | | | | $ | (7,579) | | | | | $ | (23,149) | | | | | $ | (3,927) | | | | | $ | (1,044) | | | | | $ | — | | | | | $ | (50,018) | | |
Net book value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
As of December 31, 2020
|
| | | $ | 94,493 | | | | | $ | 19,971 | | | | | $ | 14,437 | | | | | $ | 75,487 | | | | | $ | 3,766 | | | | | $ | 1,453 | | | | | $ | 19,197 | | | | | $ | 228,804 | | |
As of December 31, 2021
|
| | | $ | 139,386 | | | | | $ | 32,147 | | | | | $ | 18,648 | | | | | $ | 129,629 | | | | | $ | 4,221 | | | | | $ | 2,214 | | | | | $ | 42,847 | | | | | $ | 369,092 | | |
($ in thousands)
|
| |
Total
|
| |
Operating
Leases |
| |
Finance
Leases |
| |||||||||
2022
|
| | | $ | 24,242 | | | | | $ | 18,971 | | | | | $ | 5,271 | | |
2023
|
| | | | 24,260 | | | | | | 18,832 | | | | | | 5,428 | | |
2024
|
| | | | 24,593 | | | | | | 18,989 | | | | | | 5,604 | | |
2025
|
| | | | 26,102 | | | | | | 20,348 | | | | | | 5,754 | | |
2026
|
| | | | 26,423 | | | | | | 20,528 | | | | | | 5,895 | | |
Thereafter
|
| | | | 207,288 | | | | | | 174,141 | | | | | | 33,147 | | |
Total lease payments
|
| | | $ | 332,908 | | | | | $ | 271,809 | | | | | $ | 61,099 | | |
Less: imputed interest
|
| | | | (184,810) | | | | | | (154,871) | | | | | | (29,939) | | |
少:租户改善津貼
|
| | | | (8,370) | | | | | | (7,671) | | | | | | (699) | | |
租賃負債現值
|
| | | | 139,728 | | | | | | 109,267 | | | | | | 30,461 | | |
減去:當期租賃負債
|
| | | | (20,792) | | | | | | (16,348) | | | | | | (4,444) | | |
長期租賃負債現值
|
| | | $ | 118,936 | | | | | $ | 92,919 | | | | | $ | 26,017 | | |
($ in thousands)
|
| |
Financing
Liabilities |
| |||
2022
|
| | | $ | 12,881 | | |
2023
|
| | | | 13,204 | | |
2024
|
| | | | 13,535 | | |
2025
|
| | | | 13,875 | | |
2026
|
| | | | 14,223 | | |
Thereafter
|
| | | | 126,445 | | |
Total finance payments
|
| | | $ | 194,163 | | |
Less: interest
|
| | | | (96,094) | | |
少:租户改善津貼
|
| | | | (273) | | |
金融負債現值
|
| | | | 97,796 | | |
減去:短期金融負債
|
| | | | (10,217) | | |
長期金融負債現值
|
| | | $ | 87,579 | | |
| | |
2021
|
| |
2020
|
| ||||||||||||||||||
($ in thousands)
|
| |
Operating
Leases |
| |
Finance
Leases |
| |
Operating
Leases |
| |
Finance
Leases |
| ||||||||||||
Right-of-use assets
|
| | | $ | 62,329 | | | | | $ | 25,688 | | | | | $ | 47,765 | | | | | $ | 24,029 | | |
租賃負債(流動)
|
| | | | 16,348 | | | | | | 4,444 | | | | | | 14,013 | | | | | | 4,027 | | |
租賃負債(非流動)
|
| | | | 92,919 | | | | | | 26,017 | | | | | | 47,528 | | | | | | 26,940 | | |
加權平均剩餘租期(1)
|
| | | | 4.7 | | | | | | 11.2 | | | | | | 13.3 | | | | | | 12.1 | | |
加權平均剩餘貼現率
|
| | | | 13.5% | | | | | | 13.8% | | | | | | 14.8% | | | | | | 14.0% | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
融資租賃支付的利息
|
| | | $ | 4,742 | | | | | $ | 2,268 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
420 Capital
|
| | | $ | 68 | | | | | $ | 68 | | |
Lighthouse
|
| | | | 542 | | | | | | 1,049 | | |
Fleurish
|
| | | | — | | | | | | 51 | | |
Old Pal
|
| | | | 592 | | | | | | — | | |
IMC
|
| | | | 4,710 | | | | | | — | | |
Total Investments
|
| | | $ | 5,912 | | | | | $ | 1,168 | | |
($ in thousands)
|
| |
Customer
Relationships |
| |
Trade
Names |
| |
Permit
Application Costs |
| |
Licenses
|
| |
Other
Intangibles(a) |
| |
Goodwill
|
| |
Total
|
| |||||||||||||||||||||
Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at January 1, 2020
|
| | | $ | 6,929 | | | | | $ | — | | | | | $ | 6,842 | | | | | $ | 83,447 | | | | | $ | 2,133 | | | | | $ | 134,735 | | | | | $ | 234,086 | | |
Additions
|
| | | | — | | | | | | — | | | | | | 1,910 | | | | | | — | | | | | | 2,720 | | | | | | — | | | | | | 4,630 | | |
收購帶來的額外收益
|
| | | | 52,200 | | | | | | 41,800 | | | | | | — | | | | | | 5,900 | | | | | | 2,865 | | | | | | 321,928 | | | | | | 424,693 | | |
Foreign exchange
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 5 | | | | | | 5 | | |
Impairment
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,217) | | | | | | — | | | | | | (1,217) | | |
測算期調整
|
| | | | 11,400 | | | | | | (2,100) | | | | | | — | | | | | | — | | | | | | (111) | | | | | | (6,099) | | | | | | 3,090 | | |
Balance at December 31, 2020
|
| | | $ | 70,529 | | | | | $ | 39,700 | | | | | $ | 8,752 | | | | | $ | 89,347 | | | | | $ | 6,390 | | | | | $ | 450,569 | | | | | $ | 665,287 | | |
Additions
|
| | | | — | | | | | | — | | | | | | 3,169 | | | | | | | | | | | | 3,002 | | | | | | — | | | | | | 6,171 | | |
收購帶來的額外收益
|
| | | | 24,250 | | | | | | 1,400 | | | | | | — | | | | | | 317,200 | | | | | | 1,151 | | | | | | 212,140 | | | | | | 556,141 | | |
Foreign exchange
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Impairment
|
| | | | (62,900) | | | | | | (39,000) | | | | | | — | | | | | | — | | | | | | (3,783) | | | | | | (215,551) | | | | | | (321,234) | | |
測算期調整
|
| | | | — | | | | | | — | | | | | | — | | | | | | (2,240) | | | | | | — | | | | | | (391) | | | | | | (2,631) | | |
Disposals
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (476) | | | | | | — | | | | | | (476) | | |
Balance at December 31, 2021
|
| | | $ | 31,879 | | | | | $ | 2,100 | | | | | $ | 11,921 | | | | | $ | 404,307 | | | | | $ | 6,284 | | | | | $ | 446,767 | | | | | $ | 903,258 | | |
累計攤銷 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at January 1, 2020
|
| | | $ | (858) | | | | | $ | — | | | | | $ | (3,265) | | | | | $ | — | | | | | $ | (1,022) | | | | | $ | — | | | | | $ | (5,145) | | |
Amortization
|
| | | | (4,271) | | | | | | (3,970) | | | | | | (3,853) | | | | | | — | | | | | | (1,938) | | | | | | — | | | | | | (14,032) | | |
Balance at December 31, 2020
|
| | | | (5,129) | | | | | | (3,970) | | | | | | (7,118) | | | | | | — | | | | | | (2,960) | | | | | | — | | | | | $ | (19,177) | | |
Amortization
|
| | | | 932 | | | | | | 3,275 | | | | | | (3,330) | | | | | | — | | | | | | (642) | | | | | | — | | | | | | 235 | | |
Disposals
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 95 | | | | | | — | | | | | | 95 | | |
Balance at December 31, 2021
|
| | | $ | (4,197) | | | | | $ | (695) | | | | | $ | (10,448) | | | | | $ | — | | | | | $ | (3,507) | | | | | $ | — | | | | | $ | (18,847) | | |
Net book value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
December 31, 2020
|
| | | $ | 65,401 | | | | | $ | 35,730 | | | | | $ | 1,632 | | | | | $ | 89,347 | | | | | $ | 3,431 | | | | | $ | 450,569 | | | | | $ | 646,110 | | |
December 31, 2021
|
| | | $ | 27,682 | | | | | $ | 1,405 | | | | | $ | 1,473 | | | | | $ | 404,307 | | | | | $ | 2,777 | | | | | $ | 446,767 | | | | | $ | 884,411 | | |
($ in thousands)
|
| |
Estimated
Amortization |
| |||
2022
|
| | | $ | 8,672 | | |
2023
|
| | | | 4,786 | | |
2024
|
| | | | 4,276 | | |
2025
|
| | | | 4,349 | | |
2026
|
| | | | 4,200 | | |
Thereafter
|
| | | | 7,054 | | |
預計攤銷總額
|
| | | $ | 33,337 | | |
(in thousands)
|
| |
Redeemable
Units |
| |
Subordinate
Voting Shares (SVS)* |
| |
Proportionate
Voting Shares (PVS)** |
| |
Super
Voting Shares (MVS) |
| |
Special Subordinate
Voting Shares |
| |||||||||||||||
Beginning balance, January 1, 2020
|
| | | | 142,172 | | | | | | 73,600 | | | | | | 57,937 | | | | | | 500 | | | | | | — | | |
行使期權和認股權證
|
| | | | — | | | | | | 1,711 | | | | | | 12 | | | | | | — | | | | | | — | | |
RSU issued
|
| | | | — | | | | | | 2,062 | | | | | | — | | | | | | — | | | | | | — | | |
與收購相關的股票發行
|
| | | | — | | | | | | 69,929 | | | | | | 233 | | | | | | — | | | | | | — | | |
發行與分銷協議相關的股票
|
| | | | — | | | | | | 249 | | | | | | — | | | | | | — | | | | | | — | | |
Cresco LLC redemption
|
| | | | (15,834) | | | | | | 15,681 | | | | | | — | | | | | | — | | | | | | — | | |
PVS converted to SVS
|
| | | | — | | | | | | 28,871 | | | | | | (28,871) | | | | | | — | | | | | | — | | |
與某些股份支付安排的員工税有關的問題
|
| | | | — | | | | | | 1,336 | | | | | | — | | | | | | — | | | | | | — | | |
Share issuances
|
| | |
|
—
|
| | | | | 792 | | | | |
|
—
|
| | | |
|
—
|
| | | | | 1 | | |
Ending balance, December 31, 2020
|
| | | | 126,338 | | | | | | 194,231 | | | | | | 29,311 | | | | | | 500 | | | | | | 1 | | |
行使期權和認股權證
|
| | | | — | | | | | | 3,030 | | | | | | — | | | | | | — | | | | | | — | | |
RSUs issued
|
| | | | — | | | | | | 351 | | | | | | — | | | | | | — | | | | | | — | | |
與收購相關的股票發行
|
| | | | — | | | | | | 35,425 | | | | | | — | | | | | | — | | | | | | — | | |
發行與分銷協議相關的股票
|
| | | | — | | | | | | (249) | | | | | | — | | | | | | — | | | | | | — | | |
Cresco LLC redemption
|
| | | | (16,897) | | | | | | 16,897 | | | | | | — | | | | | | — | | | | | | — | | |
PVS converted to SVS
|
| | | | — | | | | | | 8,644 | | | | | | (8,644) | | | | | | — | | | | | | — | | |
與某些股份支付安排的員工税有關的問題
|
| | | | — | | | | | | 173 | | | | | | — | | | | | | — | | | | | | — | | |
Share issuances
|
| | | | — | | | | | | 11,469 | | | | | | — | | | | | | — | | | | | | — | | |
Ending balance, December 31, 2021
|
| | | | 109,441 | | | | | | 269,971 | | | | | | 20,667 | | | | | | 500 | | | | | | 1 | | |
(in thousands)
|
| |
Acquisition date
|
| |
SVS shares
issued |
| |
Replacement
shares issued |
| |
Equity-based
consideration |
| |||||||||
Verdant
|
| |
February 16, 2021
|
| | | | 127 | | | | | | — | | | | | $ | 2,004 | | |
Bluma
|
| |
April 14, 2021
|
| | | | 15,061 | | | | | | 814 | | | | | | 193,310 | | |
Cultivate
|
| |
September 02, 2021
|
| | | | 4,818 | | | | | | — | | | | | | 46,643 | | |
Cure Penn
|
| |
November 25, 2021
|
| | | | 6,167 | | | | | | — | | | | | | 54,240 | | |
Laurel Harvest
|
| |
December 10, 2021
|
| | | | 8,354 | | | | | | — | | | | | | 65,844 | | |
| | |
Number of warrants*
(in thousands) |
| |
Weighted-average
exercise price |
| ||||||
Balance as of January 1, 2020
|
| | | | 6,454 | | | | | $ | 7.73 | | |
Exercised
|
| | | | (271) | | | | | | 6.05 | | |
Balance as of December 31, 2020
|
| | | | 6,183 | | | | | $ | 7.80 | | |
Bluma更換認股權證
|
| | | | 4,665 | | | | | | 11.64 | | |
Exercised
|
| | | | (721) | | | | | | 6.15 | | |
Forfeited
|
| | | | (285) | | | | | | 11.64 | | |
Balance as of December 31, 2021
|
| | | | 9,842 | | | | | $ | 9.63 | | |
($ in thousands)
|
| |
TSC
Cresco, LLC |
| |
MedMar
Inc. (Lakeview) |
| |
MedMar
Inc. (Rockford) |
| |
Cresco
Labs Ohio, LLC |
| |
SLO
Cultivation Inc. |
| |
Other
entities including Cresco Labs |
| |
Eliminations
|
| |
Total
|
| ||||||||||||||||||||||||
Non-current assets
|
| | | $ | 5,208 | | | | | $ | 33,698 | | | | | $ | 22,934 | | | | | $ | 16,093 | | | | | $ | 23,422 | | | | | $ | 1,257,353 | | | | | $ | — | | | | | $ | 1,358,708 | | |
Current assets
|
| | | | 54,506 | | | | | | 95,522 | | | | | | 154,929 | | | | | | 64,897 | | | | | | 97,276 | | | | | | 250,029 | | | | | | (295,404) | | | | | | 421,755 | | |
非流動負債
|
| | | | — | | | | | | (11,213) | | | | | | (3,443) | | | | | | (12,286) | | | | | | (14,071) | | | | | | (653,320) | | | | | | — | | | | | | (694,333) | | |
Current liabilities
|
| | | | (49,726) | | | | | | (92,049) | | | | | | (124,597) | | | | | | (73,441) | | | | | | (147,993) | | | | | | (107,143) | | | | | | 306,555 | | | | | | (288,394) | | |
Net assets
|
| | | $ | 9,988 | | | | | $ | 25,958 | | | | | $ | 49,823 | | | | | $ | (4,737) | | | | | $ | (41,366) | | | | | $ | 746,919 | | | | | $ | 11,151 | | | | | $ | 797,736 | | |
Net assets
attributable to NCI |
| | | $ | 2,850 | | | | | $ | 3,910 | | | | | $ | 6,123 | | | | | $ | 18 | | | | | $ | (9,143) | | | | | $ | 38,424 | | | | | $ | — | | | | | $ | 42,182 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | — | | |
Revenue
|
| | | $ | 21,549 | | | | | $ | 48,435 | | | | | $ | 84,932 | | | | | $ | 22,661 | | | | | $ | 21,011 | | | | | $ | 663,602 | | | | | $ | (40,508) | | | | | $ | 821,682 | | |
Gross profit
|
| | | | 13,592 | | | | | | 32,020 | | | | | | 47,922 | | | | | | 10,650 | | | | | | (6,250) | | | | | | 320,419 | | | | | | (12,006) | | | | | | 406,347 | | |
Net income (loss)
|
| | | $ | 12,387 | | | | | $ | 12,043 | | | | | $ | 30,666 | | | | | $ | (4,627) | | | | | $ | (19,247) | | | | | $ | (328,056) | | | | | $ | — | | | | | $ | (296,834) | | |
Net income (loss)
allocated to NCI |
| | | $ | 3,097 | | | | | $ | 1,493 | | | | | $ | 7,666 | | | | | $ | (46) | | | | | $ | (3,849) | | | | | $ | 14,402 | | | | | $ | — | | | | | $ | 22,763 | | |
NCI percentage at December 31, 2021
|
| | | | 25.0% | | | | | | 12.4% | | | | | | 25.0% | | | | | | 1.0% | | | | | | 20.0% | | | | | | 43.3% | | | | | | | | | | | | | | |
($ in thousands)
|
| |
TSC
Cresco, LLC |
| |
MedMar
Inc. (Lakeview) |
| |
MedMar
Inc. (Rockford) |
| |
Cresco
Labs Ohio, LLC |
| |
SLO
Cultivation Inc. |
| |
Other
entities including Cresco Labs |
| |
Eliminations
|
| |
Total
|
| ||||||||||||||||||||||||
Non-current assets
|
| | | $ | 4,064 | | | | | $ | 32,397 | | | | | $ | 20,957 | | | | | $ | 13,626 | | | | | $ | 22,744 | | | | | $ | 889,341 | | | | | $ | — | | | | | $ | 983,129 | | |
Current assets
|
| | | | 31,099 | | | | | | 26,022 | | | | | | 38,178 | | | | | | 42,934 | | | | | | 80,219 | | | | | | 184,871 | | | | | | (153,856) | | | | | | 249,467 | | |
非流動負債
|
| | | | — | | | | | | (11,755) | | | | | | (2,188) | | | | | | (12,328) | | | | | | (10,666) | | | | | | (367,481) | | | | | | — | | | | | | (404,418) | | |
Current liabilities
|
| | | | (24,852) | | | | | | (32,922) | | | | | | (28,248) | | | | | | (46,953) | | | | | | (118,870) | | | | | | (164,422) | | | | | | 163,421 | | | | | | (252,846) | | |
Net assets
|
| | | $ | 10,311 | | | | | $ | 13,742 | | | | | $ | 28,699 | | | | | $ | (2,721) | | | | | $ | (26,573) | | | | | $ | 542,309 | | | | | $ | 9,565 | | | | | $ | 575,332 | | |
Net assets
attributable to NCI |
| | | $ | 2,521 | | | | | $ | 3,308 | | | | | $ | 4,334 | | | | | $ | 64 | | | | | $ | (5,293) | | | | | $ | 97,161 | | | | | $ | — | | | | | $ | 102,095 | | |
Revenue
|
| | | $ | 16,874 | | | | | $ | 31,320 | | | | | $ | 38,417 | | | | | $ | 14,646 | | | | | $ | 19,772 | | | | | $ | 386,257 | | | | | $ | (31,035) | | | | | $ | 476,251 | | |
Gross profit
|
| | | | 10,033 | | | | | | 16,411 | | | | | | 20,092 | | | | | | 5,097 | | | | | | (4,461) | | | | | | 164,116 | | | | | | (4,587) | | | | | | 206,701 | | |
Net income (loss)
|
| | | $ | 7,884 | | | | | $ | 3,606 | | | | | $ | 10,430 | | | | | $ | (6,238) | | | | | $ | (11,219) | | | | | $ | (97,234) | | | | | $ | — | | | | | $ | (92,771) | | |
Net income (loss)
allocated to NCI |
| | | $ | 1,971 | | | | | $ | 447 | | | | | $ | 2,607 | | | | | $ | (62) | | | | | $ | (2,244) | | | | | $ | 6,667 | | | | | $ | — | | | | | $ | 9,386 | | |
NCI percentage at December 31,
2020 |
| | | | 25.0% | | | | | | 12.4% | | | | | | 25.0% | | | | | | 1.0% | | | | | | 20.0% | | | | | | 50.1% | | | | | | | | | | | | | | |
(Shares in thousands)
|
| |
Number of
stock options outstanding |
| |
Weighted-average
exercise price |
| |
Weighted-average
remaining contractual life (years) |
| |
Aggregate
intrinsic value |
| ||||||||||||
Outstanding – January 1, 2020
|
| | | | 22,920 | | | | | $ | 3.18 | | | | | | 8.60 | | | | | $ | 99,142 | | |
Granted
|
| | | | 6,628 | | | | | | 5.04 | | | | | | | | | | | | | | |
Exercised
|
| | | | (1,820) | | | | | | 2.12 | | | | | | | | | | | | | | |
原產地房屋更換獎
|
| | | | 629 | | | | | | 4.24 | | | | | | | | | | | | | | |
Forfeited
|
| | | | (5,850) | | | | | | 2.77 | | | | | | | | | | | | | | |
Outstanding – December 31, 2020
|
| | | | 22,507 | | | | | $ | 3.96 | | | | | | 8.10 | | | | | $ | 133,604 | | |
Exercisable – December 31, 2020
|
| | | | 9,853 | | | | | $ | 3.19 | | | | | | 3.40 | | | | | $ | 65,743 | | |
Granted
|
| | | | 5,227 | | | | | | 11.29 | | | | | | | | | | | | | | |
Exercised
|
| | | | (2,589) | | | | | | 1.97 | | | | | | | | | | | | | | |
Forfeited
|
| | | | (1,535) | | | | | | 9.51 | | | | | | | | | | | | | | |
Outstanding – December 31, 2021
|
| | | | 23,610 | | | | | $ | 5.54 | | | | | | 7.70 | | | | | $ | 53,455 | | |
Exercisable – December 31, 2021
|
| | | | 12,772 | | | | | $ | 3.69 | | | | | | 7.20 | | | | | $ | 40,209 | | |
| | |
Year Ended December 31,
|
| |||||||||
(單位為千,每股數據除外)
|
| |
2021
|
| |
2020
|
| ||||||
授予股票期權單位的加權平均授予日公允價值(每股)
|
| | | $ | 7.39 | | | | | $ | 3.05 | | |
按行權日市場價格計算的行權股票期權單位內在價值
|
| | | $ | 21,131 | | | | | $ | 7,000 | | |
| | |
2021
|
| |
2020
|
|
無風險年利率
|
| |
0.4% – 1.2%
|
| |
0.6% – 1.8%
|
|
預期年度股息收益率
|
| |
0%
|
| |
0%
|
|
預期股價波動
|
| |
67% to 82.2%
|
| |
64.9% to 81.0%
|
|
股票期權的預期期限
|
| |
5 to 7 years
|
| |
5 to 7 years
|
|
Forfeiture rate
|
| |
7.5% – 24.9%
|
| |
5.0% – 15.0%
|
|
Fair value at grant date
|
| |
$4.47 to $8.78
|
| |
$1.84 to $6.33
|
|
Stock price at grant date
|
| |
$6.62 to $13.10
|
| |
$2.99 to $9.86
|
|
Exercise price range
|
| |
$6.62 to $13.10
|
| |
$2.99 to $9.86
|
|
(Shares in thousands)
|
| |
Number of
RSUs outstanding |
| |
Weighted
average fair value |
| ||||||
Outstanding – January 1, 2020
|
| | | | 404 | | | | | $ | 8.58 | | |
Granted
|
| | | | 661 | | | | | | 6.00 | | |
原產地房屋更換獎
|
| | | | 3,431 | | | | | | 5.96 | | |
Vested and settled
|
| | | | (3,436) | | | | | | 5.23 | | |
Forfeited
|
| | | | (66) | | | | | | 8.91 | | |
Outstanding – December 31, 2020
|
| | | | 994 | | | | | $ | 6.54 | | |
Granted
|
| | | | 544 | | | | | | 11.78 | | |
Bluma更換獎
|
| | | | 207 | | | | | | 12.17 | | |
Vested and settled
|
| | | | (501) | | | | | | 9.20 | | |
Forfeited
|
| | | | (151) | | | | | | 8.21 | | |
Outstanding – December 31, 2021
|
| | | | 1,093 | | | | | $ | 8.83 | | |
負債-截至2021年12月31日分類
|
| | | | 4 | | | | | $ | 6.62 | | |
| | |
Year Ended December 31,
|
| |||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
歸屬RSU的總公允價值,按歸屬日期的市場價格計算
|
| | | $ | 4,783 | | | | | $ | 20,528 | | |
(單位為千,每股數據除外)
|
| |
Shares issued
|
| |
Fair value
(per share) |
| |
Compensation
expense |
| |||||||||
Bluma更換共享
|
| | | | 814 | | | | | $ | 12.17 | | | | | $ | 239 | | |
Subscription award
|
| | | | 62 | | | | | $ | 11.25 | | | | | $ | 694 | | |
($ in thousands)
|
| |
Verdant (i)
|
| |
Bluma (ii)
|
| |
Cultivate
(iii) |
| |
Cure Penn
(iv) |
| |
Laurel
Harvest (v) |
| |
Total
|
| ||||||||||||||||||
總體考慮 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common shares issued
|
| | | $ | 2,000 | | | | | $ | 183,262 | | | | | $ | 46,643 | | | | | $ | 52,610 | | | | | $ | 65,844 | | | | | $ | 350,359 | | |
Cash
|
| | | | 1,500 | | | | | | — | | | | | | — | | | | | | 33,304 | | | | | | 20,480 | | | | | | 55,284 | | |
貸款無現金行權選項
|
| | | | 10,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,000 | | |
Settlement of leases
|
| | | | 90 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 90 | | |
Loan settlement
|
| | | | 11,414 | | | | | | 21,226 | | | | | | 1,852 | | | | | | — | | | | | | 3,339 | | | | | | 37,831 | | |
Warrants issued
|
| | | | — | | | | | | 18,415 | | | | | | — | | | | | | — | | | | | | — | | | | | | 18,415 | | |
Replacement RSU awards
|
| | | | — | | | | | | 10,048 | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,048 | | |
代表被收購方支付與收購相關的交易成本
|
| | | | — | | | | | | 3,373 | | | | | | 1,001 | | | | | | 3,135 | | | | | | 331 | | | | | | 7,840 | | |
代表被收購方支付第三方債務
|
| | | | — | | | | | | — | | | | | | 20,125 | | | | | | — | | | | | | — | | | | | | 20,125 | | |
延期考慮
|
| | | | — | | | | | | 1,806 | | | | | | — | | | | | | — | | | | | | 46,677 | | | | | | 48,483 | | |
或有對價
|
| | | | — | | | | | | — | | | | | | 29,642 | | | | | | — | | | | | | — | | | | | | 29,642 | | |
Total consideration
|
| | | $ | 25,004 | | | | | $ | 238,130 | | | | | $ | 99,263 | | | | | $ | 89,049 | | | | | $ | 136,671 | | | | | $ | 588,117 | | |
取得的可確認淨資產(負債) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash
|
| | | $ | 1,360 | | | | | $ | 1,623 | | | | | $ | 2,938 | | | | | $ | 751 | | | | | $ | 937 | | | | | $ | 7,609 | | |
Accounts receivable
|
| | | | — | | | | | | — | | | | | | 6,494 | | | | | | 33 | | | | | | — | | | | | | 6,527 | | |
Inventory
|
| | | | 1,519 | | | | | | 19,244 | | | | | | 24,862 | | | | | | 2,963 | | | | | | 506 | | | | | | 49,094 | | |
短期應收貸款
|
| | | | — | | | | | | 1,600 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,600 | | |
Other current assets
|
| | | | 76 | | | | | | 1,205 | | | | | | 662 | | | | | | 134 | | | | | | 36 | | | | | | 2,113 | | |
Property & equipment
|
| | | | 996 | | | | | | 26,152 | | | | | | 30,128 | | | | | | 1,845 | | | | | | 11,873 | | | | | | 70,994 | | |
Right-of-use assets
|
| | | | 127 | | | | | | 13,709 | | | | | | 1,304 | | | | | | 1,834 | | | | | | 859 | | | | | | 17,833 | | |
Other non-current assets
|
| | | | 47 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 47 | | |
客户關係
|
| | | | 1,370 | | | | | | 6,700 | | | | | | 13,600 | | | | | | 2,320 | | | | | | 260 | | | | | | 24,250 | | |
License
|
| | | | 16,320 | | | | | | 117,000 | | | | | | 12,000 | | | | | | 70,950 | | | | | | 98,690 | | | | | | 314,960 | | |
Trade name
|
| | | | — | | | | | | — | | | | | | 1,400 | | | | | | — | | | | | | — | | | | | | 1,400 | | |
Non-compete agreements
|
| | | | — | | | | | | — | | | | | | 800 | | | | | | 270 | | | | | | 80 | | | | | | 1,150 | | |
Investments
|
| | | | — | | | | | | 693 | | | | | | — | | | | | | — | | | | | | — | | | | | | 693 | | |
獲得的可識別資產總額
|
| | | $ | 21,815 | | | | | $ | 187,926 | | | | | $ | 94,188 | | | | | $ | 81,100 | | | | | $ | 113,241 | | | | | $ | 498,270 | | |
Short-term liabilities
|
| | | | (1,601) | | | | | | (3,733) | | | | | | (14,585) | | | | | | (1,186) | | | | | | (151) | | | | | | (21,256) | | |
Lease liability
|
| | | | (127) | | | | | | (13,685) | | | | | | (1,304) | | | | | | (1,834) | | | | | | (859) | | | | | | (17,809) | | |
合同責任-忠誠度計劃
|
| | | | — | | | | | | (456) | | | | | | — | | | | | | (355) | | | | | | — | | | | | | (811) | | |
Deferred tax liability
|
| | | | (3,968) | | | | | | (36,940) | | | | | | (10,597) | | | | | | — | | | | | | (30,753) | | | | | | (82,258) | | |
已獲得的可確認負債總額
|
| | | | (5,696) | | | | | | (54,814) | | | | | | (26,486) | | | | | | (3,375) | | | | | | (31,763) | | | | | | (122,134) | | |
取得的可確認淨資產
|
| | | $ | 16,119 | | | | | $ | 133,112 | | | | | $ | 67,702 | | | | | $ | 77,725 | | | | | $ | 81,478 | | | | | $ | 376,136 | | |
採購價格分配 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
取得的可確認淨資產
|
| | | | 16,119 | | | | | | 133,112 | | | | | | 67,702 | | | | | | 77,725 | | | | | | 81,478 | | | | | | 376,136 | | |
Goodwill
|
| | | | 8,885 | | | | | | 105,018 | | | | | | 31,561 | | | | | | 11,324 | | | | | | 55,193 | | | | | | 211,981 | | |
Total consideration
|
| | | $ | 25,004 | | | | | $ | 238,130 | | | | | $ | 99,263 | | | | | $ | 89,049 | | | | | $ | 136,671 | | | | | $ | 588,117 | | |
($ in thousands)
|
| |
Verdant (i)
|
| |
Bluma (ii)
|
| |
Cultivate
(iii) |
| |
Cure Penn
(iv) |
| |
Laurel
Harvest (v) |
| |
Total
|
| ||||||||||||||||||
Contributed revenue
|
| | | $ | 26,547 | | | | | $ | 26,642 | | | | | $ | 29,279 | | | | | $ | 2,966 | | | | | $ | 328 | | | | | $ | 85,762 | | |
Net (loss) income
|
| | | | 5,352 | | | | | | (8,382) | | | | | | 14,944 | | | | | | (50) | | | | | | (136) | | | | | $ | 11,728 | | |
| | |
For the year ended December 31, 2021
|
| |||||||||||||||||||||||||||||||||||||||
| | |
Cresco Labs Inc.
|
| |
Verdant (i)
|
| |
Bluma (ii)
|
| |
Cultivate
(iii) |
| |
Cure Penn
(iv) |
| |
Laurel
Harvest (v) |
| |
Total
|
| |||||||||||||||||||||
($ in thousands)
|
| | | | | | | |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| ||||||||||||||||||
Pro forma revenue
|
| | | $ | 821,682 | | | | | $ | 2,677 | | | | | $ | 7,906 | | | | | $ | 39,033 | | | | | $ | 29,281 | | | | | $ | 1,966 | | | | | $ | 902,545 | | |
Pro forma net income: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
收購前淨收益
|
| | | | | | | | | | (846) | | | | | | (13,784) | | | | | | 4,550 | | | | | | 8,161 | | | | | | (2,121) | | | | | | | | |
Pro forma adjustments:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) Transaction
costs |
| | | | | | | | | | 399 | | | | | | 1,461 | | | | | | 1,555 | | | | | | 439 | | | | | | 1,081 | | | | | | | | |
(B)收購後股份薪酬
|
| | | | | | | | | | — | | | | | | 2,440 | | | | | | — | | | | | | — | | | | | | — | | | | | | | | |
(C)無形攤銷
|
| | | | | | | | | | (150) | | | | | | (599) | | | | | | (860) | | | | | | (355) | | | | | | (68) | | | | | | | | |
預計調整總額
|
| | | | | | | | | $ | 250 | | | | | $ | 3,302 | | | | | $ | 695 | | | | | $ | 84 | | | | | $ | 1,013 | | | | | | | | |
預計淨收入合計
|
| | | $ | (296,834) | | | | | $ | (596) | | | | | $ | (10,482) | | | | | $ | 5,245 | | | | | $ | 8,245 | | | | | $ | (1,109) | | | | | $ | (295,531) | | |
| | |
For the year ended December 31, 2020
|
| |||||||||||||||||||||||||||||||||||||||
| | |
Cresco
Labs Inc. |
| |
Verdant
(i) |
| |
Bluma (ii)
|
| |
Cultivate
(iii) |
| |
Cure Penn
(iv) |
| |
Laurel
Harvest (v) |
| |
Total
|
| |||||||||||||||||||||
($ in thousands)
|
| | | | | | | |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| ||||||||||||||||||
Pro forma revenue
|
| | | $ | 476,251 | | | | | $ | 15,195 | | | | | $ | 12,338 | | | | | $ | 22,965 | | | | | $ | 29,119 | | | | | $ | 1 | | | | | $ | 555,869 | | |
Pro forma net income:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
收購前淨收益
|
| | | | | | | | | | (1,982) | | | | | | (25,998) | | | | | | 772 | | | | | | 8,384 | | | | | | (650) | | | | | | | | |
Pro forma adjustments:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) Transaction costs
|
| | | | | | | | | | (399) | | | | | | (1,461) | | | | | | (1,555) | | | | | | (439) | | | | | | (1,081) | | | | | | | | |
(b) Post-acquisition
share-based compensation |
| | | | | | | | | | — | | | | | | (2,440) | | | | | | — | | | | | | — | | | | | | — | | | | | | | | |
(C)無形攤銷
|
| | | | | | | | | | (171) | | | | | | (853) | | | | | | (3,483) | | | | | | (387) | | | | | | (73) | | | | | | | | |
預計調整總額
|
| | | | | | | | | $ | (571) | | | | | $ | (4,754) | | | | | $ | (5,037) | | | | | $ | (826) | | | | | $ | (1,153) | | | | | | | | |
預計淨收入合計
|
| | | $ | (92,771) | | | | | $ | (2,553) | | | | | $ | (30,752) | | | | | $ | (4,266) | | | | | $ | 7,558 | | | | | $ | (1,803) | | | | | $ | (124,587) | | |
($ in thousands)
|
| |
Origin House
(ii) |
| |||
總體考慮 | | | | | | | |
Common shares issued
|
| | | $ | 396,575 | | |
Replacement awards
|
| | | | 31,671 | | |
Total consideration
|
| | | $ | 428,246 | | |
取得的可確認淨資產(負債) | | | | | | | |
Cash
|
| | | $ | 32,984 | | |
Accounts receivable
|
| | | | 7,565 | | |
Inventory
|
| | | | 16,660 | | |
Other current assets
|
| | | | 2,197 | | |
Property and equipment
|
| | | | 18,079 | | |
Right-of-use assets
|
| | | | 17,984 | | |
長期應收貸款
|
| | | | 331 | | |
權益法投資
|
| | | | 4,302 | | |
Investments
|
| | | | 139 | | |
客户關係
|
| | | | 63,600 | | |
Trade names
|
| | | | 39,700 | | |
Licenses
|
| | | | 5,900 | | |
市場相關無形資產
|
| | | | 2,374 | | |
內部開發的軟件
|
| | | | 380 | | |
獲得的可識別資產總額
|
| | | $ | 212,195 | | |
($ in thousands)
|
| |
Origin House
(ii) |
| |||
Short-term liabilities
|
| | | $ | (25,758) | | |
Lease liabilities
|
| | | | (18,002) | | |
延期和或有對價
|
| | | | (3,807) | | |
Notes payable
|
| | | | (22,045) | | |
遞延納税義務
|
| | | | (29,622) | | |
取得的可確認淨資產
|
| | | $ | 112,961 | | |
採購價格分配 | | | | | | | |
取得的可確認淨資產
|
| | | $ | 112,961 | | |
Goodwill
|
| | | | 315,285 | | |
Total consideration
|
| | | $ | 428,246 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
谷銀或有對價
|
| | | $ | — | | | | | $ | 19,093 | | |
培養或有對價
|
| | | | 33,969 | | | | | | — | | |
月桂收穫延期對價,短期
|
| | | | 37,847 | | | | | | — | | |
與短期 - 收購相關的遞延對價、或有對價和其他應付款項合計
|
| | | $ | 71,816 | | | | | $ | 19,093 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
硅谷農業營運現金流考慮因素
|
| | | $ | 8,577 | | | | | $ | 7,247 | | |
月桂收穫延期對價,長期
|
| | | | 9,074 | | | | | | — | | |
長期遞延和或有對價合計
|
| | | $ | 17,651 | | | | | $ | 7,247 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
高級貸款,扣除未攤銷債務發行成本後的淨額
|
| | | $ | 400,000 | | | | | $ | — | | |
Amended Term Loan
|
| | | | — | | | | | | 200,000 | | |
Interest payable
|
| | | | 9,711 | | | | | | 3,656 | | |
Financing liability – leases
|
| | | | 97,797 | | | | | | 91,265 | | |
減少:未攤銷債務發行成本 - 高級貸款
|
| | | | (22,501) | | | | | | — | | |
減去:未攤銷債務發行成本 - 修訂定期貸款
|
| | | | — | | | | | | (13,558) | | |
借款和應付利息總額
|
| | | $ | 485,007 | | | | | $ | 281,363 | | |
減去:短期借款和應付利息
|
| | | | (9,711) | | | | | | (15,071) | | |
減去:融資負債的當前部分 - 租賃
|
| | | | (10,217) | | | | | | (10,853) | | |
應付長期票據和貸款總額
|
| | | $ | 465,079 | | | | | $ | 255,439 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Wholesale
|
| | | $ | 414,908 | | | | | $ | 274,000 | | |
Dispensary
|
| | | | 406,774 | | | | | | 202,251 | | |
Total Revenue
|
| | | $ | 821,682 | | | | | $ | 476,251 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
衍生債務 - 權證的未實現收益(虧損)
|
| | | $ | 16,669 | | | | | $ | (8,659) | | |
衍生工具收益
|
| | | | 23,909 | | | | | | 2,938 | | |
計提 - 應收貸款損失
|
| | | | (753) | | | | | | (902) | | |
按公允價值持有的投資未實現虧損
|
| | | | (7,135) | | | | | | (162) | | |
債務清償損失
|
| | | | (17,987) | | | | | | (977) | | |
處置資產損失
|
| | | | (886) | | | | | | (134) | | |
Loss on foreign currency
|
| | | | (1,228) | | | | | | (1,415) | | |
Other income (loss), net
|
| | | | 442 | | | | | | 1,016 | | |
其他收入(費用)合計,淨額
|
| | | $ | 13,031 | | | | | $ | (8,295) | | |
| | | | | |
Year Ended
December 31, |
| |||||||||
($ in thousands)
|
| |
Classification
|
| |
2021
|
| |
2020
|
| ||||||
Operating Leases | | | | | | | | | | | | | | | | |
出租人擁有SLO的少數股權
|
| |
Rent expense
|
| | | $ | 1,563 | | | | | $ | 2,138 | | |
出租人擁有MedMar的少數股權
|
| |
Rent expense
|
| | | | 238 | | | | | | 140 | | |
出租人是MVS股東
|
| |
Rent expense
|
| | | | 1,168 | | | | | | 647 | | |
Finance Leases | | | | | | | | | | | | | | | | |
出租人擁有MedMar的少數股權
|
| |
Depreciation expense
|
| | | $ | 277 | | | | | $ | 151 | | |
出租人擁有MedMar的少數股權
|
| |
Interest expense
|
| | | | 310 | | | | | | 174 | | |
出租人是MVS股東
|
| |
Depreciation expense
|
| | | | 74 | | | | | | 64 | | |
出租人是MVS股東
|
| |
Interest expense
|
| | | | 88 | | | | | | 80 | | |
| | |
As of December 31, 2021
|
| |
As of December 31, 2020
|
| ||||||||||||||||||
($ in thousands)
|
| |
ROU Asset
|
| |
Lease Liability
|
| |
ROU Asset
|
| |
Lease Liability
|
| ||||||||||||
Operating Leases | | | | | | | | | | | | | | | | | | | | | | | | | |
出租人擁有SLO的少數股權
|
| | | $ | 6,996 | | | | | $ | 11,938 | | | | | $ | 4,926 | | | | | $ | 8,560 | | |
出租人擁有MedMar的少數股權
|
| | | | 1,525 | | | | | | 1,549 | | | | | | 1,146 | | | | | | 1,187 | | |
出租人是MVS股東
|
| | | | 6,314 | | | | | | 4,867 | | | | | | 6,334 | | | | | | 4,783 | | |
Finance Leases | | | | | | | | | | | | | | | | | | | | | | | | | |
出租人擁有MedMar的少數股權
|
| | | $ | 2,137 | | | | | $ | 2,457 | | | | | $ | 1,201 | | | | | $ | 1,365 | | |
出租人是MVS股東
|
| | | | 616 | | | | | | 1,063 | | | | | | 648 | | | | | | 678 | | |
| | |
December 31, 2021
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized Cost
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 223,543 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 223,543 | | |
Restricted cash(1)
|
| | | | 2,559 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,559 | | |
Security deposits
|
| | | | 3,941 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,941 | | |
Accounts receivable, net
|
| | | | 43,379 | | | | | | — | | | | | | — | | | | | | — | | | | | | 43,379 | | |
短期應收貸款
|
| | | | 747 | | | | | | — | | | | | | — | | | | | | 565 | | | | | | 1,312 | | |
長期應收貸款
|
| | | | 505 | | | | | | — | | | | | | — | | | | | | — | | | | | | 505 | | |
Investments
|
| | | | — | | | | | | 4,710 | | | | | | 542 | | | | | | 660 | | | | | | 5,912 | | |
財務負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 32,278 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,278 | | |
Accrued liabilities
|
| | | | 95,442 | | | | | | — | | | | | | — | | | | | | — | | | | | | 95,442 | | |
Short-term borrowings
|
| | | | 19,928 | | | | | | — | | | | | | — | | | | | | — | | | | | | 19,928 | | |
租賃負債的當期部分
|
| | | | 20,792 | | | | | | — | | | | | | — | | | | | | — | | | | | | 20,792 | | |
延期對價、或有對價和其他應付款項,短期
|
| | | | 5 | | | | | | 12 | | | | | | — | | | | | | 71,816 | | | | | | 71,833 | | |
短期衍生負債
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,172 | | | | | | 1,172 | | |
Lease liabilities
|
| | | | 118,936 | | | | | | — | | | | | | — | | | | | | — | | | | | | 118,936 | | |
延期對價和或有對價、長期對價
|
| | | | — | | | | | | — | | | | | | — | | | | | | 17,651 | | | | | | 17,651 | | |
長期應付票據和應付貸款
|
| | | | 465,079 | | | | | | — | | | | | | — | | | | | | — | | | | | | 465,079 | | |
| | |
December 31, 2020
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized
Cost |
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 136,339 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 136,339 | | |
Restricted cash(1)
|
| | | | 4,435 | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,435 | | |
Security deposits
|
| | | | 3,558 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,558 | | |
Accounts receivable, net
|
| | | | 29,943 | | | | | | — | | | | | | — | | | | | | — | | | | | | 29,943 | | |
短期應收貸款
|
| | | | 921 | | | | | | — | | | | | | | | | | | | 1,517 | | | | | | 2,438 | | |
長期應收貸款
|
| | | | 1,204 | | | | | | — | | | | | | — | | | | | | 20,019 | | | | | | 21,223 | | |
Investments(2) | | | | | 3,192 | | | | | | — | | | | | | 1,049 | | | | | | 119 | | | | | | 4,360 | | |
財務負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 23,231 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 23,231 | | |
Accrued liabilities
|
| | | | 130,469 | | | | | | — | | | | | | — | | | | | | — | | | | | | 130,469 | | |
Short-term borrowings
|
| | | | 25,924 | | | | | | — | | | | | | — | | | | | | — | | | | | | 25,924 | | |
租賃負債的當期部分
|
| | | | 18,040 | | | | | | — | | | | | | — | | | | | | — | | | | | | 18,040 | | |
延期對價、或有對價和其他應付款項,短期
|
| | | | — | | | | | | 22 | | | | | | — | | | | | | 19,093 | | | | | | 19,115 | | |
衍生負債 - 長期
|
| | | | — | | | | | | — | | | | | | — | | | | | | 17,505 | | | | | | 17,505 | | |
Lease liabilities
|
| | | | 74,468 | | | | | | — | | | | | | — | | | | | | — | | | | | | 74,468 | | |
延期對價和或有對價、長期對價
|
| | | | — | | | | | | — | | | | | | — | | | | | | 7,247 | | | | | | 7,247 | | |
長期應付票據和應付貸款
|
| | | | 255,439 | | | | | | — | | | | | | — | | | | | | — | | | | | | 255,439 | | |
($ in thousands)
|
| |
Valuation
classification |
| |
12/31/2021
|
| |
12/31/2020
|
| ||||||
短期應收貸款 - 燈塔
|
| |
Fair value
|
| | | $ | 565 | | | | | $ | 1,517 | | |
Interest receivable
|
| |
Amortized cost
|
| | | | 747 | | | | | | 921 | | |
短期應收貸款總額
|
| | | | | | $ | 1,312 | | | | | $ | 2,438 | | |
($ in thousands)
|
| |
Valuation
classification |
| |
12/31/2021
|
| |
12/31/2020
|
| ||||||
長期應收貸款 - Verdant
|
| |
Fair value
|
| | | $ | — | | | | | $ | 20,019 | | |
長期應收貸款 - 伊利諾伊州孵化器
|
| |
Amortized cost
|
| | | | 100 | | | | | | — | | |
長期應收貸款 - 其他
|
| |
Amortized cost
|
| | | | 405 | | | | | | 367 | | |
Interest receivable
|
| |
Amortized cost
|
| | | | — | | | | | | 837 | | |
長期應收貸款總額
|
| | | | | | $ | 505 | | | | | $ | 21,223 | | |
| | |
2021
|
| |
2020
|
| ||||||
無風險年利率
|
| | | | 0.15% | | | | | | 0.13% | | |
預期年度股息收益率
|
| | | | 0.0% | | | | | | 0.0% | | |
預期股價波動
|
| | | | 47.3% | | | | | | 83.0% | | |
認股權證的預期期限
|
| |
|
| |
1.8 years
|
| ||||||
Forfeiture rate
|
| | | | 0% | | | | | | 0% | | |
Share price at period end
|
| | | $ | 6.62 | | | | | $ | 9.86 | | |
期末執行價
|
| | | $ | 9.86 | | | | | $ | 9.82 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
0 to 60 days
|
| | | $ | 37,750 | | | | | $ | 28,280 | | |
61 to 120 days
|
| | | | 4,309 | | | | | | 1,134 | | |
120 days +
|
| | | | 3,540 | | | | | | 1,225 | | |
應收賬款總額,毛
|
| | | | 45,599 | | | | | | 30,639 | | |
壞賬準備
|
| | | | 2,220 | | | | | | 696 | | |
應收賬款總額,淨額
|
| | | $ | 43,379 | | | | | $ | 29,943 | | |
($ in thousands)
|
| |
|
| |
1 to 3 Years
|
| |
3 to 5 Years
|
| |
Total
|
| ||||||||||||
應付賬款和應計負債
|
| | | $ | 127,720 | | | | | $ | — | | | | | $ | — | | | | | $ | 127,720 | | |
延期對價、或有對價和其他應付款
|
| | | | 71,833 | | | | | | — | | | | | | — | | | | | | 71,833 | | |
延期對價和或有對價
|
| | | | — | | | | | | 17,651 | | | | | | — | | | | | | 17,651 | | |
長期應付票據和應付貸款及短期借款
|
| | | | 19,928 | | | | | | — | | | | | | 465,079 | | | | | | 485,007 | | |
截至2021年12月31日的債務總額
|
| | | $ | 219,481 | | | | | $ | 17,651 | | | | | $ | 465,079 | | | | | $ | 702,211 | | |
| | |
December 31, 2021
|
| |
December 31, 2020
|
| ||||||||||||
($ in thousands)
|
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs,
LLC |
| |||||||||
Current assets
|
| | | $ | 36,850 | | | | | $ | 7,111 | | | | | $ | 830,828 | | |
Non-current assets
|
| | | | 36,320 | | | | | | 14,744 | | | | | | 143,449 | | |
Current liabilities
|
| | | | (72,476) | | | | | | (20,898) | | | | | | (849,691) | | |
非流動負債
|
| | | | (23,124) | | | | | | (2,986) | | | | | | (83,138) | | |
非控股權益
|
| | | | — | | | | | | — | | | | | | 97,180 | | |
可歸因於Cresco Labs Inc.的赤字
|
| | | | (22,430) | | | | | | (2,029) | | | | | | (55,732) | | |
| | |
December 31, 2021
|
| |
December 31, 2020
|
| ||||||||||||
($ in thousands)
|
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs
Michigan, LLC |
| |
Cresco Labs,
LLC |
| |||||||||
Revenue
|
| | | $ | 4,031 | | | | | $ | 2,916 | | | | | $ | 98,786 | | |
非控股權益應佔淨收益(虧損)
|
| | | | — | | | | | | — | | | | | | 6,666 | | |
可歸因於Cresco Labs Inc.的淨收益(虧損)
|
| | | | (9,120) | | | | | | (1,796) | | | | | | 10,204 | | |
Net income (loss)
|
| | | | (9,120) | | | | | | (1,796) | | | | | | 16,870 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Interest expense – leases
|
| | | $ | (4,053) | | | | | $ | (3,064) | | |
利息支出 - 應付票據和貸款
|
| | | | (29,661) | | | | | | (14,350) | | |
債務折扣的增加和遞延融資費用的攤銷
|
| | | | (5,153) | | | | | | (4,619) | | |
利息支出 - 融資活動以及銷售和回租
|
| | | | (11,586) | | | | | | (10,568) | | |
Other interest expense
|
| | | | (1,696) | | | | | | (39) | | |
Interest income
|
| | | | 938 | | | | | | 1,411 | | |
總利息支出,淨額
|
| | | $ | (51,211) | | | | | $ | (31,229) | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Current | | | | | | | | | | | | | |
Federal
|
| | | $ | 51,815 | | | | | $ | 27,821 | | |
State
|
| | | | 23,337 | | | | | | 11,936 | | |
Foreign
|
| | | | — | | | | | | — | | |
Total current
|
| | | $ | 75,152 | | | | | $ | 39,757 | | |
Deferred | | | | | | | | | | | | | |
Federal
|
| | | $ | (29,445) | | | | | $ | (6,253) | | |
State
|
| | | | (14,043) | | | | | | (4,394) | | |
Foreign
|
| | | | 5,759 | | | | | | (9,273) | | |
Total deferred
|
| | | $ | (37,729) | | | | | $ | (19,920) | | |
估值免税額變動
|
| | | $ | 2,684 | | | | | $ | 8,767 | | |
Total | | | | $ | 40,107 | | | | | $ | 28,604 | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Deferred tax assets | | | | | | | | | | | | | |
基於股份的薪酬
|
| | | $ | 1,029 | | | | | $ | 360 | | |
Financing fees
|
| | | | 2,542 | | | | | | 2,920 | | |
Net operating losses
|
| | | | 36,096 | | | | | | 29,708 | | |
Inventory
|
| | | | 239 | | | | | | 967 | | |
Capital losses
|
| | | | — | | | | | | 336 | | |
Lease liabilities
|
| | | | 26,761 | | | | | | 22,284 | | |
Other
|
| | | | 730 | | | | | | 4,279 | | |
遞延税金資產總額
|
| | | $ | 67,397 | | | | | $ | 60,854 | | |
遞延納税義務 | | | | | | | | | | | | | |
ROU assets
|
| | | $ | (7,824) | | | | | $ | (7,574) | | |
財產、廠房和設備
|
| | | | (11,885) | | | | | | (12,668) | | |
Intangible assets
|
| | | | (93,761) | | | | | | (48,499) | | |
Other
|
| | | | (1,948) | | | | | | (139) | | |
遞延納税負債總額
|
| | | $ | (115,418) | | | | | $ | (68,880) | | |
Valuation allowance
|
| | | $ | (31,085) | | | | | $ | (26,044) | | |
遞延納税淨負債
|
| | | $ | (79,105) | | | | | $ | (34,071) | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
按法定税率計算的預期所得税費用
|
| | | $ | (53,912) | | | | | $ | (13,475) | | |
Tax rate differences
|
| | | | (1,109) | | | | | | (13,684) | | |
傳遞實體和非控制實體
|
| | | | (7,373) | | | | | | (4,775) | | |
State tax expense, net
|
| | | | 9,319 | | | | | | 7,517 | | |
IRC Section 280E disallowance
|
| | | | 47,100 | | | | | | 35,376 | | |
遞延對價的價值變動
|
| | | | (10,103) | | | | | | 3,116 | | |
債務修改損失
|
| | | | 7,554 | | | | | | — | | |
不確定的税務處理
|
| | | | (4,749) | | | | | | 755 | | |
基於股份的薪酬
|
| | | | 3,941 | | | | | | 3,159 | | |
Goodwill impairment
|
| | | | 45,314 | | | | | | — | | |
估值免税額變動
|
| | | | 2,684 | | | | | | 8,768 | | |
Other
|
| | | | 1,440 | | | | | | 1,847 | | |
Income tax expense
|
| | | $ | 40,107 | | | | | $ | 28,604 | | |
Effective tax rate
|
| | | | (15.6)% | | | | | | (44.6)% | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||
Balance at January 1
|
| | | $ | 4,749 | | | | | $ | 3,993 | | |
根據與本年度相關的納税頭寸進行的增加
|
| | | | — | | | | | | 556 | | |
新增往年納税頭寸
|
| | | | — | | | | | | 200 | | |
前幾年税收頭寸減少
|
| | | | (4,749) | | | | | | — | | |
年終餘額
|
| | | $ | — | | | | | $ | 4,749 | | |
| | |
Three Months Ended
December 31, |
| |
Year Ended
December 31, |
| ||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
2021
|
| |
2020
|
| ||||||||||||
工資和員工成本
|
| | | $ | 33,451 | | | | | $ | 22,107 | | | | | $ | 133,143 | | | | | $ | 81,080 | | |
銷售和營銷費用
|
| | | | 4,734 | | | | | | 8,375 | | | | | | 29,733 | | | | | | 19,218 | | |
基於股份的薪酬
|
| | | | 4,496 | | | | | | 5,313 | | | | | | 24,988 | | | | | | 16,373 | | |
折舊及攤銷
|
| | | | 4,484 | | | | | | 4,141 | | | | | | 21,602 | | | | | | 17,133 | | |
Excise taxes
|
| | | | 4,867 | | | | | | 4,642 | | | | | | 15,998 | | | | | | 13,167 | | |
Facility expenses
|
| | | | 7,990 | | | | | | 4,194 | | | | | | 22,611 | | | | | | 15,672 | | |
諮詢和專業服務
|
| | | | 3,615 | | | | | | 2,943 | | | | | | 13,503 | | | | | | 17,418 | | |
Computer and software
|
| | | | 3,282 | | | | | | 2,317 | | | | | | 13,302 | | | | | | 7,744 | | |
Business insurance
|
| | | | 1,170 | | | | | | 1,549 | | | | | | 8,087 | | | | | | 4,676 | | |
Rental fees
|
| | | | 2,090 | | | | | | 1,744 | | | | | | 7,385 | | | | | | 6,069 | | |
Accounting
|
| | | | 1,346 | | | | | | 586 | | | | | | 4,675 | | | | | | 2,982 | | |
Legal
|
| | | | 1,484 | | | | | | 1,029 | | | | | | 8,863 | | | | | | 5,825 | | |
差旅和員工費用
|
| | | | 1,531 | | | | | | 536 | | | | | | 4,570 | | | | | | 3,081 | | |
Other expenses
|
| | | | 4,980 | | | | | | 14,677 | | | | | | 9,344 | | | | | | 18,508 | | |
銷售、一般和管理費用合計
|
| | | $ | 79,520 | | | | | $ | 74,153 | | | | | $ | 317,804 | | | | | $ | 228,946 | | |
| | |
Three Months Ended
December 31, |
| |
Year Ended
December 31, |
| ||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
2021
|
| |
2020
|
| ||||||||||||
衍生債務 - 權證的未實現收益(虧損)
|
| | | $ | 5,996 | | | | | $ | (8,830) | | | | | $ | 16,669 | | | | | $ | (8,659) | | |
衍生工具的收益(虧損)
|
| | | | 7,829 | | | | | | (7,022) | | | | | | 23,909 | | | | | | 2,938 | | |
計提 - 應收貸款損失
|
| | | | (666) | | | | | | (482) | | | | | | (753) | | | | | | (902) | | |
按公允價值持有的投資未實現虧損
|
| | | | (548) | | | | | | — | | | | | | (7,135) | | | | | | (162) | | |
債務清償損失
|
| | | | — | | | | | | (977) | | | | | | (17,987) | | | | | | (977) | | |
處置資產損益
|
| | | | — | | | | | | 3 | | | | | | (886) | | | | | | (134) | | |
外幣損益
|
| | | | 46 | | | | | | (1,199) | | | | | | (1,228) | | | | | | (1,415) | | |
Other (loss) income
|
| | | | (1,746) | | | | | | 38 | | | | | | 442 | | | | | | 1,016 | | |
其他收入(費用)合計,淨額
|
| | | $ | 10,911 | | | | | $ | (18,469) | | | | | $ | 13,031 | | | | | $ | (8,295) | | |
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
Q4
|
| |
Q3
|
| |
Q2
|
| |
Q1
|
| |
Q4
|
| |
Q3
|
| |
Q2
|
| |
Q1
|
| ||||||||||||||||||||||||
Revenue, net
|
| | | $ | 217,787 | | | | | $ | 215,483 | | | | | $ | 209,975 | | | | | $ | 178,437 | | | | | $ | 162,317 | | | | | $ | 153,298 | | | | | $ | 94,256 | | | | | $ | 66,380 | | |
運營利潤(虧損)
|
| | | | 15,557 | | | | | | (264,018) | | | | | | 14,872 | | | | | | 16,238 | | | | | | 329 | | | | | | 24,935 | | | | | | (20,938) | | | | | | (27,788) | | |
Net (loss) attributable
to Cresco Labs Inc. |
| | | | (14,732) | | | | | | (270,645) | | | | | | (4,827) | | | | | | (29,393) | | | | | | (54,636) | | | | | | 15,457 | | | | | | (36,433) | | | | | | (26,545) | | |
Basic EPS
|
| | | $ | (0.08) | | | | | $ | (1.00) | | | | | $ | (0.02) | | | | | $ | (0.12) | | | | | $ | (0.25) | | | | | $ | 0.07 | | | | | $ | (0.18) | | | | | $ | (0.13) | | |
Diluted EPS
|
| | | $ | (0.08) | | | | | $ | (1.00) | | | | | $ | (0.02) | | | | | $ | (0.12) | | | | | $ | (0.22) | | | | | $ | 0.04 | | | | | $ | (0.18) | | | | | $ | (0.13) | | |
| | |
截至12月31日的三個月
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
Revenue
|
| | | $ | 217,787 | | | | | $ | 162,317 | | | | | $ | 55,470 | | | | | | 34.2% | | |
Cost of goods sold
|
| | | | (107,765) | | | | | | (87,835) | | | | | | (19,930) | | | | | | 22.7% | | |
Gross profit
|
| | | | 110,022 | | | | | | 74,482 | | | | | | 35,540 | | | | | | 47.7% | | |
總運營費用
|
| | | | 94,465 | | | | | | 74,153 | | | | | | 20,312 | | | | | | 27.4% | | |
Total other (expense), net
|
| | | | (3,940) | | | | | | (27,335) | | | | | | 23,395 | | | | | | (85.6)% | | |
Income tax expense
|
| | | | (23,528) | | | | | | (14,181) | | | | | | (9,347) | | | | | | 65.9% | | |
Net (loss)(1)
|
| | | $ | (11,911) | | | | | $ | (41,187) | | | | | $ | 29,276 | | | | |
|
(71.1)%
|
| |
| | |
Year Ended December 31,
|
| |||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
Revenue, net
|
| | | $ | 821,682 | | | | | $ | 476,251 | | | | | $ | 128,534 | | |
Loss from operations
|
| | | | (217,351) | | | | | | (23,462) | | | | | | (61,607) | | |
Cresco,Inc.造成的虧損
|
| | | | (319,597) | | | | | | (102,157) | | | | | | (51,594) | | |
Basic and Diluted EPS
|
| | | $ | (1.22) | | | | | $ | (0.49) | | | | | $ | (0.44) | | |
($ in thousands)
|
| |
December 31,
2021 |
| |
December 31,
2020 |
| |
December 31,
2019 |
| |||||||||
Total Assets
|
| | | $ | 1,780,463 | | | | | $ | 1,232,596 | | | | | $ | 589,646 | | |
非流動租賃負債
|
| | | | 118,936 | | | | | | 74,468 | | | | | | 35,780 | | |
非流動金融負債總額
|
| | | | 465,079 | | | | | | 255,439 | | | | | | 65,000 | | |
| | |
Year Ended December 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
Revenue
|
| | | $ | 821,682 | | | | | $ | 476,251 | | | | | $ | 345,431 | | | | | | 72.5% | | |
Cost of goods sold
|
| | | | (415,335) | | | | | | (269,550) | | | | | | (145,785) | | | | | | 54.1% | | |
Gross profit
|
| | | | 406,347 | | | | | | 206,701 | | | | | | 199,646 | | | | | | 96.6% | | |
總運營費用
|
| | | | 623,698 | | | | | | 230,163 | | | | | | 393,535 | | | | | | 171.0% | | |
Total other (expense), net
|
| | | | (39,376) | | | | | | (40,705) | | | | | | 1,329 | | | | | | (3.3)% | | |
Income tax expense
|
| | | | (40,107) | | | | | | (28,604) | | | | | | (11,503) | | | | | | 40.2% | | |
Net (loss)(1)
|
| | | $ | (296,834) | | | | | $ | (92,771) | | | | | $ | (204,063) | | | | |
|
220.0%
|
| |
| | |
截至12月31日的三個月
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
$ Change
|
| |
% Change(2)
|
| ||||||||||||
Net (loss)(1)
|
| | | $ | (11,911) | | | | | $ | (41,187) | | | | | $ | 29,276 | | | | | | (71.1)% | | |
折舊及攤銷
|
| | | | 8,197 | | | | | | 8,616 | | | | | | (419) | | | | | | (4.9)% | | |
Interest expense, net
|
| | | | 14,851 | | | | | | 7,939 | | | | | | 6,912 | | | | | | 87.1% | | |
Income tax expense
|
| | | | 23,528 | | | | | | 14,181 | | | | | | 9,347 | | | | | | 65.9% | | |
EBITDA (non-GAAP)
|
| | | $ | 34,665 | | | | | $ | (10,451) | | | | | $ | 45,116 | | | |
nm
|
| |||
Other (income) expense, net
|
| | | | (10,911) | | | | | | 18,469 | | | | | | (29,380) | | | | | | (159.1)% | | |
權益法投資虧損
|
| | | | — | | | | | | 927 | | | | | | (927) | | | | | | (100.0)% | | |
收購庫存的公允價值加價
|
| | | | 8,407 | | | | | | — | | | | | | 8,407 | | | | | | 100.0% | | |
收購和其他非核心成本的調整
|
| | | | 4,954 | | | | | | 15,540 | | | | | | (10,586) | | | | | | (68.1)% | | |
Impairment loss
|
| | | | 14,945 | | | | | | — | | | | | | 14,945 | | | | | | 100.0% | | |
基於股份的薪酬
|
| | | | 4,933 | | | | | | 5,545 | | | | | | (612) | | | | | | (11.0)% | | |
Adjusted EBITDA (non-GAAP)
|
| | | $ | 56,993 | | | | | $ | 30,030 | | | | | $ | 26,963 | | | | | | 89.8% | | |
| | |
Year Ended December 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| |
$ Change
|
| |
% Change(2)
|
| ||||||||||||
Net (loss)(1)
|
| | | $ | (296,834) | | | | | $ | (92,771) | | | | | $ | (204,063) | | | | | | 220.0% | | |
折舊及攤銷
|
| | | | 38,640 | | | | | | 31,788 | | | | | | 6,852 | | | | | | 21.6% | | |
Interest expense, net
|
| | | | 51,211 | | | | | | 31,229 | | | | | | 19,982 | | | | | | 64.0% | | |
Income tax expense
|
| | | | 40,107 | | | | | | 28,604 | | | | | | 11,503 | | | | | | 40.2% | | |
EBITDA (non-GAAP)
|
| | | $ | (166,876) | | | | | $ | (1,150) | | | | | $ | (165,726) | | | | |
|
網管
|
| |
Other (income) expense, net
|
| | | | (13,031) | | | | | | 8,295 | | | | | | (21,326) | | | | | | (257.1)% | | |
權益法投資虧損
|
| | | | 1,196 | | | | | | 1,181 | | | | | | 15 | | | | | | 1.3% | | |
收購庫存的公允價值加價
|
| | | | 23,441 | | | | | | 3,749 | | | | | | 19,692 | | | | | | 網管 | | |
收購和其他非核心成本的調整
|
| | | | 15,803 | | | | | | 28,654 | | | | | | (12,851) | | | | | | (44.8)% | | |
Impairment loss
|
| | | | 305,894 | | | | | | 1,194 | | | | | | 304,700 | | | | | | 網管 | | |
基於股份的薪酬
|
| | | | 27,536 | | | | | | 18,839 | | | | | | 8,697 | | | | | | 46.2% | | |
Adjusted EBITDA (non-GAAP)
|
| | | $ | 193,963 | | | | | $ | 60,762 | | | | | $ | 133,201 | | | | | | 219.2% | | |
($ in thousands)
|
| |
Total
|
| |
Operating Leases
|
| |
Finance Leases
|
| |||||||||
2022
|
| | | $ | 24,242 | | | | | $ | 18,971 | | | | | $ | 5,271 | | |
2023
|
| | | | 24,260 | | | | | | 18,832 | | | | | | 5,428 | | |
2024
|
| | | | 24,593 | | | | | | 18,989 | | | | | | 5,604 | | |
2025
|
| | | | 26,102 | | | | | | 20,348 | | | | | | 5,754 | | |
2026
|
| | | | 26,423 | | | | | | 20,528 | | | | | | 5,895 | | |
Thereafter
|
| | | | 207,288 | | | | | | 174,141 | | | | | | 33,147 | | |
Total lease payments
|
| | | $ | 332,908 | | | | | $ | 271,809 | | | | | $ | 61,099 | | |
Less: imputed interest
|
| | | | (184,810) | | | | | | (154,871) | | | | | | (29,939) | | |
少:租户改善津貼
|
| | | | (8,370) | | | | | | (7,671) | | | | | | (699) | | |
租賃負債現值
|
| | | | 139,728 | | | | | | 109,267 | | | | | | 30,461 | | |
減去:短期租賃負債
|
| | | | (20,792) | | | | | | (16,348) | | | | | | (4,444) | | |
長期租賃負債現值
|
| | | $ | 118,936 | | | | | $ | 92,919 | | | | | $ | 26,017 | | |
($ in thousands)
|
| |
|
| |
1 to 3 Years
|
| |
3 to 5 Years
|
| |
Total
|
| ||||||||||||
應付賬款和應計負債
|
| | | $ | 127,720 | | | | | $ | — | | | | | $ | — | | | | | $ | 127,720 | | |
延期對價、或有對價和其他應付款項,短期
|
| | | | 71,833 | | | | | | — | | | | | | — | | | | | | 71,833 | | |
延期對價和或有對價、長期對價
|
| | | | — | | | | | | 17,651 | | | | | | — | | | | | | 17,651 | | |
長期應付票據和應付貸款及短期借款
|
| | | | 19,928 | | | | | | — | | | | | | 465,079 | | | | | | 485,007 | | |
截至2021年12月31日的債務總額
|
| | | $ | 219,481 | | | | | $ | 17,651 | | | | | $ | 465,079 | | | | | $ | 702,211 | | |
| | | | | |
Year Ended December 31,
|
| |||||||||
($ in thousands)
|
| |
Classification
|
| |
2021
|
| |
2020
|
| ||||||
Operating Leases | | | | | | | | | | | | | | | | |
出租人擁有SLO的少數股權
|
| | Rent expense | | | | $ | 1,563 | | | | | $ | 2,138 | | |
出租人擁有MedMar的少數股權
|
| | Rent expense | | | | | 238 | | | | | | 140 | | |
出租人是MVS股東
|
| | Rent expense | | | | | 1,168 | | | | | | 647 | | |
Finance Leases | | | | | | | | | | | | | | | | |
出租人擁有MedMar的少數股權
|
| |
Depreciation expense
|
| | | $ | 277 | | | | | $ | 151 | | |
出租人擁有MedMar的少數股權
|
| | Interest expense | | | | | 310 | | | | | | 174 | | |
出租人是MVS股東
|
| |
Depreciation expense
|
| | | | 74 | | | | | | 64 | | |
出租人是MVS股東
|
| | Interest expense | | | | | 88 | | | | | | 80 | | |
| | |
As of December 31, 2021
|
| |
As of December 31, 2020
|
| ||||||
($ in thousands)
|
| |
ROU Asset
|
| |
Lease Liability
|
| |
ROU Asset
|
| |
Lease Liability
|
|
Operating Leases | | | | | | | | | | | | | |
出租人擁有SLO的少數股權
|
| |
$6,996
|
| |
$11,938
|
| |
$4,926
|
| |
$8,560
|
|
出租人擁有MedMar的少數股權
|
| |
1,525
|
| |
1,549
|
| |
1,146
|
| |
1,187
|
|
出租人是MVS股東
|
| |
6,314
|
| |
4,867
|
| |
6,334
|
| |
4,783
|
|
Finance Leases | | | | | | | | | | | | | |
出租人擁有MedMar的少數股權
|
| |
$2,137
|
| |
$2,457
|
| |
$1,201
|
| |
$1,365
|
|
出租人是MVS股東
|
| |
616
|
| |
1,063
|
| |
648
|
| |
678
|
|
| | |
2021
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized Cost
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 223,543 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 223,543 | | |
Restricted cash(1)
|
| | | | 2,559 | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,559 | | |
Security deposits
|
| | | | 3,941 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,941 | | |
Accounts receivable, net
|
| | | | 43,379 | | | | | | — | | | | | | — | | | | | | — | | | | | | 43,379 | | |
短期應收貸款
|
| | | | 747 | | | | | | — | | | | | | — | | | | | | 565 | | | | | | 1,312 | | |
長期應收貸款
|
| | | | 505 | | | | | | — | | | | | | — | | | | | | — | | | | | | 505 | | |
Investments
|
| | | | — | | | | | | 4,710 | | | | | | 542 | | | | | | 660 | | | | | | 5,912 | | |
財務負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 32,278 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,278 | | |
Accrued liabilities
|
| | | | 95,442 | | | | | | — | | | | | | — | | | | | | — | | | | | | 95,442 | | |
Short-term borrowings
|
| | | | 19,928 | | | | | | — | | | | | | — | | | | | | — | | | | | | 19,928 | | |
租賃負債的當期部分
|
| | | | 20,792 | | | | | | — | | | | | | — | | | | | | — | | | | | | 20,792 | | |
延期對價、或有對價和其他應付款項,短期
|
| | | | 5 | | | | | | 12 | | | | | | — | | | | | | 71,816 | | | | | | 71,833 | | |
短期衍生負債
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,172 | | | | | | 1,172 | | |
Lease liabilities
|
| | | | 118,936 | | | | | | — | | | | | | — | | | | | | — | | | | | | 118,936 | | |
延期對價和或有對價,
long-term |
| | | | — | | | | | | — | | | | | | — | | | | | | 17,651 | | | | | | 17,651 | | |
長期應付票據和應付貸款
|
| | | | 465,079 | | | | | | — | | | | | | — | | | | | | — | | | | | | 465,079 | | |
| | |
2020
|
| |||||||||||||||||||||||||||
($ in thousands)
|
| |
Amortized Cost
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |||||||||||||||
Financial Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 136,339 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 136,339 | | |
Restricted cash(1)
|
| | | | 4,435 | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,435 | | |
Security deposits
|
| | | | 3,558 | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,558 | | |
Accounts receivable, net
|
| | | | 29,943 | | | | | | — | | | | | | — | | | | | | — | | | | | | 29,943 | | |
短期應收貸款
|
| | | | 921 | | | | | | — | | | | | | | | | | | | 1,517 | | | | | | 2,438 | | |
長期應收貸款
|
| | | | 1,204 | | | | | | — | | | | | | — | | | | | | 20,019 | | | | | | 21,223 | | |
Investments(2) | | | | | 3,192 | | | | | | — | | | | | | 1,049 | | | | | | 119 | | | | | | 4,360 | | |
財務負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 23,231 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 23,231 | | |
Accrued liabilities
|
| | | | 130,469 | | | | | | — | | | | | | — | | | | | | — | | | | | | 130,469 | | |
Short-term borrowings
|
| | | | 25,924 | | | | | | — | | | | | | — | | | | | | — | | | | | | 25,924 | | |
租賃負債的當期部分
|
| | | | 18,040 | | | | | | — | | | | | | — | | | | | | — | | | | | | 18,040 | | |
延期對價、或有對價和其他應付款項,短期
|
| | | | — | | | | | | 22 | | | | | | — | | | | | | 19,093 | | | | | | 19,115 | | |
長期衍生負債
|
| | | | — | | | | | | — | | | | | | — | | | | | | 17,505 | | | | | | 17,505 | | |
Lease liabilities
|
| | | | 74,468 | | | | | | — | | | | | | — | | | | | | — | | | | | | 74,468 | | |
延期對價和或有對價,
long-term |
| | | | — | | | | | | — | | | | | | — | | | | | | 7,247 | | | | | | 7,247 | | |
長期應付票據和應付貸款
|
| | | | 255,439 | | | | | | — | | | | | | — | | | | | | — | | | | | | 255,439 | | |
Securities
|
| |
Number of Shares
(in thousands) |
| |||
已發行且未償還的 | | | | | | | |
Super Voting Shares
|
| | | | 500 | | |
從屬表決權股份(3)
|
| | | | 269,971 | | |
比例投票權股份(1)
|
| | | | 20,667 | | |
特殊從屬表決權股份(2)
|
| | | | 1 | | |
Redeemable Shares
|
| | | | 109,441 | | |
Warrants
|
| | | | 9,842 | | |
Stock Options
|
| | | | 23,610 | | |
Restricted Stock Units
|
| | | | 1,093 | | |
| | | | Yours truly, | |
| | | | (signed) “Thomas J. Manning” | |
| | | |
Thomas J. Manning
董事會執行主席 |
|
Name of
Shareholder |
| |
Number and
Percentage of Super Voting Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly |
| |
Number and
Percentage of Proportionate Voting Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly(1)(2)(3) |
| |
Number and
Percentage of Subordinate Voting Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly(2) |
| |
Number and
Percentage of Special Subordinate Voting Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly(2)(4) |
| |
Percentage of
Votes Attaching to All Outstanding Shares Beneficially Owned, or Controlled or Directed, Directly or Indirectly(5) |
|
Charles Bachtell(6)
|
| |
100,000
|
| |
4,363(5)
|
| |
103,886
|
| |
0
|
| |
15.9%
|
|
|
(20%)
|
| |
(3.32%)
|
| |
(
|
| |
(0%)
|
| | | | ||
Joseph Caltabiano
|
| |
100,000
|
| |
200
|
| |
2,780,000(7)
|
| |
0
|
| |
16.0%
|
|
|
(20%)
|
| |
(0.15%)
|
| |
(1.17%)
|
| |
(0%)
|
| | | | ||
Brian McCormack
|
| |
100,000
|
| |
0
|
| |
61,700
|
| |
0
|
| |
15.8%
|
|
|
(20%)
|
| |
(0%)
|
| |
(
|
| |
(0%)
|
| | | | ||
Robert M. Sampson
|
| |
100,000
|
| |
4
|
| |
0
|
| |
0
|
| |
15.8%
|
|
|
(20%)
|
| |
(
|
| |
(0%)
|
| |
(0%)
|
| | | | ||
Dominic A. Sergi
|
| |
100,000
|
| |
0
|
| |
0
|
| |
0
|
| |
15.8%
|
|
|
(20%)
|
| |
(0%)
|
| |
(0%)
|
| |
(0%)
|
| | | |
Name and Province or
居住地國家和州 |
| |
Director Since
|
| |
Principal Occupation
for Past Five Years |
| |
Voting Shares
Beneficially Owned, Controlled or Directed, Directly or Indirectly(1) |
|
Charles Bachtell(2)
Chicago, IL, United States |
| |
November 2018
|
| |
公司首席執行官;曾任住宅抵押貸款公司Guaraned Rate執行副總裁兼總法律顧問。
|
| |
100,000 Super Voting Shares
103,886 Subordinate Voting Shares
4363份比例投票權股份
13,102,342 Cresco Redeemable Units
|
|
Robert M. Sampson(3)
美國伊利諾伊州唐納斯格羅夫 |
| |
November 2018
|
| |
CrossCountry Mortgage,Inc.執行副總裁;前首席運營官The Corporation,Bountgage首席執行官和住宅抵押貸款公司Guaraned Rate首席運營官。
|
| |
100,000 Super Voting Shares
100,000 Subordinate Voting Shares
4份比例投票權股份
13,001,049 Cresco Redeemable Units
|
|
Name and Province or
居住地國家和州 |
| |
Director Since
|
| |
Principal Occupation
for Past Five Years |
| |
Voting Shares
Beneficially Owned, Controlled or Directed, Directly or Indirectly(1) |
|
John R. Walter(4)
Naples, FL, United States |
| |
November 2018
|
| |
諮詢公司阿什林管理公司董事長兼首席執行官。
|
| |
1,177股比例投票權股份
|
|
Gerald F. Corcoran(2)(5)
美國伊利諾伊州温尼特卡 |
| |
November 2018
|
| |
期貨經紀公司R.J.O‘Brien&Associates,LLC董事會主席兼首席執行官。
|
| |
18,500 Subordiante Voting Shares
997,395 Cresco Redeemable Units
|
|
Thomas J. Manning(6)
美國伊利諾伊州埃文斯頓 |
| |
November 2018
|
| |
公司董事會執行主席,曾任數據分析公司Dun and BradStreet董事長兼首席執行官。
|
| |
500份比例投票權股份
|
|
Randy D. Podolsky(3)(7)
美國伊利諾伊州萊克福里斯特 |
| |
December 2016
|
| |
房地產公司Podolsky Circle Corfac International(現為高力國際)的管理負責人。
|
| |
814,387 Cresco Redeemable Units
|
|
Marc Lustig
加拿大不列顛哥倫比亞省温哥華 |
| |
January 2020
|
| |
公司資本市場主管;自2019年以來擔任IM Cannabis Corp.非執行主席;自2016年以來擔任CannaRoyalty Corp.(Dba Origin House)創始人、董事長兼首席執行官;2012年至2014年擔任Dundee Capital Markets資本市場主管。
|
| |
63,868,296特殊從屬表決權股份
|
|
Michele Roberts(8)
美國紐約州紐約市 |
| |
June 2020
|
| |
自2014年起擔任美國國家籃球運動員協會執行董事。在此之前,羅伯茨是世達律師事務所的律師。
|
| |
—
|
|
Name and Province or
居住地國家和州 |
| |
Director Since
|
| |
Principal Occupation
for Past Five Years |
| |
Voting Shares
Beneficially Owned, Controlled or Directed, Directly or Indirectly(1) |
|
Carol Vallone(2)(9)
美國馬薩諸塞州曼徹斯特 |
| |
July 2020
|
| |
麥克萊恩醫院董事會主席,麻省理工學院健康專業學院董事會成員,麻省總醫院財務委員會成員,貝恩資本雙重影響投資組合公司Arosa的董事會成員,伯克希爾合夥公司的董事顧問,以及專注於醫療保健的風險增長公司經度資本的顧問委員會成員;前首席執行官和流星學習公司董事會成員。
|
| |
—
|
|
Tarik Brooks
美國加利福尼亞州洛杉磯 |
| |
April 2021
|
| |
康姆斯企業總裁。在此之前,布魯克斯先生是Bridgewater Associates的客户管理和交易首席運營官,以及RLJ Companies的執行副總裁。
|
| |
—
|
|
Sidney Dillard
Chicago, IL, United States |
| |
May 2021
|
| |
Loop Capital合夥人兼企業投資銀行部主管。Dillard女士是Loop Capital管理委員會和公平與估值委員會的成員。
|
| |
—
|
|
| | |
不包括薪酬證券的薪酬表
|
| |||||||||||||||||||||||||||||||||||||||
Name and position
|
| |
Year
|
| |
Salary,
consulting fee, retainer or commission ($US) |
| |
Bonus
($US) |
| |
Committee
or meeting fees(1) ($US) |
| |
Value of
perquisites ($US) |
| |
Value of all
other compensation ($US) |
| |
Total
compensation ($US) |
| |||||||||||||||||||||
Charles Bachtell
|
| | | | 2020 | | | | | $ | 450,000 | | | | | $ | 87,500 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 537,500 | | |
Director and Chief
Executive Officer(1) |
| | | | 2019 | | | | | $ | 350,000 | | | | | $ | 275,000 | | | | | $ | 50,000 | | | | | $ | 1,200(4) | | | | | | — | | | | | $ | 676,200 | | |
Ken Amann
|
| | | | 2020 | | | | | $ | 274,995 | | | | | $ | 31,250 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 306,245 | | |
Former Chief
Financial Officer(2) |
| | | | 2019 | | | | | $ | 250,000 | | | | | $ | 125,000 | | | | | | — | | | | | $ | 3,300 | | | | | | — | | | | | $ | 378,300 | | |
Dennis Olis
|
| | | | 2020 | | | | | $ | 201,515 | | | | | | — | | | | | | — | | | | | $ | 600 | | | | | | — | | | | | $ | 201,515 | | |
Chief Financial
Officer(2) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||
David Ellis
|
| | | | 2020 | | | | | $ | 291,667 | | | | | $ | 59,375 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 351,042 | | |
Former Chief
Operating Officer(3) |
| | | | 2019 | | | | | $ | 200,000 | | | | | $ | 87,500 | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 287,500 | | |
| | |
補償證券(1)
|
| ||||||||||||||||||
Name and position
|
| |
Type of
compensation security(2) |
| |
Number of
compensation securities, number of underlying securities, and percentage of class |
| |
Date of
issue or grant |
| |
Issue,
conversion or exercise price ($US) |
| |
Closing
price of security or underlying security on date of grant ($CDN) |
| |
Closing
price of security or underlying security at year end ($CDN) |
| |
Expiry
date |
|
查爾斯·巴切特爾董事兼首席執行官
|
| |
Options
|
| |
1500,000股從屬投票股可行使的1500,000份期權
(0.6%) |
| |
May 20, 2020
|
| |
$6.55
|
| |
$4.56
|
| |
$12.55
|
| |
May 20, 2030
|
|
Thomas J. Manning
董事和執行主席 |
| |
Options
|
| |
200,000,000從屬投票股可行使的200,000,000份期權
(0.8%) |
| |
May 29, 2020
|
| |
$4.56
|
| |
$6.77
|
| |
$12.55
|
| |
May 29, 2030
|
|
Dennis Olis
首席財務官 |
| |
Options
|
| |
500,000股從屬投票股可行使的500,000份期權
(0.2%) |
| |
June 30, 2020
|
| |
$4.11
|
| |
$5.60
|
| |
$12.55
|
| |
June 30, 2030
|
|
Randy D. Podolsky
Director |
| |
Options(3)
|
| |
79,359股從屬投票股可行使的79,359份期權
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
John R. Walter
Director |
| |
Options(3)
|
| |
79,359股從屬投票股可行使的79,359份期權
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
Gerald F. Corcoran
Director |
| |
Options(3)
|
| |
79,359股從屬投票股可行使的79,359份期權
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
Robert M. Sampson
Director |
| |
Options(3)
|
| |
79,359股從屬投票股可行使的79,359份期權
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
Michele Roberts
Director |
| |
Options(3)
|
| |
62,432個從屬表決權股份可行使的62,432個期權
( |
| |
37,898 on June 29, 2020 and 24,534 on December 16, 2021
|
| |
$4.56 and $10.19, respectively
|
| |
$5.48 and $13.00, respectively
|
| |
$12.55
|
| |
June 29, 2030 and December 16, 2030, respectively
|
|
| | |
補償證券(1)
|
| ||||||||||||||||||
Name and position
|
| |
Type of
compensation security(2) |
| |
Number of
compensation securities, number of underlying securities, and percentage of class |
| |
Date of
issue or grant |
| |
Issue,
conversion or exercise price ($US) |
| |
Closing
price of security or underlying security on date of grant ($CDN) |
| |
Closing
price of security or underlying security at year end ($CDN) |
| |
Expiry
date |
|
Carol Vallone
Director |
| |
Options(3)
|
| |
46,078個從屬表決權股份可行使的46,078個期權
( |
| |
21,544 on July 30, 2020 and 24,534 on December 16, 2020
|
| |
$5.39 and $10.19, respectively
|
| |
$7.56 and $13.00, respectively
|
| |
$12.55
|
| |
July 30, 2030 and December 16, 2030, respectively
|
|
Dominic Sergi
Former Director |
| |
Options(3)
|
| |
79,359股從屬投票股可行使的79,359份期權
( |
| |
54,825 on May 20, 2020 and 24,534 on December 16, 2020
|
| |
$4.56 and $10.19, respectively
|
| |
$6.34 and $13.00, respectively
|
| |
$12.55
|
| |
May 20, 2030 and December 16, 2030, respectively
|
|
Brian McCormack
Former Director |
| |
Options(3)
|
| |
54,825個從屬表決權股份可行使的54,825個期權
( |
| |
May 20, 2020
|
| |
$4.56
|
| |
$6.34
|
| |
$12.55
|
| |
May 20, 2030
|
|
David Ellis
前首席運營官 |
| |
Restricted Share Units(4)
|
| |
59,880股限售股可轉換為59,880股從屬表決權股
( |
| |
September 30, 2020
|
| |
$6.00
|
| |
$8.00
|
| |
$12.55
|
| |
N/A
|
|
| | |
董事和指定高管行使補償證券
|
| ||||||||||||||||||
Name and position
|
| |
Type of
compensation security |
| |
Number of
underlying securities exercised |
| |
Exercise
price per security ($US) |
| |
Date of
exercice |
| |
Closing
price per security on date of exercise ($US) |
| |
Difference
between exercise price and closing price on date of exercise ($US) |
| |
Total value
on exercise date ($US)(1) |
|
Carol Vallone
Director |
| |
Options
|
| |
2,000 Subordinate Voting Shares
|
| |
$5.39
|
| |
December 23, 2020
|
| |
$10.09
|
| |
$4.70
|
| |
$9,400
|
|
Charles Bachtell
董事和首席執行官 |
| |
Options
|
| |
100,000 Subordinate Voting Shares
|
| |
$1.14
|
| |
July 22, 2020
|
| |
$5.29
|
| |
$4.15
|
| |
$415,000
|
|
Ken Amann
前首席財務官 |
| |
Options
|
| |
62,500 Subordinate Voting Shares
|
| |
$2.25
|
| |
January 1, 2020
|
| |
$6.86
|
| |
$4.61
|
| |
$288,125
|
|
Name
|
| |
Name of Reporting Issuer
|
| |
Name of
Exchange or Market |
| |
Position
|
| |
From
|
|
Thomas J. Manning | | |
CommScope Holding Company,Inc.
|
| |
NASDAQ
|
| | Director | | |
2014
|
|
Marc Lustig
|
| |
IM大麻公司(前身為Navasota Resources Inc.)
|
| |
CSE
|
| |
董事非執行主席
|
| |
2019
|
|
| PharmaCeielo Ltd.(前身為AAJ Capital 1 Corp.) | | |
TSXV
|
| | Lead Director | | |
2020
|
| ||
| Aequus PharmPharmticals Inc. | | |
TSXV
|
| | Director | | |
2021
|
|
| Gerald F. Corcoran | | | Independent | | | 懂金融的 | |
| Robert M. Sampson | | | Not Independent | | | 懂金融的 | |
| Randy D. Podolsky | | | Independent | | | 懂金融的 | |
Financial Year Ending
|
| |
Audit Fees(1)
|
| |
Audit-Related
Fees(2) |
| |
Tax Fees
|
| |
All Other Fees
|
| ||||||
December 31, 2020
|
| |
US$1,512,525
|
| |
US$61,800
|
| | | | — | | | | | | — | | |
December 31, 2019
|
| |
US$1,061,415
|
| |
US$66,435
|
| | | | — | | | | | | — | | |
Plan Category
|
| |
Number of Subordinate
Voting Shares to be issued upon exercise of outstanding options, warrants and rights |
| |
加權平均鍛鍊
price of outstanding options, warrants and rights |
| |
Number of Subordinate
Voting Shares remaining available for future issuance under equity compensation plans |
| |||||||||
由
批准的股權薪酬計劃
security holders |
| | | | 23,481,042 | | | | | 美元 | 4.07 | | | | | | 11,542,492 | | |
股權薪酬計劃未獲批准
by security holders |
| | | | — | | | | | | — | | | | | | — | | |
Total
|
| | | | 23,481,042 | | | | | 美元 | 4.07 | | | | | | 11,542,492 | | |
| | |
March 31, 2022
|
| |||||||||||||||||||||||||||
| | |
Columbia Care,
Inc. |
| |
Cresco Labs
Inc. |
| |
Pro-forma
Adjustments |
| | | | | | | |
Pro-forma
Combined |
| ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash
|
| | | $ | 168,424 | | | | | $ | 179,320 | | | | | $ | — | | | | | | | | | | | $ | 347,744 | | |
應收賬款,淨額
|
| | | | 16,550 | | | | | | 48,691 | | | | | | (846) | | | |
(a)
|
| | | | 64,395 | | | |||
Inventory
|
| | | | 109,263 | | | | | | 156,432 | | | | | | (359) | | | |
(b)
|
| | | | 265,336 | | | |||
預付費用和其他流動資產
|
| | | | 27,526 | | | | | | 15,357 | | | | | | — | | | | | | | | | | | | 42,883 | | |
待售資產
|
| | | | 2,120 | | | | | | — | | | | | | — | | | | | | | | | | | | 2,120 | | |
流動資產總額
|
| | | | 323,883 | | | | | | 399,800 | | | | | | (1,205) | | | | | | | | | | | | 722,478 | | |
財產和設備,淨額
|
| | | | 355,968 | | | | | | 394,994 | | | | | | — | | | | | | | | | | | | 750,962 | | |
使用權資產
|
| | | | 250,413 | | | | | | 90,150 | | | | | | — | | | | | | | | | | | | 340,563 | | |
Goodwill
|
| | | | 184,018 | | | | | | 448,336 | | | | | | — | | | | | | | | | | | | 632,354 | | |
無形資產,淨額
|
| | | | 355,583 | | | | | | 435,930 | | | | | | — | | | | | | | | | | | | 791,513 | | |
其他非流動資產
|
| | | | 12,578 | | | | | | 15,727 | | | | | | — | | | | | | | | | | | | 28,305 | | |
Total assets
|
| | | $ | 1,482,443 | | | | | $ | 1,784,937 | | | | | $ | (1,205) | | | | | | | | | | | $ | 3,266,175 | | |
負債和股權 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
流動負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
應付賬款
|
| | | $ | 26,130 | | | | | $ | 33,285 | | | | | $ | (846) | | | |
(a)
|
| | | $ | 58,569 | | | |||
應計費用和其他流動負債
|
| | | | 118,315 | | | | | | 95,962 | | | | | | 37,060 | | | |
(f)
|
| | | | 251,337 | | | |||
應付所得税
|
| | | | 31,709 | | | | | | 64,180 | | | | | | (100) | | | |
(g)
|
| | | | 95,789 | | | |||
或有對價
|
| | | | 29,345 | | | | | | 86,619 | | | | | | — | | | | | | | | | | | | 115,964 | | |
租賃責任的當期部分
|
| | | | 14,517 | | | | | | 21,137 | | | | | | — | | | | | | | | | | | | 35,654 | | |
長期債務的當期部分,淨額
|
| | | | 1,697 | | | | | | 29,202 | | | | | | 38,582 | | | |
(e)
|
| | | | 69,481 | | | |||
衍生負債
|
| | | | — | | | | | | 809 | | | | | | — | | | | | | | | | | | | 809 | | |
持有待售的負債
|
| | | | 1,122 | | | | | | — | | | | | | — | | | | | | | | | | | | 1,122 | | |
流動負債總額
|
| | | | 222,835 | | | | | | 331,194 | | | | | | 74,696 | | | | | | | | | | | | 628,725 | | |
長期債務,淨額
|
| | | | 306,387 | | | | | | 466,076 | | | | | | (38,200) | | | | | | (e) | | | | | | 734,263 | | |
遞延税金
|
| | | | 74,917 | | | | | | 84,206 | | | | | | — | | | | | | | | | | | | 159,123 | | |
長期租賃責任
|
| | | | 251,519 | | | | | | 124,104 | | | | | | — | | | | | | | | | | | | 375,623 | | |
或有對價
|
| | | | 11,680 | | | | | | 8,607 | | | | | | — | | | | | | | | | | | | 20,287 | | |
衍生負債
|
| | | | 7,478 | | | | | | — | | | | | | — | | | | | | | | | | | | 7,478 | | |
其他長期負債
|
| | | | 77,927 | | | | | | 7,005 | | | | | | — | | | | | | | | | | | | 84,932 | | |
總負債
|
| | | | 952,743 | | | | | | 1,021,192 | | | | | | 36,496 | | | | | | | | | | | | 2,010,431 | | |
Stockholders’ Equity: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
股本和額外實收資本
|
| | | | 1,046,509 | | | | | | 1,607,008 | | | | | | 28,851 | | | | | | | | | | | | 2,682,368 | | |
累計赤字
|
| | | | (494,971) | | | | | | (880,395) | | | | | | (66,552) | | | |
(a) (b) (c) (d)
|
| | | | | | | |||
| | | | | | | | | | | | | | | | | | | | |
(e) (f) (g)
|
| | | | (1,441,918) | | | |||
公司應佔權益
|
| | | | 551,538 | | | | | | 726,613 | | | | | | (37,701) | | | | | | | | | | | | 1,240,450 | | |
非控股權益
|
| | | | (21,838) | | | | | | 37,132 | | | | | | | | | | | | | | | | | | 15,294 | | |
Total equity
|
| | | | 529,700 | | | | | | 763,745 | | | | | | (37,701) | | | | | | | | | | | | 1,255,744 | | |
負債和權益合計
|
| | | $ | 1,482,443 | | | | | $ | 1,784,937 | | | | | $ | (1,205) | | | | | | | | | | | $ | 3,266,175 | | |
| | |
Three Months ended March 31, 2022
|
| | ||||||||||||||||||||||||||
| | |
Columbia Care,
Inc. |
| |
Cresco Labs
Inc. |
| |
Pro-forma
Adjustments |
| | | | |
Pro-forma
combined |
| | ||||||||||||||
| | |
Three Months Ended March 31, 2022
|
| | | | ||||||||||||||||||||||||
扣除折扣後的收入
|
| | | $ | 123,087 | | | | | $ | 214,391 | | | | | $ | (1,778) | | | |
(a)
|
| | | $ | 335,700 | | | | ||
與庫存生產相關的銷售成本
|
| | | | (66,460) | | | | | | (107,018) | | | | | | 1,419 | | | |
(a)
|
| | | | (172,059) | | | | ||
Gross profit
|
| | | | 56,627 | | | | | | 107,373 | | | | | | (359) | | | | | | | | | 163,641 | | | | ||
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
銷售、一般和行政
|
| | | | 71,292 | | | | | | 87,106 | | | | | | 65,911 | | | |
(b)(d)
|
| | | | 224,309 | | | | ||
減值損失
|
| | | | — | | | | | | — | | | | | | | | | | | | | | | — | | | | ||
總運營費用
|
| | | | (71,292) | | | | | | (87,106) | | | | | | (65,911) | | | | | | | | | (224,309) | | | | ||
運營虧損
|
| | | | (14,665) | | | | | | 20,267 | | | | | | (66,270) | | | | | | | | | (60,668) | | | | ||
Other expense: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
租賃利息支出,淨額
|
| | | | (1,426) | | | | | | (994) | | | | | | — | | | | | | | | | (2,420) | | | | ||
利息支出,淨額
|
| | | | (11,244) | | | | | | (13,369) | | | | | | (382) | | | |
(c)
|
| | | | (24,995) | | | | ||
其他(費用)收入,淨額
|
| | | | 61 | | | | | | (6,772) | | | | | | — | | | | | | | | | (6,711) | | | | ||
其他費用合計
|
| | | | (12,609) | | | | | | (21,135) | | | | | | (382) | | | | | | | | | (34,126) | | | | ||
計提所得税準備前的虧損
|
| | | | (27,274) | | | | | | (868) | | | | | | (66,652) | | | | | | | | | (94,794) | | | | ||
所得税(費用)福利,淨額
|
| | | | (632) | | | | | | (22,807) | | | | | | 100 | | | |
(e)
|
| | | | (23,339) | | | | ||
淨虧損和綜合虧損
|
| | | | (27,906) | | | | | | (23,675) | | | | | | (66,552) | | | | | | | | | (118,133) | | | | ||
非控股權益的淨(虧損)收入
|
| | | | (1,270) | | | | | | 3,706 | | | | | | — | | | | | | | | | 2,436 | | | | ||
股東應佔淨虧損
|
| | | $ | (26,636) | | | | | $ | (27,381) | | | | | $ | (66,552) | | | | | | | | $ | (120,569) | | | | ||
加權平均每股收益 - 基本和稀釋後使用的股數
|
| | | | 376,397,260 | | | | | | 292,719,359 | | | | | | (161,057,679) | | | |
(f)
|
| | | | 508,058,940 | | | | ||
可歸屬於股票的收益(基本收益和稀釋收益)
|
| | | $ | (0.07) | | | | | $ | (0.09) | | | | | $ | 0.41 | | | | | | | | $ | (0.24) | | | |
| | |
December 31, 2021
|
| ||||||||||||||||||||||||
| | |
Columbia Care,
Inc. |
| |
Cresco Labs
Inc. |
| |
Pro-forma
Adjustments |
| | | | |
Pro-forma
Combined |
| ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash
|
| | | $ | 82,198 | | | | | $ | 223,543 | | | | | | | | | | | | | | $ | 305,741 | | |
應收賬款,淨額
|
| | | | 18,302 | | | | | | 43,379 | | | | | | (598) | | | |
(a)
|
| | | | 61,083 | | |
Inventory
|
| | | | 94,567 | | | | | | 136,643 | | | | | | (266) | | | |
(b)
|
| | | | 230,944 | | |
預付費用和其他流動資產
|
| | | | 29,252 | | | | | | 18,190 | | | | | | | | | | | | | | | 47,442 | | |
待售資產
|
| | | | 2,120 | | | | | | — | | | | | | | | | | | | | | | 2,120 | | |
流動資產總額
|
| | | | 226,439 | | | | | | 421,755 | | | | | | (864) | | | | | | | | | 647,330 | | |
財產和設備,淨額
|
| | | | 339,692 | | | | | | 369,092 | | | | | | | | | | | | | | | 708,784 | | |
使用權資產
|
| | | | 245,541 | | | | | | 88,017 | | | | | | | | | | | | | | | 333,558 | | |
Goodwill
|
| | | | 184,018 | | | | | | 446,767 | | | | | | | | | | | | | | | 630,785 | | |
無形資產,淨額
|
| | | | 367,787 | | | | | | 437,644 | | | | | | | | | | | | | | | 805,431 | | |
其他非流動資產
|
| | | | 13,035 | | | | | | 17,188 | | | | | | | | | | | | | | | 30,223 | | |
Total assets
|
| | | $ | 1,376,512 | | | | | $ | 1,780,463 | | | | | $ | (864) | | | | | | | | $ | 3,156,111 | | |
負債和股權 | | | | | | | | | | | | | | | | | | | | | | |||||||
流動負債: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
應付賬款
|
| | | $ | 44,007 | | | | | $ | 32,278 | | | | | $ | (598) | | | |
(a)
|
| | | $ | 75,687 | | |
應計費用和其他當期費用
liabilities |
| | | | 126,954 | | | | | | 95,442 | | | | | | 30,324 | | | |
(f)
|
| | | | 252,720 | | |
應付所得税
|
| | | | 26,537 | | | | | | 46,949 | | | | | | (72) | | | |
(g)
|
| | | | 73,414 | | |
或有對價
|
| | | | 29,345 | | | | | | 71,833 | | | | | | | | | | | | | | | 101,178 | | |
租賃責任的當期部分
|
| | | | 14,148 | | | | | | 20,792 | | | | | | | | | | | | | | | 34,940 | | |
長期債務的當期部分,淨額
|
| | | | 1,884 | | | | | | 19,928 | | | | | | 38,582 | | | |
(e)
|
| | | | 60,394 | | |
衍生負債
|
| | | | — | | | | | | 1,172 | | | | | | | | | | | | | | | 1,172 | | |
持有待售的負債
|
| | | | 1,122 | | | | | | — | | | | | | | | | | | | | | | 1,122 | | |
流動負債總額
|
| | | | 243,997 | | | | | | 288,394 | | | | | | 68,237 | | | | | | | | | 600,628 | | |
長期債務,淨額
|
| | | | 159,017 | | | | | | 465,079 | | | | | | (38,200) | | | |
(e)
|
| | | | 585,896 | | |
遞延税金
|
| | | | 79,477 | | | | | | 85,666 | | | | | | | | | | | | | | | 165,143 | | |
長期租賃責任
|
| | | | 246,272 | | | | | | 118,936 | | | | | | | | | | | | | | | 365,208 | | |
或有對價
|
| | | | 11,596 | | | | | | 17,651 | | | | | | | | | | | | | | | 29,247 | | |
衍生負債
|
| | | | 6,795 | | | | | | — | | | | | | | | | | | | | | | 6,795 | | |
其他長期負債
|
| | | | 78,535 | | | | | | 7,001 | | | | | | | | | | | | | | | 85,536 | | |
總負債
|
| | | | 825,689 | | | | | | 982,727 | | | | | | 30,037 | | | | | | | | | 1,838,453 | | |
Stockholders’ Equity: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
股本和其他
實收資本 |
| | | | 1,039,726 | | | | | | 1,597,461 | | | | | | 28,851 | | | | | | | | | 2,666,038 | | |
累計赤字
|
| | | | (468,335) | | | | | | (841,907) | | | | | | (59,752) | | | |
(a) (b) (c)
|
| | | | (1,369,994) | | |
| | | | | | | | | | | | | | | | | | | | |
(d) (e) (f) (g)
|
| | | | | | |
公司應佔權益
|
| | | | 571,391 | | | | | | 755,554 | | | | | | (30,901) | | | | | | | | | 1,296,044 | | |
非控股權益
|
| | | | (20,568) | | | | | | 42,182 | | | | | | | | | | | | | | | 21,614 | | |
Total equity
|
| | | | 550,823 | | | | | | 797,736 | | | | | | (30,901) | | | | | | | | | 1,317,658 | | |
負債和權益合計
|
| | | $ | 1,376,512 | | | | | $ | 1,780,463 | | | | | $ | (864) | | | | | | | | $ | 3,156,111 | | |
| | |
Year ended December 31, 2021
|
| ||||||||||||||||||||||||
| | |
Columbia Care, Inc.
|
| |
Cresco Labs Inc.
|
| |
Pro-forma
Adjustments |
| | | | |
Pro-forma
combined |
| ||||||||||||
| | |
Year ended December 31, 2021
|
| ||||||||||||||||||||||||
扣除折扣後的收入
|
| | | $ | 460,080 | | | | | $ | 821,682 | | | | | $ | (6,367) | | | |
(a)
|
| | | $ | 1,275,395 | | |
與庫存生產相關的銷售成本
|
| | | | (266,065) | | | | | | (415,335) | | | | | | 6,101 | | | |
(a)
|
| | | | (675,299) | | |
Gross profit
|
| | | | 194,015 | | | | | | 406,347 | | | | | | (266) | | | | | | | | | 600,096 | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
銷售、一般和行政
|
| | | | 232,052 | | | | | | 317,804 | | | | | | 59,175 | | | |
(b) (d)
|
| | | | 609,031 | | |
減值損失
|
| | | | 72,328 | | | | | | 305,894 | | | | | | | | | | | | | | | 378,222 | | |
總運營費用
|
| | | | (304,380) | | | | | | (623,698) | | | | | | (59,175) | | | | | | | | | (987,253) | | |
營業收入(虧損)
|
| | | | (110,365) | | | | | | (217,351) | | | | | | (59,441) | | | | | | | | | (387,157) | | |
Other expense: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
租賃利息(費用)收入,淨額
|
| | | | (5,280) | | | | | | (4,100) | | | | | | — | | | | | | | | | (9,380) | | |
利息支出,淨額
|
| | | | (24,734) | | | | | | (47,111) | | | | | | (382) | | | |
(c)
|
| | | | (72,227) | | |
其他費用,淨額
|
| | | | (6,335) | | | | | | 11,835 | | | | | | — | | | | | | | | | 5,500 | | |
其他費用合計
|
| | | | (36,349) | | | | | | (39,376) | | | | | | (382) | | | | | | | | | (76,107) | | |
未計提所得税準備的收入(虧損)
|
| | | | (146,714) | | | | | | (256,727) | | | | | | (59,823) | | | | | | | | | (463,264) | | |
所得税優惠(費用)
|
| | | | (139) | | | | | | (40,107) | | | | | | 72 | | | |
(e)
|
| | | | (40,174) | | |
淨(虧損)收益和綜合(虧損)收益
|
| | | | (146,853) | | | | | | (296,834) | | | | | | (59,752) | | | | | | | | | (503,439) | | |
非控股權益的淨(虧損)收入
|
| | | | (3,756) | | | | | | 22,763 | | | | | | — | | | | | | | | | 19,007 | | |
股東應佔淨虧損
|
| | | $ | (143,097) | | | | | $ | (319,597) | | | | | $ | (59,752) | | | | | | | | $ | (522,446) | | |
加權平均每股收益 - 基本和稀釋後使用的股數
|
| | | | 338,754,694 | | | | | | 262,326,138 | | | | | | (144,415,901) | | | |
(f)
|
| | | | 456,664,931 | | |
可歸屬於股票的收益(基本收益和稀釋收益)
|
| | | $ | (0.42) | | | | | $ | (1.22) | | | | | $ | 0.41 | | | | | | | | $ | (1.14) | | |